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The morphogen transforming growth factor β (TGFβ) can initiate diverse cellular 
responses associated with development, cancer, and fibrosis.  TGFβ signaling results in 
down-regulation of numerous antioxidant species but itself has been shown to exhibit 
redox sensitivity.  In the context of TGFβ-mediated epithelial-mesenchymal transition 
(EMT), there exists a possibility of a positive feedback loop operating over multiple 
temporal and biological scales to stabilize a mesenchymal phenotype.  Additionally, 
drug-resistant side populations (SP) arise in populations that exhibit heterogeneity of 
activity of a glutathione transporter, ABCG2, which is regulated within the same cellular 
program as antioxidants.  Therefore, it is possible that SPs reflect heterogeneity in redox 
regulation within a population; however, how single-cell ABCG2 activity heterogeneity 
manifests population level characteristics is not known.  The overall objective of this 
research was to investigate the relationship of redox-regulated processes to the complex 
phenotypes that arise in the context of TGFβ-mediated EMT using multivariate modeling 
approaches. 
The dynamics of redox regulation were investigated in the context of EMT, based 
upon the hypothesis that decreased nucleophilic tone acquired during EMT strengthens 
TGFβ signaling, enhancing acquisition and stabilization of the mesenchymal phenotype.  
Customized in-cell western assays were developed to evaluate multivariate phenotype 
states as they developed during EMT.  TGFβ treatment decreased H2O2 degradation rates 
and increased glutathione (GSH) redox potential, indicating decreased nucleophilic tone.  
 xvii 
Epithelial/mesenchymal differentiation markers and redox time course data were paired 
using principal component analysis (PCA) to construct a multivariate representation of 
phenotype over the time course of EMT.  Decreased nucleophilic tone during EMT 
coincided with acquisition of a mesenchymal phenotype over time scales too large to 
enable enhancement of EMT. 
Next, the role of heterogeneity in the activity levels of a GSH transporter, 
ABCG2, was investigated at the single cell level for the emergence of drug-resistant SPs 
at the population level.  The objective was to develop a multiscale ensemble model 
consisting of a heterogeneous population of individual cells to interrogate multiple 
kinetic schemas and determine the means by which TGFβ signaling modulates 
heterogeneity to affect SP size.  TGFβ was found to decrease the size of SPs as well as 
the magnitude of response.  A highly active subpopulation juxtaposed by an inactive 
main population was identified, suggesting the SP cells may exhibit a distinct redox 
profile from main cells, the frequency of which was decreased with TGFβ.  
In summary, this work represents systems approaches to investigate the dynamics 
of redox regulation during TGFβ-mediated EMT from the perspective of a multivariate 
phenotype, simultaneously accounting for changes in epithelial/mesenchymal 
differentiation and to the intracellular redox environment.  Additionally, an outcome of 
this project is a multiscale ensemble modeling methodology that is generalizable for 
future mechanistic studies of drug intracellular interactions that influence multivariate 








1.1.1 Phenotype Transitions Drive Cancer Progression 
Cancers are the second leading cause of mortality in adults in the United States 
(Murphy et al., 2013) and globally (World Health Organization, 2012).  Growth of 
cancerous tumors arises from a series of transformations cellular phenotype that enable 
cancer cells to engage in continuous proliferation and escape both intrinsic and extrinsic 
inhibitory signals. (Hanahan and Weinberg, 2011)  Secondary tumors, or metastases, 
exhibiting resistance to therapy represent the most substantial disease burden in cancer 
patients and arise when cells from a primary tumor acquire the capability to escape the 
local environment and survive in secondary tissues. (Talmadge and Fidler, 2010)  Thus, 
the acquisition of phenotypic traits that enable cancer cells to migrate, invade tissues, and 
escape chemotherapeutic-mediated killing represent significant milestones in the course 
of carcinogenesis. 
Epithelial-mesenchymal transition (EMT) is a form of cellular transdifferentiation 
in which cells of an epithelial origin acquire mesenchymal phenotypic traits.  Nascent 
mesenchymal traits following EMT include decreased cell-to-cell adhesion, cytoskeletal 
remodeling, and an enhanced ability to interact with extracellular matrix (ECM), which 
confer migratory and invasive properties. (Zavadil and Böttinger, 2005)  Carcinoma cells, 
being of epithelial origin, can employ EMT as a means to dissociate and migrate from the 
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primary tumor, invade surrounding tissues and potentially gain access to the circulatory 
system. (Thiery, 2002)  Investigating the control of entry into an EMT program is, 
therefore, of particular significance for understanding the mechanisms that drive 
development of malignant states. 
1.1.2 Transforming Growth Factor β Promotes EMT 
EMT is a key process during normal growth and development, which is tightly 
regulated; however, acquisition of aberrant cellular signaling in cancer cells can prime 
them for entry into the transdifferentiation process through exposure to the morphogen 
transforming growth factor β (TGFβ). (Janda et al., 2002; Xie et al., 2004)  TGFβ 
activates Smad2 and Smad3 transcription factors, which initiate an extensive 
transcriptional response that results in the conversion of epithelial to mesenchymal 
differentiation states. (Valcourt et al., 2005)  The investigation of TGFβ-mediated EMT 
is complex, because EMT is inherently a process defined by a multitude of phenotypic 
responses. (Thiery and Sleeman, 2006)  Additionally, as a morphogen, TGFβ initiates a 
pleiotropic response and its effects differ depending on the particular cellular context. 
(Ahmed and Nawshad, 2007; Ranganathan et al., 2007)  However, activation of Smad3 is 
clearly a critical component in the initiation of TGFβ-mediated EMT. (Borthwick et al., 
2012; Dzwonek et al., 2009; Jinnin, 2005; Vincent et al., 2009)   
1.1.3 Bidirectional Regulation Between Redox Processes & TGFβ 
Oxidation-reduction (redox) reactions are by definition chemical reactions 
involving electron transfer from a nucleophile to an electrophile.  In a cellular context, 
reactive oxygen species (ROS) are electrophiles that are byproducts of cellular 
metabolism or primary products of enzymatic activity. (Winterbourn, 2008)  Antioxidants 
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are nucleophiles that exhibit exceptional reactivity with ROS and counterbalance against 
ROS, preventing excess accumulation within the cell. (Lyakhovich et al., 2006)  
Extensive cellular systems exist to detect the redox state of the cell and to buffer 
chemical insults. (Hurd and Murphy, 2009; Ortiz de Orué Lucana, 2012) Alteration of the 
redox balance by increasing antioxidants (increased nucleophilic tone) or by decreasing 
antioxidants (decreased nucleophilic tone) has the potential to significantly affect 
intracellular processes, such as metabolism and signal transduction. 
Down-regulation of a variety of intracellular antioxidants is among the numerous 
cellular responses to TGFβ signaling. (Arsalane et al., 1997; Boudreau et al., 2012; 
Felton et al., 2009; Hecker et al., 2009; Lee et al., 2010; Peltoniemi et al., 2004; Zhang et 
al., 2009)  Meanwhile, antioxidants antagonize Smad3 activation by TGFβ (Cucoranu et 
al., 2005; Fatma et al., 2009; Meurer et al., 2005; Michaeloudes et al., 2011; Ono et al., 
2009) and prevent TGFβ-mediated EMT (Felton et al., 2009; Lee et al., 2010; 
Michaeloudes et al., 2011; Rhyu et al., 2005; Zhang et al., 2009).  The down-regulation 
of antioxidants during the course of EMT may have a critical role in the enabling or 
enhancement of TGFβ signaling. 
1.1.4 Drug Resistance Mediated by Redox Related Transporter  
Chemotherapeutic drug resistance is another mechanism driving carcinogenesis.  
A major mechanism for acquiring a multidrug resistance (MDR) phenotype is through 
elevated expression of transporters on the plasma membrane that efflux a diverse 
substrate repertoire, including various chemotherapeutic agents. (Sharom, 2008) The 
ABCG2 transporter, for example, is capable of inducing a MDR phenotype. (Stacy et al., 
2013)  The antioxidant GSH is among the many substrates exported by ABCG2 and 
 4 
transcriptional programs that control ABCG2 up-regulation also control antioxidant 
expression. (Brechbuhl et al., 2010; Ji et al., 2013)  Therefore, MDR cells may also 
exhibit increased antioxidant activity.  
MDR phenotypes can be assessed through a functional assay for ABCG2 
transporter activity.  In a cellular staining assay, cells with high transporter activity do not 
take up as much dye as the rest of the cells, which results in a discernible subpopulation 
upon flow cytometric analysis. (Hirschmann-Jax et al., 2004)  This subpopulation, the so-
called side population (SP), is recognized as a source of highly tumorigenic cancer cells. 
(Wu and Alman, 2008)  Thus the presence of a SP reflects heterogeneity of transporter 
activity within a cell line; however, the actual kinetic mechanisms responsible SP 
formation are unclear.  TGFβ signaling, like antioxidants, leads to the down-regulation of 
ABCG2 as well as the size of the SP.  This modulation of the SP size may be a good 
setting in which the kinetic mechanisms that generate a SP and are responsible for MDR 
can be uncovered. 
1.2 Overall Objective 
Transformation of cancer cells via TGFβ signaling results in wide spread 
phenotypic responses, including transdifferentiation via EMT, remodeling of the 
intracellular redox environment through antioxidant down-regulation, and reduction of 
SP size.  TGFβ signaling itself is inhibited by antioxidants.  The possibility, therefore, 
exists that TGFβ-mediated modification of the redox environment functions to further 
enhance TGFβ signaling.  The ABCG2 transporter shares an upstream regulator with 
antioxidants and may directly participate in redox processes through transport of 
glutathione.  Side populations are population-level phenotypes that arise when a 
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subpopulation of cells expresses elevated ABCG2 transporter-mediated efflux.  
Therefore, the presence of a SP in a population may reflect heterogeneity of redox 
regulation within a population; however, how heterogeneity of ABCG2 activity manifests 
at a basic kinetic level is not understood.  The overall objective of this research was to 
investigate how redox regulated processes contribute to complex phenotypes that 
arise in the context of TGFβ-mediated EMT using multivariate and systems 
approaches.  The central hypothesis of this dissertation is that differential activation of 
antioxidant pathways operates across multiple temporal or physical scales, but within 
specific constraints, to define complex phenotypes during TGFβ-mediated EMT.  
Specifically, TGFβ down-regulates intracellular antioxidant function at the scale of gene 
transcription, mediated by Smad3, which renders the intracellular environment more 
conducive to Smad3 activation at the level of signal transduction such that a positive 
feedback loop is established that stabilizes mesenchymal differentiation.  Additionally, 
co-regulation of ABCG2 with antioxidant genes will result in decreased SP size, a 
population level property, following TGFβ-mediated EMT through heterogeneous 
attenuation of transporter activity at the single-cell level.   
These hypotheses were tested by first establishing the co-existence of TGFβ-
mediated regulation of the redox environment with redox regulation of TGFβ signaling 
within the same experimental context, then by implementing multivariate approaches to 
simultaneously investigate the time courses of TGFβ signaling, redox regulation, and 
epithelial-mesenchymal transition.  Finally, the role of single-cell heterogeneity of 
ABCG2 activity within a population during TGFβ-mediated EMT was investigated 
through multiscale computational modeling. 
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1.3 Specific Aim 1: Define The Biological Scales In Which Redox Regulation Of 
And In Response To TGFβ Occur Within A Singular Experimental Model 
The relationship between the intracellular redox environment and TGFβ is 
multifaceted.  TGFβ is known to remodel the intracellular redox environment through 
enhancement of ROS production and antioxidant down-regulation while TGFβ signaling 
can be inhibited by antioxidants or enhanced by ROS.  However, most investigations 
study these processes in isolation of one another and it was not known if both redox 
relationships could coincide within the same experimental model.  The hypothesis of 
Specific Aim 1 was that A549 cells down-regulate antioxidants in response to TGFβ 
signaling and attenuate TGFβ signaling by antioxidant functions.  Using biochemical 
techniques, we demonstrated the loss of epithelial phenotypic markers and acquisition of 
mesenchymal phenotypic markers following TGFβ treatment.  We also observed 
decreased expression of antioxidants proteins coupled with upregulation of NOX4, a 
source of ROS, which coincided with increased oxidation of a redox sensitive dye.  
Additionally, we demonstrated the sensitivity to inhibition of TGFβ-mediated signal 
transduction (Smad3 activation), transcription (Smad3 promoter activity), and phenotypic 
transition (E-cadherin downregulation) by intracellular antioxidants.  Therefore, we 
identified multiple relationships between TGFβ and the redox environment, operating at 
multiple biological scales, within the same experimental model. 
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1.4 Specific Aim 2: Interrogate The Roles And Time Scales Of Regulation Of The 
Redox Environment And TGFβ Signaling In The Context Of EMT Using 
Multivariate Analysis 
Following TGFβ treatment, A549 cells exhibit mesenchymal differentiation and a 
perturbed redox environment, including downregulation of antioxidants.  The resultant 
phenotype represents the culmination of a dynamic process, during which the multiple 
aspects of the TGFβ/redox relationship can operate.  Whether TGFβ signaling and redox 
processes integrate across multiple time scales to drive EMT is unknown.  The hypothesis 
of Specific Aim 2 was that increased cellular oxidation during TGFβ-mediated EMT 
reinforces TGFβ signaling in a feed-forward manner during EMT as well as contribute to 
maintenance of mesenchymal phenotype.  Using custom in-cell western blotting (ICW) 
assay, we interrogated the multivariate phenotype of A549 cells during the course of 
EMT.  Through principal component analysis (PCA) we were able to reduce the number 
of dimensions in the data into multivariate phenotype trajectories.  PCA was then applied 
to an extensive microarray data set in which it was identified that TGFβ treatment 
resulted in widespread downregulation of cellular antioxidants in parallel time course 
with epithelial-mesenchymal transdifferentiation.  Redox reprogramming was extensive, 
resulting in functional modification that decreased nucleophilic tone and impaired the 
cell’s ability to eliminate electrophilic insults.  Finally, we challenged TGFβ-transformed 
cells with antioxidants and found the resultant mesenchymal phenotype to be stable to 
redox perturbation.  Therefore, we find that during TGFβ-mediated EMT, regulation of 
the redox environment coincides with transdifferentiation and that redox-enhanced 
TGFβ-signaling is unlikely to promote EMT or stabilize the mesenchymal phenotype. 
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1.5 Specific Aim 3: Define The Role Of Transporter Heterogeneity On The 
Emergence Of Side Populations And Dynamic Regulation Of Side Populations 
During TGFβ-Mediated EMT.  
ABCG2 transporter shares transcriptional regulation with many antioxidants.  
During TGFβ-mediated EMT, down-regulation of ABCG2 results in decreased SP size; 
however, it is not understood how single-cell heterogeneity of ABCG2 activity can 
manifest within the population as a SP nor is it known how TGFβ-mediated down-
regulation of transporter activity modulates the SP size.  The hypothesis of Specific Aim 3 
was that the transporter activity of SP cells is significantly higher than that of NSP cells 
and that that down-regulation of ABCG2 during EMT results in decreased frequency of 
high transporter-activity cells, suppressing the size of the SP.  In A549 cells we observed 
that SP size was dynamic in culture, which was attenuated with TGFβ treatment, where 
SP size was correlated with ABCG2 expression.  To counteract the subjective nature of 
the conventional SP measurement, we developed objective tools to measure SP size, and 
validated these tools with a new experimental condition using the antioxidant tBHQ to 
increase SP size.  Using the newly developed tools, we implemented a multiscale model 
in which heterogeneity of transporter activity was simulated at the single-cell level as 
means to investigate emergence of a SP at the population level.  We found that SPs 
formed within kinetic scenarios in which a majority of the cell population exhibited very 
little transporter activity while a subpopulation of cells exhibited transporter activity in 
proportion to SP size and with a frequency proportional to SP size.  These results indicate 
that within cell populations exhibiting a SP, a small subpopulation of cells exhibits much 
greater transporter activity than the majority of the population.   
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CHAPTER 2  LITERATURE REVIEW 
 
 
2.1 Redox Species & Processes 
2.1.1 Hydrogen Peroxide in Redox Biology 
Reactive oxygen species (ROS) participate in a wide variety of cellular processes, 
including metabolism and signal transduction.  When electrophiles, such as ROS, accept 
donated electrons from a nucleophile in a chemical reaction, we describe the event as an 
oxidation-reduction reaction, or redox reaction.  ROS is also a general term used to 
describe a class of oxygen-containing chemical species including hydrogen peroxide 
(H2O2), superoxide (O2˙
-
), hydroxyl radical (˙OH), and others. (Murphy et al., 2011)  
Each ROS is a distinct chemical entity, with unique reactive properties.  Radical species, 
such as O2˙
-
 and ˙OH, are distinct from non-radical species, such as H2O2, in that they 
possess an unpaired electron, which upon reaction can initiate a chain reaction until 
reacting with another radical species in 1-electron transfer reactions. (Nordberg and 
Arnér, 2001)  The radicals O2˙
-
 and ˙OH are also distinguished from H2O2 by their 
exceptionally short lifetimes in the cell.  Where ˙OH is short-lived due to indiscriminate 
reactivity with nearby biomolecules, O2˙
-
 is short lived because of the exceptionally fast 
reaction kinetics of superoxide dismutase (SOD). (Winterbourn, 2008) The short 
lifetimes, lack of reaction specificity, and potential to initiate free radical chain reactions 
preclude O2˙
-
 and ˙OH from participating as redox regulators of signal transduction. 
(Forman et al., 2010)  H2O2 is, relatively, much more stable than O2˙
-
 and ˙OH, with 
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extracellular diffusion scales on the order of 1 mm, and on the order of 5 µm within the 
intracellular compartment, where it is subject to degradation by antioxidant clearance 
systems. (Winterbourn, 2008)  With appropriate scales of diffusion and favorable 
reaction kinetics, H2O2 engages in specific reversible 2-electron reactions with protein 
thiols. (Forman et al., 2010)  The favorable chemistries of H2O2 position it to be the 
primary ROS responsible for exerting control in biological systems through redox 
mechanisms.  
2.1.2 Control of the Redox State 
It is critical that signaling systems demonstrate the capacity to initiate and 
terminate signals.  In cellular systems, a vast network of biochemical pathways produces 
and degrades ROS in a context dependent manner.  Incomplete reduction of oxygen in 
mitochondria during oxidative phosphorylation results in the formation of O2˙
-
, which is 
rapidly dismutated by SOD into H2O2, which can diffuse into other parts of the cell and 
engage in redox signaling through reversible thiol oxidation. (Murphy, 2009)  NADPH 
oxidases are a group of membrane bound enzymes that operate in a wide array of 
biochemical processes, such as microbial killing (Parkos et al., 1987) and sensing 
metabolic states (Owada et al., 2013).  A number of the NOX members (NOX1, NOX1, 
NOX3, NOX5) produce O2˙
-
 while others (NOX4, DUOX1, DUOX2) produce H2O2. 
(Leto et al., 2009; Takac et al., 2011)  Whether H2O2 is derived from a stimulated source, 
such as NOX enzymes, as part of metabolic activity in the mitochondria, or through 
interactions with the environment, once inside a cell, the diffusion of H2O2 is much more 
restricted than in the extracellular space.  Cellular antioxidant systems, such as 
peroxiredoxins and glutaredoxins, quickly react with H2O2, thereby limiting the potential 
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range of H2O2 activity to targets proximal to the source. (Winterbourn, 2008)  An 
antioxidant is a nucleophile and when referenced in general terms, represents a collection 
of nucleophilic species with diverse chemical properties.  The robustness of a cells 
capacity to negate an electrophilic insult is characterized as the nucleophilic tone of the 
cell where a larger nucleophilic tone reflects an enhanced antioxidant capacity.  Perturbed 
regulation leading to an inadequate nucleophilic tone for a given electrophilic challenge 
would reflect a state of oxidative stress. (Forman et al., 2014) 
Electrophilic insults can present through a variety of chemical mechanisms.  Each 
of the antioxidant enzymes has as distinct role in the coordinated elimination of specific 
electrophilic insults.  The thioredoxin/thioredoxin redutase system operates primarily to 
maintain balance of disulfides, an oxidized configuration of containing sulfur-sulfur 
bonds, including protein dithiols and other antioxidant such as peroxiredoxins. (Lu and 
Holmgren, 2013) Peroxiredoxins are found in high abundance in cells, exhibiting very 
high reactivity towards peroxides and other reactive species. (Poole et al., 2011)  
Glutathione (GSH) is an important and high abundance tripeptide antioxidant having a 
role in antioxidant defense mechanisms as well as in redox regulation of signaling. (Lu, 
2013) Glutathione is found in the reduced state (GSH) and oxidized state (GSSG) in the 
cell where glutathione peroxidase, among others, can reduce a substrate, such as 
hydrogen peroxide, at the expense of oxidizing GSH, converting 2 GSH into GSSG.  
Glutahione reductase subsequently reduces GSSG. (Lillig et al., 2008)  Though numerous 
cellular antioxidants participate in cellular signaling of some form, GSH has a unique role 
in the redox regulation of signaling. 
 12 
2.1.3 Redox Signaling via S-Glutathionylation 
H2O2 is the prototypical example of a ROS possessing proper traits to operate as a 
second messenger in signal transduction; however, there are several other species with 
similar chemistries.  H2O2, peroxinitrie, and peroxynitrous acid react via 2-electron 
oxidation with protein thiols to form sulfenic acid adducts. (Bindoli and Rigobello, 2013; 
Radi et al., 1991; Trujillo and Radi, 2002)  Sulfenic acids are highly labile, reacting 
rapidly with abundant GSH in a process of S-glutathionylation, which can be reversed by 
antioxidants such as thioredoxin or glutaredoxin. (Grek et al., 2013)  The post-
translational GSH modification of a protein can have a role in inactivating or localizing to 
specific cellular compartments. (Janssen-Heininger et al., 2013)  The vast intracellular 
antioxidant networks are charged with the task of buffering exogenous and endogenous 
electrophilic challenges to protect the integrity of intracellular redox signaling pathways. 
2.2 Epithelial-Mesenchymal Transition in Cancer 
2.2.1 Defining Features of EMT 
Epithelial-mesenchymal transition (EMT) is a form of cellular transdifferentiation 
in which cells of an epithelial origin acquire mesenchymal phenotypic traits.  The 
transition is accompanied by a loss of cell-to-cell contacts, loss of apical-basal polarity, 
increased processing of and interaction with the extracellular matrix, enhanced motility, 
and resistance to apoptosis. (Savagner, 2010)  A switch of relative abundances of E-
cadherin and N-cadherin form the basis of the cadherin switch during EMT. (Araki et al., 
2011; Hazan et al., 2004; Maeda et al., 2005; Wheelock et al., 2008)  Though several key 
markers, such as E-cadherin and N-cadherin, are used as surrogate markers, vast 
differences in phenotypes manifest morphologically and biochemically following EMT. 
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2.2.2 Induction of EMT 
EMT can be induced in transformed carcinoma cells through a variety of 
mechanisms, such as TGFβ (Oft et al., 1998), angiotensin II (Chang et al., 2011), H2O2 
treatment (Gorowiec et al., 2012), and ionizing radiation (Zhou et al., 2011).  Recently it 
was observed that interactions between tumor cells and platelets can lead to release of 
platelet-derived TGFβ and induction of EMT. (Labelle et al., 2011) Also, within the 
tumor microenvironment cancer-associated fibroblasts induced EMT in a redox-
dependent manner, generating cells with cancer stem cell like features. (Giannoni et al., 
2011) 
2.2.3 EMT Promotes Deleterious Cancer Phenotypes 
TGFβ is a morphogen of differentiation.  In breast tumors, TGFβ was a major 
determinant of intra-tumor heterogeneity and activation of cancer stem cell marker 
expression. (Shipitsin et al., 2007)  TGFβ-mediated EMT has been linked to the induction 
of a cancer stem cell phenotype in breast and pancreatic tumors. (Blick et al., 2010; Mani 
et al., 2008; Wang et al., 2012)  It has also been shown to play a role in producing 
circulating tumor cells, which are potential sources of metastases. (Yu et al., 2013)  




2.3 Transforming Growth Factor β Signaling 
2.3.1 Canonical TGFβ Signaling via Smad Transcription Factors 
Transforming growth factor β (TGFβ) is a cytokine that can be produced within a 
tumor microenvironment by stromal cells and act upon carcinoma cells. (Bierie and 
Moses, 2006; Hawinkels et al., 2012)  TGFβ is produced as a homodimer in a latent 
form, which can be sequestered in the extracellular matric and activated via cleavage by a 
v integrin. (Munger et al., 1999; Shi et al., 2011; Wakefield et al., 1988)  Homodimeric 
TGFβ bids to a TGFβ receptor complex, initiating a cross-linking causing type II 
receptors to phosphorylate type I receptors.  Then type I receptors phosphorylate Smad2 
and Smad3 transcription factors. (Attisano and Wrana, 2002; Nakao et al., 1997)  C-
terminus phosphorylation of Smad2 and Smad3 primes the transcription factors to bind 
with Smad4, which initiates nucleocytoplasmic shuttling of Smads into the nucleus in the 
phosphorylated state and exports dephosphorylated Smads in a dynamic process that 
encodes TGFβ signal strength and duration in the subsequent transcriptional response. 
(Inman et al., 2002; Schmierer et al., 2008)  Upon reaching the nucleus, phosphorylated 
Smads are free to establish transcription activation or repression complexes with 
additional nuclear factors.  
2.3.2 Non-canonical TGFβ Signaling 
Signaling at the activated TGFβ receptor complex diverges from the typical Smad 
activation and lead to the activation of several alternative singling pathways, including 
MAPK, Rho-like, and PI3K pathways. (Zhang, 2009)  Non-canonical signaling provides 
a means expand the combinatorial response to a singular ligand and alters the context in 
which the Smad responses can occur. (Samarakoon and Higgins, 2008)  Integration of 
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canonical and non-canonical pathways can have a critical role in the response to TGFβ, 
such as in the induction of EMT, in which MAPK and PI3K pathways contribute 
necessary transcription factors to the response. (Chen et al., 2011)  
Epithelial/mesenchymal differentiation states are not simple phenotypes; the 
orchestration of moving from one to the other presents a substantial challenge in 
coordination of such extensive responses. 
2.3.3 Extent of Transcriptional Response in TGFβ-mediated EMT 
TGFβ-mediated EMT relies upon the activation of Smad3 to carry out key 
components of the phenotypic response. (Borthwick et al., 2012; Dzwonek et al., 2009; 
Jinnin, 2005; Vincent et al., 2009) The extent of the transcriptional reprogramming is 
impressive with over 2000 genes demonstrating differential regulation with TGFβ 
treatment in A549 cells. (Ranganathan et al., 2007) It is clear that the scope of the 
transcriptional response is not limited to the narrow set of markers used to define EMT. 
2.3.4 Regulation of Redox Active Cellular Components 
TGFβ can modulate the redox environment through numerous pathways, 
including up-regulation of NOX4, which is constitutively active and produces H2O2. 
(Boudreau et al., 2007; Hecker et al., 2009; Nisimoto et al., 2010; Takac et al., 2011) 
(Michaeloudes et al., 2011)  Alternatively, TGFβ can mediate the down regulation of 
glutaredoxin, GSH synthesizing enzymes, catalase and SOD. (Arsalane et al., 1997; Lee 
et al., 2010; Michaeloudes et al., 2011; Peltoniemi et al., 2004) Therefore TGFβ has the 
potential to affect the redox environment by increasing electrophilic load and decreasing 
nucleophilic tone. 
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2.3.5 Redox Regulation of TGFβ Signaling 
Numerous redox regulatory responses have identified at several points of TGFβ 
signaling.  TGFβ growth factors are active as dimeric species, capable of activating 
dimeric TGFβ receptors. (Attisano and Wrana, 2002) Dimeric TGFβ is stabilized by an 
interchain disulfide bond as well as hydrophobic interactions. (Daopin et al., 1992) 
Treatment of monocyte-derived TGFβ with NAC and DTT resulted in monomeric TGFβ 
species with decreased Smad2 phosphorylation upon treatment. (Lichtenberger et al., 
2006) NAC conditioning resulted in reduction of the TGFβ dimer to monomer in a dose-
dependent manner. (Meurer et al., 2005) The potential redox sensitivity of these 
components indicates redox regulation may operate with the extracellular space before 
signaling has an opportunity in the cell. 
A larger body of work supports a mechanism of antioxidant attenuation of Smad 
activation by TGFβ.  Treatment of cells with NAC or GSH decreased phospho-Smad 
levels (Cucoranu et al., 2005; Fatma et al., 2009; Meurer et al., 2005; Ono et al., 2009; 
Rhyu et al., 2005; Samarakoon et al., 2011) and decreased Smad-mediated transcriptional 
responses (Junn et al., 2000; Kopp et al., 2006; Meurer et al., 2005; Vayalil et al., 2007). 









 coordinate zinc and mediated DNA binding in a 
coordinated water-dependent manner. (Chai et al., 2003) Zinc binding represents a mode 
of redox regulation in which loss of zinc could abolish DNA-binding potential. (Maret, 
2006) This motif was identified in a computational investigation of sequences as a 
potential site of redox regulation. (Fan et al., 2009)  Smad3 may exhibit redox sensitivity 
 17 
based upon a differential DNA affinity that is determined by redox-mediated zinc 
coordination.  
2.4 ABCG2 Establishes Multidrug Resistant Phenotypes 
2.4.1 Multidrug Resistant Phenotypes & SP Cells 
Multidrug resistance (MDR) is a cellular phenotype in which cells display 
improved survival in presence of cytotoxic agents.  ABCG2 is a drug efflux pump and its 
up-regulation in a portion of a cell population can confer a MDR phenotype to the cells. 
(Videira et al., 2014)  The side population (SP) assay is a method to identify cells with a 
particularly high rate of ABCG2 transporter-mediated efflux. (Goodell et al., 1996; Zhou 
et al., 2001) The SP assay therefore identifies MDR subpopulations. 
2.4.2 ABCG2 Expression 
The ABC superfamily transporters are characterized by their ability to bind and 
efflux a wide array of substrates in an ATP-dependent manner. (Sharom, 2008)  ABCG2 
and a number of related transporters accept GSH as a substrate and mediate its efflux. 
(Brechbuhl et al., 2010; 2009; Leier et al., 1996; Lorendeau et al., 2014; Salerno and 
Garnier-Suillerot, 2001; Salerno et al., 2004; SHEN et al., 1996)  Additionally, ABCG2 
expression is regulated by the antioxidant master regulator Nrf2 (Adachi et al., 2007; 
Hong et al., 2010; Singh et al., 2010; Wang et al., 2014), and ABCG2 activity produced 
antioxidant-like effects. (Kubota et al., 2010; Maher et al., 2014; Shen et al., 2010)  These 
findings indicate that ABCG2 activity and the MDR phenotype may be correlated with 
antioxidant expression within a cell population.   
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During carcinogenesis, cells undergo a progression of transformations that enable 
them to undergo indefinite proliferation, a hallmark of cancer, and invade healthy 
surrounding tissues, and avoid cell death. (Hanahan and Weinberg, 2000)  Transforming 
growth factor β (TGFβ) induces epithelial-mesenchymal transition (EMT) and also alters 
intracellular redox regulation.  These processes are the subjects of many investigations; 
however, they are mostly studied in isolation.  A higher fidelity understanding of the 
carcinogenic process is achieved through the investigation of TGFβ-mediated EMT from 
a multidimensional standpoint in which modulation of the redox environment is 
understood in the context of the change in phenotype associated with EMT. 
The extent of tumor growth and invasion into normal tissues is of great 
importance to clinical outcomes for cancer patients.  For example, in non-small cell lung 
carcinoma, TNM staging has the greatest prognostic value, where larger primary tumors 
(T), more extensive lymph node involvement (N), and presence of metastases (M) are 
associated with poorer outcomes. (Goldstraw et al., 2011)  EMT is a process whereby 
epithelial cells transdifferentiate into cells with a mesenchymal phenotype.  Properties of 
enhanced motility and migration may enable EMT-derived cells to break away from 
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primary tumors, forming metastases in distant tissues, and establishing secondary disease 
sites. (Yu et al., 2013)  Furthermore, EMT has been attributed to generation of a stem 
cell-like phenotype, so called “cancer stem cells” (CSCs). (Mani et al., 2008)  EMT-
derived CSCs exhibit chemotherapeutic resistance and may represent a cellular subset 
that survives chemotherapy and mediates recurrence of tumors. (Chen et al., 2013; Jiang 
et al., 2014)  The means by which carcinoma cells undergo EMT and acquire such 
deleterious properties is, therefore, of great interest.  
Within the tumor microenvironment, TGFβ participates in a variety of processes.  
TGFβ signaling acts on carcinoma cells directly, on the surrounding stromal cells, and on 
immune cells within the microenvironment. (Pickup et al., 2013)  In particular, TGFβ can 
mediate the induction of EMT in carcinoma cells. (Bierie and Moses, 2010; Ikushima and 
Miyazono, 2010) TGFβ signaling leads to phosphorylation of Smad2 and Smad3 
transcription factors, which translocate into the nucleus and are then able to modify gene 
expression. (Moustakas et al., 2001; Santibanez et al., 2011; Shi and Massague, 2003; 
Thatcher, 2010)  A key means of carcinogenic progression due to EMT is the change in 
relative cadherin expression typified by decreased E-Cadherin expression and increased 
N-Cadherin expression, known as a “cadherin switch”, which facilities cell motility and 
invasion. (Appolloni et al., 2014; Araki et al., 2011; Hazan et al., 2004)  Poorer 
prognoses are associated with patients whose tumors were found to have undergone a 
cadherin switch. (Gravdal et al., 2007; Jäger et al., 2010; Tomita et al., 2000)  
Phosphorylation of Smad3 is a critical aspect of TGFβ signaling for initiating a cadherin 
switch. (Diamond et al., 2008; Do et al., 2008; Kocić et al., 2011; Vyas-Read et al., 2014)  
 20 
Thus, Smad3 and its activation via phosphorylation are of particular interest in resolving 
the mechanisms of TGFβ-mediated phenotypic transitions. 
The TGFβ receptor complex, upon TGFβ stimulation, rapidly activates Smad3 via 
phosphorylation.  Smad3 activity is regulated at number of levels.  In addition to the 
requirement of phosphorylation, Smad3 must be translocated into the nucleus in order to 
mediate changes in transcription. (Hill, 2009)  Smad localization in the nucleus rapidly 
follows TGFβ signaling and phosphorylation of Smads results in differential 
nucleocytoplasmic shuttling, which leads to nuclear accumulation. (Inman et al., 2002; 
Schmierer and Hill, 2005)  pSmad2 and pSmad3 are dephosphorylated by PPM1A in the 
nucleus, facilitating nuclear export. (Lin et al., 2006)  Down-stream transcriptional 
activities of Smads are tightly regulated by the kinetic processes that determine pSmad 
levels. (Zi et al., 2011)  Thus the processes promoting and detracting from pSmad levels 
can have a significant impact on transcriptional activity and therefore on phenotypes 
resulting from TGFβ exposure.  
All intracellular processes occur within the context of the intracellular redox 
environment.  A wide variety of factors influence the rates of redox reactions at any given 
time.  Of particular interest is the observation that the addition of the antioxidant N-
acetyl-L-cysteine (NAC) to cells results in decreased Smad phosphorylation upon TGFβ 
stimulation. (Samarakoon et al., 2011)  NAC has been shown to mediate a number of 
distinct mechanisms.  TGFβ growth factors are active as dimeric species, capable of 
activating dimeric TGFβ receptors. (Attisano and Wrana, 2002) Dimeric TGFβ is 
stabilized by an interchain disulfide bond as well as by hydrophobic interactions. (Daopin 
et al., 1992) Treatment of monocyte-derived TGFβ with NAC and DTT resulted in 
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decreased TGFβ activity through the formation of TGFβ monomeric species that exhibit 
competitive binding for the TGFβ receptor.  Conditioning of TGFβ with reductants 
decreased Smad2 phosphorylation upon treatment. (Lichtenberger et al., 2006) Thus 
NAC may function at a step prior to intracellular signal transduction; however, GSH, 
DPI, and the SOD mimetic (MnTBaP) treatment decreased PAI-1 promoter activity. 
(Vayalil et al., 2007) Thus, the role of antioxidant antagonism of TGFβ signaling in A549 
cells may manifest through a variety of mechanisms.  Furthermore, direct treatment with 
H2O2 has been associated with enhanced levels of Smad phosphorylation. (Gorowiec et 
al., 2012; Vyas-Read et al., 2014)  These observations suggest that the redox environment 
may directly participate in the regulation of Smad phosphorylation. 
Perturbed redox regulation is a common feature of cancer cells.  Alterations in 
cellular metabolism shift ATP production away from more efficient oxidative 
phosphorylation and towards aerobic glycolysis, termed the “Warburg effect”, which 
better situates the cells for enhanced proliferation rates. (vander Heiden et al., 2009)  
Metabolic process in the glycolytic pathway can regulate the redox environment.  
Perturbation of the glycolytic pathway has a direct impact on the redox state of the cell. 
(Anastasiou et al., 2011)  As such, the resting redox state of cancer cells is often altered. 
The redox state of the cell can also be modulated in cancer cells by changes in 
expression of antioxidant enzymes.  The redox processes within the cell are diverse and 
are regulated by a variety of sources of electrophiles and nucleophiles.  Electrophiles, 
such as ROS and RNS, react with nucleophiles.  These reactions can take place on 
proteins involved in signal transduction or may be mediated by antioxidant proteins, 
clearing electrophiles through enzymatic reactions. 
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The response to TGFβ exposure is extensive.  In addition to the induction of 
EMT, TGFβ signaling is known to modulate the intracellular redox environment through 
up-regulation of NADPH oxidase 4 (NOX4) (Boudreau et al., 2012), a source of ROS, 
and down-regulation of antioxidant enzymes. . (Arsalane et al., 1997; Lee et al., 2010; 
Michaeloudes et al., 2011; Peltoniemi et al., 2004)  Though TGFβ-mediated induction of 
EMT and down-regulation of antioxidant enzymes is fairly well studied, the recognition 
that the two processes coincide has only recently been appreciated. (Michaeloudes et al., 
2011) Further, these processes are often investigated in various cellular model systems.  
It is unclear to what extent the process occurring within a singular experimental model.  
More importantly, it is unclear whether redox regulation on one scale (i.e. antioxidant 
expression) influences redox regulation on another scale (i.e. antioxidant inhibition of 
TGFβ signaling) within the context of the same initiating signal.  We hypothesize that 
A549 cells will exhibit multiscale redox regulation with respect to TGFβ signaling.  That 
is to say A549 cells will simultaneously display redox regulation at the scale of signal 
transduction in the antioxidant inhibition of TGFβ signaling and at the scale of protein 
expression due to down-regulation of antioxidant system enzymes. 
We aim to determine the scope of redox processes in A549 cells during TGFβ 
signaling, specifically whether cells simultaneously exhibit 1) antioxidant sensitivity in 
induction of TGFβ-mediated EMT and 2)  TGFβ-mediated antioxidant down-regulation.  
We aim to identify the kinetic profile of antioxidant antagonism of TGFβ-mediated Smad 
phosphorylation and activity.  Additionally, we aim to develop approaches that enable the 
multivariate characterization of phenotype, with respect to epithelial/mesenchymal 
differentiation and antioxidant expression, during TGFβ-mediated EMT. 
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In this investigation, we establish the antioxidant sensitivity of TGFβ-mediated 
induction of EMT and the down-regulation of cellular regulators of antioxidant function 
within the same experimental model.  In doing so, we demonstrate the efficacy of higher-
throughput approaches to investigate multivariate aspects of cellular phenotype during 
EMT. 
3.2 Results 
3.2.1 Pleiotropic Response to TGFβ Stimulation 
TGFβ treatment of A549 cells results in differential regulation of numerous 
species.  Over the course of 3 days, TGFβ treatment (100 pM) led to the progressive 
down-regulation of E-Cadherin (Figure 3.1-A) and up-regulation of numerous 
mesenchymal markers (Figure 3.1-B).  In addition to markers of phenotype, species 
involved in redox regulation exhibited altered expression with TGFβ treatment, such as 
the down-regulation of thioredoxin reductase 1 (TrxR1) and up-regulation of NADPH 
oxidase 4 (NOX4) (Figure 3.1-C).  Altered expression of these species was accompanied 
by increased pSmad2 and pSmad3 levels (Figure 3.1-D), which was highest after 24 







Figure 3.1  Changes in Protein Expression During TGFβ-Mediated EMT . 
Western blot analysis of A) epithelial markers, B) mesenchymal markers C) thioredoxin 
reductase 1 (TrxR1) & NADPH oxidase 4 (NOX4), and D) pSmad2 and pSmad3 
expression levels over the course of 3 days of 100 pM TGFβ treatment of A549 cells 
along with α-tubulin loading control staining.  Data are representative of 3 independent 
biological replicates (n=3). 
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3.2.2 NAC Antagonizes TGFβ-Mediated Smad2/3 Phosphorylation 
NAC has been reported to inhibit TGFβ-mediated Smad phosphorylation by a 
number of mechanisms.  To identify the susceptibility of recombinant TGFβ-mediated 
Smad2 & Smad3 phosphorylation in A549 cells to NAC co-treatment several NAC 
treatment conditions were assessed.  In the control condition, no NAC was used and cells 
were treated with 20 pM TGFβ for 30 minutes.  The ligand treatment condition consisted 
of 10 mM NAC treatment of TGFβ for 1 hour at 37˚C prior to treatment of the cells with 
the NAC-treated TGFβ.  For the cell treatment condition, A549 cells were treated with 10 
mM NAC for 1 hour prior to treatment with TGFβ.  Following treatment, cells were lysed 
and lysates were loaded onto SDS-PAGE for electrophoresis.  Cellular protein transferred 
to PVDF membranes were then probed via western blotting and imaged with a LiCor 
Odyssey imaging system (Figure 3.2).  The fluorescence intensities were quantified and 
normalized against α-tubulin loading control (Figure 3.3). 
Upon stimulation with 20 pM TGFβ for 30 min, pSmad2 and pSmad3 levels were 
found to be dramatically increased compared to unstimulated control (Figure 3.3).  The 
magnitudes of pSmad2 and pSmad3 levels in the ligand and cell NAC-treatment 
conditions were decreased compared to the untreated control.  Furthermore, the 
magnitudes of response in the cell treatment condition were decreased (~50%) compared 









Figure 3.2  pSmad2 & pSmad3 Western Blots of NAC Conditions. 
Phospho-Smad2 & Smad3 levels in A549 cells measured via western blot after 
stimulation with 20 pM TGFβ for 30 minutes.  In the ligand treatment condition, TGFβ 
was incubated with 10 mM NAC for 1 hour at 37˚C prior to treatment of cells.  In the cell 
treatment condition, A549 cells were treated with 10 mM NAC for  1 hour.  Phospho-
Smad signals were normalized to α-tubulin loading control.  Blots are representative of 









Figure 3.3  Quantification of pSmad2 & pSmad 3 NAC Conditions Western Blot. 
Western blot band intensities for A) pSmad2 and B) pSmad3 were measured using a 
LiCor Odyssey imaging system with infrared fluorescently labeled secondary antibodies 
against primary antibodies or pSmad2, pSmad3, and α-tubulin.  Fluorescence intensities 
for the pSmad2 and pSmad3 bands were normalized to the fluorescence intensity of the 
respective α-tubulin band.  Normalized intensities are plotted as mean±standard error of 
the mean.  Statistical differnces were assessed using two-way ANOVA with multiple 
comparisons (* p < 0.05).  Experiments were performed in triplicate (n=3).  
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3.2.3 In-Cell Western Analysis of pSmad3 Expression Levels 
To assess pSmad3 phosphorylation kinetics in A549 cells, we implemented a 
higher-throughput approach to assess phospho-protein expression, an in-cell western 
(ICW) assay.  Cells were plated in 96-well plates and stimulated with TGFβ for the 
specified time.  Cells were fixed within the wells and stained with a primary antibody 
against pSmad3, to which a fluorescently labeled secondary antibody was targeted.  The 
fluorescence intensity of the stained cells was assessed via imaging in a LiCor Odyssey 
(Figure 3.4).  The 96-well format enables higher throughput analyses.  The time course of 
pSmad3 levels across 4 orders of magnitude of TGFβ stimulation was assessed using the 
ICW format (Figure 3.5).  In general, the time courses followed a profile of steep 
activation followed by a plateau of intensity.  With increasing TGFβ dose, the time to 
peak response was decreased.  With the exception of the 200 pM condition, increasing 
does corresponded with increased signal amplitude.  Finally, in all conditions, except the 




Figure 3.4  ICW Assay Wells with pSmad3 Staining. 
Fluorescence intesities in pSmad3 stained wells of a 96-well plate from an ICW assay 





Figure 3.5  pSmad3 In-Cell Western TGFβ Time Course & Dose Response. 
ICW analysis of pSmad3 levels in A549 cells during the course of TGFβ treatment across 
4 orders of concentration.  Intensities are plotted a mean ± standard error of the mean.  
Experiments were performed in triplicate (n=3). 
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3.2.4 Antioxidants Attenuate TGFβ-Mediated Smad3 Phosphorylation 
The influence of antioxidants on the time course profile of pSmad3 expression 
levels during TGFβ stimulation was assessed using an ICW assay.  While pSmad3 levels 
following 30 minutes of TGFβ stimulation are decreased in A549 cells pre-treated with 
NAC, this snapshot in time fails to capture the kinetics of Smad3 phosphorylation in the 
presence of antioxidant perturbation.  To address this, we assessed pSmad3 levels in 
A549 cells across a time course with antioxidant co-treatment conditions in which cells 
were pre-treated with NAC (5 mM, 1 hour), GSH (5 mM, 1 hour), or catalase (0.5 mg/ml, 
18 hours).  Following TGFβ stimulation, pSmad3 levels in the control condition quickly 
rose and then plateaued (Figure 3.6).  In the presence of the antioxidants NAC, GSH, and 
catalase, pSmad3 levels failed to reach the same intensities compared to the control, had a 
delayed peak response time compared to the control, and did not maintain a sustained 








Figure 3.6  ICW pSmad3 Response to TGFβ with Antioxidant Co-Treatment. 
ICW analysis of pSmad3 levels during the course of 20 pM TGFβ treatment in A549 
cells with 1 hour pre-treatment consisting of 5 mM NAC, 5 mM GSH, or 0.5 mg/ml 
catalase (18 hour pre-treatment), which persisted as a co-treatment during the course of 
the TGFβ treatment.  Data are plotted a mean ± standard error of the mean.  Experiments 
were performed in triplicate (n=3). 
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3.2.5 Generation of a Smad3-Responsive Promoter Cell Line 
A derivative of the A549 cell line was produced via lentiviral transfection for use 
in a dual-luciferase assay.  A cell line (SBE-Luc) with Smad-Binding Element (SBE)-
driven expression of Firefly luciferase and constitutively expressed Renilla luciferase as a 
means to assess the transcriptional activity at Smad3-driven promoters.  In parallel, a 
negative control cell line (Neg-Luc) was produced using the same lentiviral constructs 
with the exception of an absence of SBE sites on the Firefly luciferase promoter.  
SBE-Luc and Neg-Luc A549 cells were plated in 96-well plates and subsequently 
treated with TGFβ for 10 hours before being prepared with luciferin and coelenterazine-
containing reaction solutions as chemiluminescent substrates for Firefly and Renilla 
luciferase enzymes, respectively.  The Firefly luciferase activity, normalized to Renilla 
luciferase activity, of SBE-Luc cells exhibits a dose-response to TGFβ treatment, with 
saturation in the 20-200 pM TGFβ conditions (Figure 3.7).  This is contrasted by the 
Neg-Luc cell line, which exhibited lower overall Firefly luciferase activity and was 
insensitive to induction by TGFβ treatment.  
3.2.6 NAC Antagonizes pSmad3-Mediated Transcription 
Smad3-mediated transcription during TGFβ signaling was measured in the 
presence of NAC using the SBE-Luc cells in a dual-luciferase assay.  TGFβ-driven 
Firefly luciferase expression after 6 hours of treatment of SBE-Luc cells was modest at 2 
pM and increased with both 20 and 200 pM conditions (Figure 3.8).  Pre-treatment of 
SBE-Luc cells with NAC for 1 hour resulted in decreased normalized Firefly luciferase 




Figure 3.7  TGFβ-Induced Luciferase Activity in Control & SBE Cell Lines. 
Normalized Firefly luminescence of Smad-responsive SBE-Luc and negative control 
Neg-Luc A549 cells in a dual-luciferase assay following 10 hours of TGFβ treatment.  





Figure 3.8  Attenuation of TGFβ-Induced SBE Promoter Activity by NAC. 
Normalized luminescence of SBE-Luc A549 cells in a dual-luciferase assay following 6 
hours of TGFβ treatment.  NAC pre-treatment was applied 1 hour prior to TGFβ 
treatment and persisted as a co-treatment during the TGFβ treatment.  Neg-Luc cells were 
also assayed as controls.  No change in activities were measured and the conditions were 
omitted from the plot for clarity.   
 34 
3.2.7 Antioxidants Antagonize E-Cadherin Down-Regulation 
To determine the ability of antioxidants to prevent TGFβ-mediated E-Cadherin 
down-regulation, A549 cells we plated in a 96-well plate with NAC (5 mM) and GSH (5 
mM) pre-treatment conditions 1 hour prior to treatment with 20 pM TGFβ.  After 48 
hours of treatment, untreated control, TGFβ, TGFβ+NAC, and TGFβ+GSH conditions 
were stained with anti-E-Cadherin antibody and analyzed via ICW assay (Figure 3.9).  
TGFβ-treatment alone led to decreased E-cadherin expression while pre-treatment with 
NAC or GSH prevented TGFβ-mediated down-regulation. 
3.2.8 Analysis of TGFβ-Induced EMT Using ICW 
The multi-well format used in the ICW assay enables higher-throughput analyses 
compared to conventional western blotting techniques.  This technical advantage was 
used to derive a broader multivariate understanding of response of A549 cells to TGFβ 
treatment.  Cells were plated in 96-well plates and treated with increasing doses of TGFβ, 
ranging from 0 to 200 pM, for 48 hours, after which the plates were processed in an ICW 
assay.  Each biological replicate consisted of a 96-well plate with 2 technical replicates of 
6 treatment conditions, 6 primary antibody staining conditions and 12 technical control 
wells.  Using this approach, we observed a dose-dependent down-regulation of E-
Cadherin, glutaredoxin, and catalase expression (Figure 3.10-A, E, F).  In contrast, we 
observed a dose-dependent up-regulation of β-catenin, vimentin, and pSmad3 (Figure 
3.10-B, C, D).  Differences in expression compared to untreated controls were apparent 








Figure 3.9  NAC & GSH Antagonize TGFβ-Mediated E-Cadherin Repression. 
ICW analysis of E-Cadherin expression in A549 cells following 48 hours of 20 pM TGFβ 
treatment compared to untreated control (grey line).  NAC (5 mM) or GSH (5 mM) 
conditions consisted of pretreatment for 1 hour followed by co-treatment for the duration 
of the 48 hour treatment course.  Statistical differnces were assessed using one-way 
ANOVA with multiple comparisons (* p < 0.05).  Data are plotted a mean ± standard 








Figure 3.10  ICW Enables Multivariate Characterization of TGFβ-Mediated EMT. 
ICW analysis of A)  E-Cadherin, B) β-catenin, C)  Vimentin, D) pSmad3, E)  
Glutaredoxin, and F)  Catalase expression in A549 cells, compared to untreated control 
(grey line), following 48 hours of TGFβ treatement.  Data are plotted a mean ± standard 
error of the mean.  Experiments were performed in triplicate (n=3). 
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3.2.9 Increased CM-H2DCF-DA Oxidation Following TGFβ Treatment 
Untreated control and TGFβ-treated A549 cells were stained with 10 µM CM-
H2DCF-DA for 30 minutes and analyzed via flow cytometry (Figure 3.11).  TGFβ 
treatment increased FITC channel fluorescence compared to control.  In both control and 





Figure 3.11  CM-H2DCF-DA Fluorescence After 48 Hours of TGFβ Treatment. 
A)  Representative flow cytometric distributions of CM-H2DCF-DA fluorescence in 
A549 following 48 hours of 100 pM TGFβ treatment with and without the addition of 
100 µM H2O2.  B)  Quantification of geometric mean fluorescence intesntiy (GMFI) from 
all of the replicates.  Statistical differnces were assessed using two-way ANOVA with 
multiple comparisons (* p < 0.05).  Data are plotted as geometric mean ± 95% 




Treatment of A549 cells with TGFβ led to a progressive induction of EMT, 
indicated by the progressive decrease in E-Cadherin and increase in mesenchymal 
markers (Figure 3.1-A, B).  These changes in phenotype are similar to previous reports of 
TGFβ-mediated EMT in A549 cells. (Kasai et al., 2005; Kim et al., 2006) Strongly 
elevated levels of pSmad2 and pSmad3 coincide with this change in phenotype (Figure 
3.1-D).  The phosphorylation of Smad3 is reported to be a critical component of TGFβ-
mediated EMT. (Borthwick et al., 2012; Boudreau et al., 2007; Ivanova et al., 2008; 
Kolosionek et al., 2009; Shan et al., 2008)  Simultaneous with EMT-defining responses 
are modifications to redox regulators, with decreasing TrxR1 (Figure 3.1-C), 
gluaredoxin-1, and catalase (Figure 3.10-E, F), antioxidant system enzymes, and 
increasing NOX4 (Figure 3.1-C), a source of ROS.  The trends in TrxR1, glutaredoxin-1, 
catalase, and NOX4 expression might suggest that the intracellular redox environment 
undergoes a modification during EMT that would favor greater production and stability 
of ROS via antioxidant down regulation.  Perturbed regulation of the redox environment 
is reflected in the increased CM-H2DCF-DA oxidation following TGFβ treatment (Figure 
3.11).  Therefore the response of A549 cells to TGFβ treatment is multifaceted, involving 
induction of EMT and modification of the redox environment at the scale of protein 
expression. 
Our findings highlight the sensitivity of TGFβ signaling via pSmad3 to inhibition 
by antioxidants in A549 cells.  A decreased, but still evident, pSmad2 and pSmad3 signal 
were present in A549 cells following treatment with NAC-treated TGFβ ligand (Figure 
3.2 & 3.3).  This indicates that NAC treatment does not completely inactivate TGFβ 
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ligand and that in the presence of NAC it is capable of activating down-stream signaling.  
Alternately, pre-treatment of A549 cells with NAC resulted in a significant decrease in 
pSmad2 and pSmad3 upon subsequent exposure to TGFβ in absence of extracellular 
NAC (Figure 3.2 & 3.3).  These findings indicate that antioxidant-mediated antagonism 
of TGFβ signaling can proceed through a cell-based mechanism.  NAC treatment of 
A549 cells does not delay but rather attenuates Smad3 phosphorylation following TGFβ 
treatment (Figure 3.6).  Additionally, NAC treatment diminishes the transcriptional 
response of a SBE-driven luciferase reporter in response to TGFβ treatment (Figure 3.8).  
The specific SBE promoter is derived from a PAI-1 promoter region, which is activated 
by pSmad3 activity. (Dennler et al., 1998; Hua et al., 1999; Stroschein et al., 1999)  
Further, treatment with the antioxidants NAC and GSH prevented TGFβ-mediated 
change in phenotype (Figure 3.9).  TGFβ-mediated induction of EMT has been shown to 
be sensitive to inhibition with NAC in cell lines other than A549 cells. (Felton et al., 
2009; Lee et al., 2010; Michaeloudes et al., 2011; Rhyu et al., 2005)  One report has 
identified the antioxidant sensitivity of EMT-induction in A549 cells.  (Zhang et al., 
2009)  Others have reported attenuation of TGFβ-mediated Smad3 phosphorylation 
following increases in cellular antioxidants. (Oh et al., 2012a; 2012b; Ryoo et al., 2014)  
Further, direct application of H2O2 has been reported to induce EMT in A549 cells. 
(Gorowiec et al., 2012)  TGFβ-mediated phosphorylation of Smad3 is also critical for the 
down-regulation of antioxidant genes.  In airway smooth muscle cells, phosphorylation of 
Smad3 was necessary for down-regulation of SOD2 and catalase (Michaeloudes et al., 
2011), while in mouse mammary cells, phosphorylation of Smad3 was necessary for the 
down-regulation of genes responsible for GSH production (Bakin et al., 2005)  Thus, 
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TGFβ signaling in A549 is redox regulated on the scale of signal transduction and protein 
phosphorylation.  Therefore, TGFβ-mediated EMT and down-regulation of antioxidants 
relies on transcriptional activity of pSmad3, which exhibits diminished activation in the 
presence of antioxidants. 
EMT is a highly complex process that encompasses numerous cellular systems.  
Some studies have linked changes in the redox environment to induction of EMT 
(Gorowiec et al., 2012; Vyas-Read et al., 2014), while others have linked induction of 
EMT to changes in the redox environment. (Lee et al., 2010; Michaeloudes et al., 2011; 
Rhyu et al., 2005)  Likewise, the A549 cell line has been used extensively for studies of 
perturbed redox regulation and for studies of transdifferentiation; however, there is an 
absence of investigations into the possibility that TGFβ-mediated induction of EMT and 
remodeling of the redox environment may be interrelated within a singular experimental 
model.  A particular challenge to this is the multivariate nature of such studies.  We have 
addressed this issue though the implementation of ICW assays to measure the expression 
of antioxidant proteins in parallel with markers of epithelial and mesenchymal phenotype 
(Figure 3.10).  Our results demonstrate that redox regulation during TGFβ-mediated 
EMT in A549 cells occurs at multiple scales where TGFβ signaling is inhibited by 
intracellular antioxidants and initiates the down-regulation of antioxidant expression.  
This relationship can be interpreted as a double-negative feedback loop (Figure 3.12).  
Cellular systems possessing double-negative feedback loops can exhibit bistability, which 







Figure 3.12  Schematic of Multiscale Redox Regulation During TGFβ Signaling. 
A schematic of the redox regulatory relationships observed during TGFβ-mediated EMT 
that may be responsible for maintaining A549 in bistable epithelial (A) or mesenchymal 
(B) states.  A)  Under unstimulated conditions, E-Cadherin and antioxidant expression is 
un-repressed and N-Cadherin expression is un-stimulated.  B)  Upon the addition of 
TGFβ, Smad3 is phosphorylated, which drives repression of E-Cadherin and antioxidants 
while stimulating N-Cadherin expression.  Down-regulation of antioxidants allows 




Cellular phenotypes are often ascribed a particular state, i.e. “epithelial” or 
“mesenchymal”; however, our results demonstrate the simplicity in using this 
perspective.  In addition to a cadherin switch following TGFβ treatment, multiple cellular 
programs are sensitive to regulation in the presence of TGFβ.  Parallel investigation of 
numerous molecular species, which define various dimensions of phenotype, is a 
technical challenge.  We address this through the implementation of ICW assays, which 
enable higher throughput compared to conventional western blotting approaches.  Such 
approaches are critical for multivariate investigations, such as the investigation of redox 
regulation in the context of EMT.  Temporal studies expand the technical demand of an 
investigation as the volume of data collection expands significantly with each 
intermediate time point studied.  We have identified multiscale redox regulation within 
the same experimental model in which cellular antioxidants attenuated TGFβ signaling 
and TGFβ signaling resulted in decreased antioxidant expression.  Investigation of the 
temporal inter-relationship between 1) antioxidant sensitive TGFβ-mediated signaling 
and 2)  TGFβ-mediated regulation of the redox environment as possible mechanism of 
bistability in epithelial or mesenchymal phenotype states presents a significant technical 
challenge in terms of experimental scope and analysis.  To address this challenge, we 




3.5 Materials & Methods 
3.5.1 Cell Culture & Treatments 
A549 lung carcinoma cells were obtained from American Type Culture Collection 
(ATCC; CCL-185) and maintained in high glucose DMEM with L-glutamine (Sigma 
D5796), 10% FBS (Sigma F4135) and penicillin (50 IU/ml)-streptomycin (50 µg/ml) 
(Cellgro 30-001-CI).  Cells were plated in T-75 flasks at density of 4,000 cells per cm
2
 in 
15 ml growth media and maintained at 37˚C and supplemented with 5% CO2.  Cells were 
plated in 96-well plates at a density of 5,000 cells per well and maintained in 200 µl of 
growth media.  Treatments consisted of TGFβ (Millipore, GF111), NAC (Sigma-Aldrich, 
A9165), GSH (VWR, A18014-06), and catalase (Sigma-Aldrich, C9322). 
3.5.2 Western Blotting 
Following treatment, cellular lysates were prepared with a lysis buffer that 
consisted of 50 mM TrisHCl pH 7.5, 150 mM NaCl, 2 mM EGTA, 10 mM NaPP, 30 mM 
NaF, 2% Triton X-100, 1 mM benzamidine, 1 mM β-glycerophosphate, 100 µM sodium 
orthovanadate, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml 
aprotinin, 10 µg/ml leupeptin, 1 µg/ml pepstatin, and 1 µg/ml microcystin.  Lysate 
protein concentrations were determined via BCA assay and diluted to uniform 
concentration with lysis buffer.  Lysates were prepared for SDS-PAGE in 4x Laemmli 
reducing sample buffer (Boston Bioproducts BP-110R) and loaded at a rate of 20 µg per 
well for sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).  
Electrophoresis of cellular proteins was run at a constant voltage of 130V for 1 hour and 
transferred to PVDF membranes at 100V for one hour.  The PVDF membranes were then 
blocked for one hour in the appropriate blocking buffer (Rockland blocking or non-fat 
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milk (NFM) buffer).  Following blocking, the PVDF membranes were incubated with the 
diluted primary antibody overnight at +4˚C with gentle rotation in blocking buffer with 
0.1% Tween-20.  Primary antibody solutions consisted of the desired target for the blot 
plus anti-α-tubulin, to serve as a loading control.  Solutions were prepared as indicate in 
Table 3.1.  Following overnight incubation with the primary antibody, membranes were 
washed four times with TBS-T for 5 minutes at ambient temperature with gentle rotation.  
Membranes were then incubated with the secondary antibodies (1:20,000) in Rockland 
blocking buffer with 0.1% Tween-20 and 0.01% SDS for 1 hour at ambient temperature 
with gentle rotation.  Secondary antibodies were purchased from LI-COR Biosciences 
targeting mouse and rabbit primary antibodies (IRDye® 680LT Conjugated Donkey 
Anti-Mouse IgG and IRDye® 800CW Donkey Anti-Rabbit IgG).  The membranes were 
washed 3 times with TBS-T and 2 times with TBS for 5 minutes at ambient temperature 
with gentle rotation and stored in TBS for imaging.  PVDF membranes were imaged on a 






Table 3.1  Western Blotting Primary Antibody Conditions. 
Primary antibodies were prepared in the indicated blocking buffer (BB) and dilution and 
allowed to incubate with the PVDF membranes overnight at +4˚C before staining with 
secondary antibody and imaging on a LiCor Odessey. (CS = Cell Signaling, M = 
Millipore, E = Epitomics, a = abcam) 
Target Vendor Clone Product No. Dilution BB 
E-cadherin CS 24E10 3195 1:1000 Rockland 
Claudin-1 CS Polyclonal 4933 1:1000 Rockland 
N-cadherin CS Polyclonal 4061 1:1000 Rockland 
Vimentin CS D21H3 5741 1:2000 Rockland 
Snail CS C15D3 3879 1:1000 Rockland 
β-catenin CS 6B3 9582 1:1000 Rockland 
α-Smooth Muscle Actin a Polyclonal ab5694 1:200 Rockland 
Thioredoxin Reductase 1 M Polyclonal 07-613 1:1000 Rockland 
NADPH Oxidase 4 E UOTR1B492 3187-1 1:2000 Rockland 
p-Smad2 CS 138D4 3108 1:1000 5% NFM 
p-Smad3 a EP823Y ab52903 1:2000 Rockland 




3.5.3 Lentiviral Transfection 
A549 cell lines were generated for use in a dual-luciferase assay.  Cells were 
passaged into wells of a 96-well plate at a density of 20,000 per well.  A transfection 
solution containing Lipofectamine 2000 Transfection Reagent (Life Technologies 
#11668) and free of antibiotics was then added to the wells and incubated for 24 hours at 
37˚C.  A Smad-Binding Element-responsive cell line was generated using Smad Reporter 
(Qiagen SA Biosciences CLS-017L) and Renilla Control (Qiagen SA Biosciences CLS-
RHL) lentiviral particles.  A negative control cell line was generated using Negative 
Control (Qiagen SA Biosciences CLS-NCL) and Renilla Control (Qiagen SA Biosciences 
CLS-RHL) lentiviral particles.  Multiplicity of infection (MOI) for transfection of A549 
cells with a lentivirus has been reported ranging from 5 MOI (Song et al., 2006) to 30 
MOI (Nan et al., 2011).  For both lentiviral particles used to generate each cell line, a 
MOI of 25 was used.  On the following day, the transfection media was replaced with 
fresh growth media.  Fourty-eight hours after transfection, growth media was replaced 
with selection media consisting of growth media supplemented with 1.5 µg/ml 
puromycin and 100 µg/ml hygromycin.  Transfected cells were maintained in selection 
media for 7 days before being assessed in a dual-luciferase assay. 
3.5.4 Dual-Luciferase Assay 
The luciferase activity of Firefly and Renilla luciferase enzymes were measured 
using the Promega Dual-Luciferase Reporter Assay System (E1910).  SBE-Luc and Neg-
Luc A549 cells were plated in 96-well plates at 5,000 cells per well and expanded for two 
days before application of a TGFβ treatment.  Following treatment, media was washed 
from the wells, which were washed with sterile 1x PBS.  Wells were then incubated with 
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20 µl of passive lysis buffer (PLB) on a shaker for 20 minutes at ambient temperature.  
The 96-well plate was then placed in a BioTek Synergy 4 plate reader where, well-by-
well, 100 µl of LAR II reagent solution was added to each well, shook for 2 seconds, and 
followed by 10 seconds of integrated measurement of Firefly bioluminescence.  Next, the 
Renilla bioluminescence was measured by the addition of 100 µl of Stop & Glo reagent 
solution to the well, followed by 20 seconds of shaking, and finally 10 seconds of 
integrated bioluminescence measurement.  For each well, the Firefly bioluminescence 
was normalized to the Renilla bioluminescence. 
3.5.5 In-Cell Western Assay 




 and fixed with 
100 µl 4% paraformaldehyde per well for 20 minutes at ambient temperature.  The cells 
were permeabilized by washing five times with 50 µl 0.1% Triton X-100 solution for 5 
min with gentle rotation at ambient temperature.  The plates were blocked with 100 µl of 
blocking buffer consisting of 0.5x Rockland Blocking Buffer for Fluorescent Western 
Blotting (MB-070) in tris-buffered saline (TBS) for 1.5 hours with gentle rocking at 
ambient temperature.  Following blocking, cells were immunostained with 35 µl of 1˚ 
antibody solutions (Table 3.2) overnight at +4˚C with gentle rotation in blocking buffer 
supplemented with 0.1% Tween-20.  The plates were then washed five times with TBS-T 
(TBS with 0.1% Tween-20) under gentle rotation at ambient temperature for 5 minutes 
each.  Plates were stained with 45 µl Donkey anti-Rabbit antibody (1:800; LiCor, IRDye 
800CW, 926-32213) and CellTag 700 (0.2 µM; LiCor, 926-41090) in blocking buffer 
supplemented with 0.2% Tween-20 for 1.5 hours.  The plates were washed four times 
with TBS-T and once with TBS before being emptied and sealed for imaging.  Signal 
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intensities in the 700 nm and 800 nm channels were measured on stained plates via LiCor 
Odyssey system and analyzed in LiCor Image Studio (v2.1.10).  
The background signal intensity of non-specific secondary binding was subtracted 
based on the amount of cells present in a given well.  For a given well, non-specific 
secondary antibody background staining (800background) was subtracted from the raw 800 
channel intensity (800raw) to yield the 800 channel signal (800signal) intensity.  Each plate 
included a set of 8-12 wells lacking any primary antibody staining and containing at least 
one sample from each biological condition.  On a given plate, the intensity of the non-
specific secondary antibody signal was determined to be a function of the amount of cells 
present (Figure 3.13).  The unstained wells were used to create a liner curve of 
background signal intensity as function of loading control signal intensity.  Raw signal 
intensities of primary antibody stained cells were augmented by background subtraction 
(800signal=800raw-800background), where the raw signal intensity was reduced by the 
background signal intensity, as determined by loading control signal intensity.  The 
loading control normalized signal intensity was determined by dividing 800signal by the 
700 channel signal intensity.  To normalize individual signals across plates, the loading 
control normalized signal intensity was divided by the average loading control 





Figure 3.13  Representative ICW Background Staining Standard Curve. 
The secondary antibody signal (800 channel) is plotted against the loading control DNA 








Table 3.2  Primary Antibody Conditions for ICW Staining 
Target Vendor Clone Product No. Dilution 
E-cadherin Cell Signaling 24E10 3195 1:400 
Vimentin Cell Signaling D21H3 5741 1:200 
β-catenin Cell Signaling 6B3 9582 1:200 
p-Smad3 abcam EP823Y ab52903 1:400 
Glutaredoxin-1 abcam Polyclonal ab45953 1:500 
Catalase Cell Signaling D4P7B 12980 1:800 
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3.5.6 CM-H2DCF-DA Fluorescence Assay 
Following treatment, cells were trypsinized (CellGro, 25-053-CI) and 
resuspended in HBSS without phenol red (Thermo Scientific HyClone, SH30268) at a 
working concentration of 5x10
5
 cells/ml and incubated with 10 µM CM-H2DCF-DA 
(Invitrogen, C6827) for 30 minutes.  Co-treatment with H2O2 (100 µM) occurred during 
the final 15 minutes of the CM-H2DCF-DA incubation.  The cells were then washed and 
co-stained with SYTOX Blue (Invitrogen, S34857, 1:1000) for live/dead discrimination.  
A BD LSR II flow cytometer was used to resolve SYTOX Blue (λex=445, λem=473/10) 
and CM-H2DCF-DA (λex=488, λem=530/30) signals.  Cells were gated by FSC/SSC to 
exclude cellular debris, then by FSC-A/FSC-H to exclude non-singular events, and 
finally by absence of SYTOX Blue staining, to exclude all non-viable cells.  CM-H2DCF-
DA signals were then characterized by their geometric mean fluorescence intensity. 
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CHAPTER 4  REDOX PROCESSES INFORM MULTIVARIATE 
TRANSDIFFERENTIATION TRAJECTORIES ASSOCIATED 




More than seven decades since Waddington first introduced the concept of 
canalization, systems biology is still very focused on how to best characterize phenotype 
robustness, in which small perturbations from a developmental trajectory are protected 
against by a steep energetic landscape of descent towards a terminal state (Waddington, 
1942).  In the modern era, however, biological insight into the reversibility of 
differentiation processes through transdifferentiation and the reacquisition of 
pluripotency have expanded our view of how cells behave dynamically as they progress 
from one phenotype to another.  The ability to measure many biomarkers in combination 
allows contemporary researchers to interrogate how cellular trajectories during 
transdifferentiation are driven or reinforced by various cellular programs.  In particular, 
the influences of genetic reprogramming of a cellular state, such as redox potential, and 
external influences on this state can be investigated in parallel with traditional phenotype 
markers to ask how cellular oxidation influences the progression from one cell type 
towards another. 
One such transdifferentiation process, epithelial-mesenchymal transition (EMT), 
occurs when epithelial cells loose certain phenotypic qualities (such as apical-basal 
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polarity and basement membrane interaction) and acquire mesenchymal characteristics 
(such as cell migration and production of extracellular matrix components) (Kalluri and 
Weinberg, 2009).  The cytokine transforming growth factor beta (TGFβ) induces EMT 
and has been implicated in increased invasiveness of cancers and in the formation of 
metastases (Hanahan and Weinberg, 2011; Oft et al., 1998; Thiery et al., 2009).  TGFβ 
signaling is enhanced within the tumor microenvironment through interactions with 
cancer-associated fibroblasts, immune cells, and extracellular matrix (Bierie and Moses, 
2006; Junk et al., 2013).  Circulating tumor cells from breast cancer patients are enriched 
for mesenchymal markers and TGFβ signaling, implicating TGFβ-mediated EMT as a 
mechanism for entry into to the circulatory system (Yu et al., 2013).  Upon reentry into 
distant tissues, reversal of the mesenchymal-like phenotype into an epithelial phenotype 
(i.e.  MET), may play a critical role in the establishment and progression of metastases 
(Hugo et al., 2007).  A recent investigation of ovarian cancer, stratification of tumor 
phenotypes into epithelial, intermediate epithelial, intermediate mesenchymal, and 
mesenchymal states found increased 5-year progression-free survival in patients whose 
tumors were classified as epithelial or intermediate epithelial.  Furthermore, of 43 
classified cell lines, intermediate states were found to be more responsive to kinase 
inhibition (Huang et al., 2013); thus, the timing of phenotype transition dynamics or 
characterization of intermediate phenotype states may have major implications for 
therapeutic strategies. 
Numerous gene expression changes are initiated by TGFβ signaling as part of 
EMT.  Upon binding of its cognate receptor, TGFβ quickly activates canonical and non-
canonical signaling.  Canonical signaling occurs through phosphorylation of Smad2 and 
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Smad3 transcription factors, which bind Smad4 before translocation into the nucleus (Liu 
et al., 1997; Souchelnytskyi, 1997).  Smad3 phosphorylation and its transcriptional 
activity are critical steps in TGFβ-mediated EMT (Dzwonek et al., 2009; Katsuno et al., 
2013).  Smads have been linked to a number of critical steps involved in the formation of 
metastases.  In one study, the formation of bone metastases by xenografted cancer cells 
relied on Smad4 (Kang et al., 2005).  In another, in vitro and in vivo metastatic processes 
were dependent on Smad3 and enhanced upon Smad2 knockdown (Petersen et al., 2010), 
while, in yet another study, Smad2 elevation enhanced in vitro and in vivo pro-metastatic 
processes (Oft et al., 2002).  Thus, the pro-carcinogenic mechanisms of TGFβ rely on 
Smad signaling to carryout transcriptional remodeling, though in ways that may be 
cancer or cell-type specific. 
In addition to induction of EMT, TGFβ can transform the regulation of the 
intracellular redox environment through a variety of mechanisms, such as the up-
regulation of NADPH oxidase 4 (NOX4), which constitutively produces hydrogen 
peroxide (H2O2) (Nisimoto et al., 2010; Serrander et al., 2007), increasing free 
intracellular iron, and the down-regulation of glutaredoxin-1 or reduced glutathione 
(GSH) levels (Arsalane et al., 1997; Boudreau et al., 2012; Felton et al., 2009; Hecker et 
al., 2009; Lee et al., 2010; Peltoniemi et al., 2004; Zhang et al., 2009).  The state of 
reduction equivalent capacity, capable of eliminating electrophiles such as ROS, has been 
defined as the nucleophilic tone of the cell and is determined by the expression of 
antioxidant system components. (Forman et al., 2014)  As such, decreased nucleophilic 
tone would impair the cell’s ability to clear ROS.  Elevation of reactive oxygen species 
(ROS) during EMT can lead to direct activation or enhancement of a variety of redox 
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sensitive signal transduction pathways (Cannito et al., 2010) and H2O2 treatment itself 
has been shown to induce EMT in a TGFβ-dependent manner (Gorowiec et al., 2012).  
Antioxidant attenuation of Smad2/3 phosphorylation and transcription has been observed 
in a variety of cell types (Cucoranu et al., 2005; Fatma et al., 2009; Meurer et al., 2005; 
Michaeloudes et al., 2011; Ono et al., 2009) and is attributed to the prevention of TGFβ-
mediated EMT (Felton et al., 2009; Lee et al., 2010; Michaeloudes et al., 2011; Rhyu et 
al., 2005; Zhang et al., 2009).  Thus TGFβ signaling has both the capacity to modify the 
redox environment and also be subject itself to regulation by the redox environment. 
Despite extensive studies devoted to the contribution of cellular oxidation on 
many individual biochemical processes involved in TGFβ-induced EMT, inclusion of 
redox markers in the characterization of the multivariate phenotype trajectory has never 
been performed in a systematic manner.  We hypothesized that the previously reported 
cellular oxidation during TGFβ-mediated EMT (Boudreau et al., 2012; Lee et al., 2010) 
reinforce TGFβ signaling in a feed-forward manner during EMT as well as contribute to 
maintenance of mesenchymal differentiation following EMT.  Investigation of the 
aforementioned processes is fraught with the complexity arising from studying a 
transition that involves evaluating epithelial, mesenchymal, Smad signaling, and redox 
regulatory phenotypic characteristics as they evolve over time.  To address the numerous 
interconnected regulators in this biological system, we developed a custom panel of 
markers for a multiwell in-cell western (ICW) assay (Stockwell et al., 1999) that could 
generate time-dependent samples for numerous epithelial, mesenchymal, TGFβ-specific, 
and redox markers.  This data was compiled with other available information for 
multivariate modeling, specifically principal component analysis (PCA), to collapse 
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features of high-dimension, temporal dynamics during EMT into latent variable space.  
This novel experimental and analytical approach allowed us to investigate whether 
cellular redox features are informative metrics of EMT transdifferentiation in A549 lung 
carcinoma cells.  Using PCA we extracted a multivariate description of phenotype during 
the time course of EMT that was capable of interrogating how the cellular redox state 





4.2.1 Visualization of EMT Phenotype Transdifferentiation Trajectories 
Response of A549 cells to TGFβ treatment has been studied extensively; within 
12 hours of treatment more than 2000 genes exhibit differential expression (Ranganathan 
et al., 2007) while down-regulation of E-cadherin and up-regulation of mesenchymal 
proteins is apparent by 24 hours (Kasai et al., 2005; Kim et al., 2007).  To characterize 
multivariate phenotype states during the time course of EMT, we measured the 
expression of 8 proteins, spanning epithelial, mesenchymal, and Smad species, following 
a 200 pM bolus addition of TGFβ.  In-cell western (ICW) assays (Stockwell et al., 1999) 
produce similar data as conventional western blotting but are more proficient in several 
ways, including increased precision and higher throughput (Aguilar et al., 2010).  
We observed decreased E-cadherin and increased αSMA, vimentin, and β-catenin 
expression (Figure 4.1-A), similar to our previous western blot data (Figure 3.1).  
However, the ICW assay yielded high precision results, reflected in the low experimental 
error.  Individual Smad species displayed distinct expression profiles during treatment 
(Figure 4.1-B).  Smad2 expression remained relatively constant up to 72 hours before 
sharply increasing.  Smad3 displayed a biphasic response, initially increasing 1.4-fold 
before decreasing 12 hours post-treatment.  Smad4 levels were suppressed from 30 
minutes through 8 hours before increasing expression at later times.  Phosphorylation of 
Smad3 occurred within minutes of addition of TGFβ and remained sustained up to a 12-




Figure 4.1  ICW Analysis of Protein Dynamics During TGFβ-Mediated EMT. 
A)  Down-regulation of E-Cadherin is apparent at later time points, as is the up-
regulation of mesenchymal markers αSMA, vimentin, and β-catenin.  B)  The dynamic 
profile of each Smad transcription factor is unique.  C)  Smad3 is quickly phosphorylated 
upon the addition of TGFβ and remains elevated until the later time points.  Normalized 
fluorescence values were analyzed using two-way ANOVA (p=0.05) with Dunnett’s 
multiple comparisons test.  The values that differ significantly from the zero time point 
are enclosed within the shaded regions.  Data are the result of 3 independent biological 
replicates (n=3) and were plotted as mean fold-change ± standard error of the mean. 
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Multivariate analysis enables the visualization of covariance among multiple 
variables, such as phenotypic markers (Janes and Yaffe, 2006).  We hypothesized that the 
aspects of differential dynamics displayed by Smad2 and Smad3 would be discernable 
using a multivariate modeling approach to characterize cellular phenotype during EMT.  
We sought to demonstrate the utility of pairing ICW data collection with PCA for 
multivariate characterization and analysis of phenotype dynamics during EMT.  A major 
strength of PCA is that it simplifies large data sets by distilling high-dimensional data 
into principal components (PCs), which are latent variables, composed of a linear 
combination of response variables.  The output of the model is a set of reduced-
dimension PCs, which are composites of weighted response variables that exhibit similar 
“behavior”, as well as a mapping of model observations according to how they align, or 
project, along the nascent PCs. 
In the Scores plot (Figure 4.2-A), which projects observations in latent variable 
space, we observed a clearly demarcated progression of time points starting in the lower 
right-hand quadrant and running counter clockwise into the lower left-hand quadrant.  
The counterclockwise trajectory of observations in the Scores plot moves along PC2 (up) 
before moving along both PC2 (down) and PC1 (left) at later time points (24+ hours); 
therefore we interpret PC1 as differentiating later time points from early or intermediate 
ones. 
Contributions of each protein to the formation of PCs and their relationships to 
each other were characterized in the Loading plot (Figure 4.2-B).  E-cadherin had a 
relatively large weighting on PC1 but essentially none along PC2, indicating that E-
cadherin contributed to the overall data variance captured by PC1 but very little by PC2.  
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Smad4 loading, opposite E-cadherin, indicated an anticorrelated response profile to E-
cadherin. Figure 4.1-A,B suggests both E-cadherin and Smad4 were largely constant 
during the early time points before diverging at later time points.  In this sense, their 
responses “behaved” similarly, contributing to the same PC, though with opposite signed 
weighting to account for their opposing nature (Figure 4.2-B). 
The Biplot (Figure 4.2-C) superimposes observation data from the Scores plot and 
variable data from the Loading plot scaled by their correlation along the PCs.  This serves 
as a tool to associate the relationships between variables and observations.  Since all of 
the response variables, according to loading weights, contributed to the PCs, phenotype 
trajectories represent dynamic responses of numerous proteins.  Close proximity of 
variables to observations indicates that high expression of the variables aids in 
differentiating those observations from the others.  EMT was apparent by the 
anticorrelation between E-cadherin and mesenchymal markers while the anticorrelation 
between Smad3/pSmad3 and Smad2/Smad4 was aligned differently within latent variable 
space, capturing the difference in regulatory time scales.  In this manner, the time course 
of EMT is resolved, according to multivariate phenotypic profiles, through 




Figure 4.2  Multivariate Phenotype Dynamics During TGFβ-Mediated EMT. 
Dimensional reduction through PCA modeling of ICW data resolves the relationships 
between response variables and the EMT time course.  A possible 9 variables (8 proteins 
+ time) are distilled into 2 PCs, or latent variables, composed of protein expression 
variables.  A)  Plots of the observation scores, from three technical replicates, trace a 
trajectory of phenotypic variation in multivariate space during EMT.  The time points are 
resolved along a counter-clockwise path.  B)  Variable contributions to the formation of 
PCs are depicted by their loading weight along the PC axes, i.e. the coordinates (p1, p2) 
where p1 is the weight along PC1.  Co-localized variables are more covariant while 
variables bisected by 0 along a PC are anticorrelated with respect to that PC.  Some 
variables exhibit simple anticorrelation, E-Cadherin with Smad4, while others are 
contextually anticorrelated, e.g. β-catenin with Smad3 along PC1 but not PC2.  C)  The 
biplot contains both scores and loading data, scaled by their correlation along the PCs, 
enabling the analysis of relationships between response dynamics and the EMT time 
course. 16 and 96 hour samples are differentiated by a down-regulation of Smad3 and 
pSmad3 paired with up-regulation of Smad2 and Smad4 over time. 
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4.2.2 Reciprocal Regulation of Antioxidants & NOX4 During EMT 
Numerous studies have examined TGFβ-induced perturbation of isolated 
components involved in redox regulation, yet these studies neglect the complexity of the 
redox environment, which encompasses numerous reactive species and is subject to 
regulation by a variety of production and clearance mechanisms.  The collective response 
of redox regulators has not been characterized.  Using qRT-PCR, we examined an 
extensive array of antioxidant and pro-oxidant modulators of the redox environment 
following 48 hours of TGFβ treatment.  The response of antioxidant and pro-oxidant 
genes were not uniform, with some increasing and some decreasing in each category 
(Figure 4.3).  Numerous antioxidant enzymes, representing distinct antioxidant 






Figure 4.3  Volcano Plot of Anti- & Pro-Oxidant Gene Modulation by TGFβ.  
A549 cells were treated with 200 pM TGFβ for 48 hours, after which the expression of 
antioxidant and pro-oxidant genes were compared against untreated controls via qRT-
PCR.  Genes demonstrating a greater than 2-fold change in expression and a p value less 
than 0.05 are labeled with the gene name.  A comprehensive overview of the PCR array 
results are depicted in Figure A.1.  P values were determined by two-way ANOVA with 
multiple comparisons and the fold-change plotted as the mean ± standard error of the 
mean.  Data are the result of 3 independent biological replicates (n=3). 
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4.2.3 Anticorrelation of Antioxidants with Mesenchymal Phenotype 
The data in Figure 4.3 represents a single point in time and the temporal 
relationship of the enzyme responses with respect to one another and to EMT are unclear.  
For example, the data does not distinguish between coordinated regulation, which would 
enable relative relationships in redox compartmentalization to be maintained, versus 
staggered dynamics, which would focus the pro-oxidant shift to particular redox couples 
or cellular compartments.  In a previous study of TGFβ-mediated EMT in A549 cells by 
Keshamouni et al., Affymetrix microarrays and quantitative mass spectrometry were used 
to identify a very high degree of concordance between transcript and protein expression 
over a 3-day time course (Keshamouni and Schiemann, 2009).  Using this dataset, we 
selected transcripts that were known to be differentiation markers, previously studied in 
TGFβ-induced EMT of A549 cells, or investigated elsewhere in this study.  The changes 
in gene expression measured by PCR (Figure 4.3) were found to be correlated with those 
measured by Keshamouni et al. (Figure A.3).  Microarray transcript expression was 
analyzed by PCA to characterize the transcription dynamics of epithelial, mesenchymal, 
Smad, and redox species. 
Similar to the ICW plot in Figure 4.2-A, the Scores plot of the microarray PCA 
yielded a rotational phenotype trajectory through the four quadrants (Figure 4.4-A).  The 
variable relationships observed are evenly distributed across latent variable space (Figure 
4.4-B); however, PC1 captures the vast majority of model variance and is responsible for 
differentiating early from late observations as they progress from right to left within 
latent variable space while PC2 differentiates early/late from intermediate time points 
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(Figure 4.4-C).  The combination of PC1 and PC2 enables resolution of the full time 
course. 
Closer inspection of the Loadings plot revealed both expected and unexpected 
results.  High antioxidant expression at early time points (Figure 4.4-B; purple diamonds) 
was anticorrelated with high mesenchymal marker expression at late time points (red 
triangles).  NOX4 expression correlated with mesenchymal markers.  Surprisingly 
epithelial markers (blue circles) did not covary during EMT; however, E-cadherin 
(CDH1) did covary with antioxidants and anticorrelate with mesenchymal markers.  























































































































































Figure 4.4  Antioxidant/mesenchymal anticorrelation during EMT. 
PCA modeling of transcript expression during the time course of EMT, from the study by 
Keshamouni et al. (Keshamouni and Schiemann, 2009), displays the transition of 
phenotype states over time.  A)  Observation scores trajectories from three technical 
replicates progress in a clock-wise manner from 0 to 72 hours of treatment.  B)  The 
model was populated by variables commonly used to define epithelial or mesenchymal 
differentiation as well as those pertinent to redox regulation and Smad transcription 
factors.  The anticorrelation of antioxidants (purple diamonds) with mesenchymal 
markers (red triangles) is prominent along PC1.  C)  The biplot, incorporating 
information from both the scores (A) and loading (B) plots, relating the variables that 
define the phenotype with the time course on which they change.  The path of the 
phenotype trajectory, predominantly along PC1, demonstrates that PC1 explains the 
majority of the model variance.  The antioxidant/mesenchymal anticorrelation is a major 
contributor to explaining differentiation between untreated and EMT-transformed cells. 
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4.2.4 TGFβ Treatment Decreases Ducleophilic Tone 
Covariance of antioxidant enzymes with epithelial markers and NOX4 with 
mesenchymal markers suggests that remodeling of the intracellular redox processes 
occurs over longer time scales, on the order of days.  However, remodeling at the 
transcriptional level does not necessarily ensure that functional remodeling of the 
intracellular redox environment will ensue.  To further investigate intracellular redox 
processes, we incubated TGFβ-treated A549 cells with the oxidation-activated 
fluorescein dye CM-H2DCF-DA.  Three days of TGFβ-treatment led to increased CM-
H2DCF-DA fluorescence (solid circles), which was enhanced in the presence of H2O2 
(open squares; Figure 4.5-A).  Furthermore, pre-incubation with antioxidants NAC and 
catalase resulted in decreased CM-H2DCF-DA fluorescence, matching levels of the 
untreated control (Figure 4.5-B).  In a time course study, mirroring the ICW analysis, 
significant increases in fluorescence of 2, 3.5, and 5-fold were observed at 48, 72, and 96 
hour treated conditions compared to untreated controls (Figure 4.5-C), indicating 








Figure 4.5  ROS Contribute to H2DCF-DA Oxidation During TGFβ-Mediated EMT. 
A)  Flow cytometric analysis of CM-H2DCF-DA (10 µM, 30 min) fluorescence in 
untreated and 200 pM TGFβ-treated A549 cells (solid circles) as well as with their 
counterparts receiving H2O2 co-administration (250 µM, 15 min; open squares).  Samples 
with respective significant differences are demarcated (*).  B)  CM-H2DCF-DA 
fluorescence following 1 hour pre-incubation with antioxidants NAC or catalase.  
Samples differing significantly from the 3-day TGFβ treated condition are enclosed 
within the shaded region.  C)  CM-H2DCF-DA fluorescence time course during EMT 
measured by plate assay.  Time points differing significantly from the untreated control 
(0 hours) are enclosed within the shaded region.  All data are the result of 3 independent 
biological replicates (n=3) and plotted as the geometric mean ± standard error of the 




Owing to pronounced down-regulation of numerous antioxidant enzymes, we 
hypothesized that TGFβ-treated cells will exhibit a decreased rate of H2O2 clearance from 
the extracellular environment.  Following a bolus addition of 20 µM H2O2, we measured 
the persistence of extracellular H2O2 using a luminol/sodium hypochlorite assay over a 60 
minute time course (Figure 4.6-A).  The extracellular H2O2 concentration decreased over 
time and was used to calculate a relative rate of H2O2 clearance from the media.  The 
H2O2 degradation rate (kdeg) was found to be decreased in TGFβ treated cells to ~3/4 the 
rate of untreated controls (Figure 4.6-B).  
Numerous regulators of GSH metabolism were among the antioxidant enzymes 
down-regulated following TGFβ treatment (Figure 4.3 & 4.4).  Among them, glutamate-
cysteine ligase catalytic subunit (GCLC) and glutamate-cysteine ligase regulatory subunit 
(GCLM) regulate GSH production, while glutathione reductase (GSR) mediates reduction 
of GSSG. (Lu, 2013) Therefore, we hypothesized that intracellular glutathione redox 
potential would become more oxidized.  Calculation of the GSSG/2GSH redox potential 
necessitates knowledge of the absolute concentrations of GSH and GSSG. (Schafer and 
Buettner, 2001) Vi-Cell XR analysis revealed a 1% reduction in viability (Figure A.5 A), 
no significant difference in circularity (Figure A.5-B), and a 1.1 µm decrease in cell 
diameter (Figure A.5-C) in 96-hour TGFβ treated cells compared to untreated control.  
Cell volumes were computed from the cell diameters (Figure A.5-D) and used to 
determine intracellular concentrations of GSH and GSSG.  Intracellular GSH and GSSG 
concentrations were measured following 0, 48 and 96 hours of TGFβ treatment and used 
to calculate the half-cell reduction potential, or redox potential, (EGSH) of the 
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GSSG/2GSH redox couple, which was observed to increase +6.8 mV (p < 0.05) 







Figure 4.6  TGFβ Treatment Decreases Nucleophilic Tone. 
A)  Exogenous H2O2 was administered to cells in a 96-well plate and the H2O2 remaining 
in the media was measured at serial time points to determine the rate of H2O2 degradation 
(kdeg).  B)  Following TGFβ treatment (200 pM), the relative rate of H2O2 degradation 
from the media (kdeg) was measured with relative to the untreated control.  C)  The GSH 
and GSSG content of A549 cells were measured after multiple days of TGFβ treatment 
and used to calculate the half-cell reduction potential, or redox potential (EGSH), of the 
GSSG/2GSH redox couple.  Data are the result of 3 independent biological replicates 
(n=3) and plotted as mean ± standard error of the mean.  Time points differing 
significantly from the untreated control, as determined by one-way ANOVA (p=0.05), 
are enclosed within the shaded regions. 
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4.2.5 Loss of Nucleophilic Tone Coincides with EMT 
We further investigated phenotype dynamics during the EMT time course by 
creating a multivariate model comprised of aggregated data from ICW protein 
expression, microarray transcript expression, CM-H2DCF-DA oxidation, H2O2 
degradation, and GSSG/2GSH redox couple studies.  The majority of microarray 
transcript data were culled, but markers related to H2O2 production and degradation and 
regulation of the GSSG/2GSH redox couple were retained.  A key strength of PCA is its 
ability to identify correlative relationships in complex, incomplete data sets, even those 
composed of data from a variety of methods of measurement and even nominal 
classifications. 
Time point observations fell roughly along the typical rotational trajectory within 
the Scores plot with PC1 resolving early from late time points and PC2 resolving 
intermediate from early and late time points (Figure 4.7-A).  The 24-hour time point 
deviated slightly, which can be partially explained by the non-monotonic trend of 
pSmad3, Smad3, Kdeg values.  The Loadings plot is consistent with the ICW and 
microarray PCA models with the anticorrelation between epithelial/antioxidant markers 
and mesenchymal markers (Figure 4.2-B; 4.4-B; 4.7-A).  Many transcript/protein pairs 
are correlated.  In fact, in a model composed of exclusively transcript/protein pairs across 
the entire time course (Figure A.11), correlation of transcript/protein dynamics is very 
evident.  
The Biplot enables the assessment of functional aspects of the redox environment 
within the context of EMT by combining the results of redox assays (black crosses) to be 
combined with transcript and ICW data (Figure 4.7-C).  The majority of model variance 
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is explained by PC1, along which several trends are apparent.  Indicators of nucleophilic 
tone (Kdeg, GSH, total GSH, and GSSG levels) correlate with antioxidant and epithelial 
marker expression, indicating regulation of dynamics along similar time scales.  
Likewise, oxidizing shifts in CM-H2DCF-DA and EGSH data correlate with NOX4 
expression and are anticorrelated with nucleophilic tone and antioxidants.  In this manner, 
we observe that the loss of nucleophilic tone that follows TGFβ-treatment coincides with 







Figure 4.7  Aggregated PCA Model from Microarray, ICW, & Redox Assays. 
PCA allows for the comparison of multiple types of data, obtained in a variety of 
experimental settings.  In this aggregated model, transcript expression, protein 
expression, CM-H2DCF-DA oxidation, H2O2 degradation rates (Kdeg), and GSSG/2GSH 
redox couple data provide a multivariate description of phenotype.  A)  The scores follow 
the phenotype through a rotational trajectory.  The single score trajectory reflects the loss 
of technical replicates upon data aggregation.  B)  Variable loading, and thus PC 
composition, is derived from multiple data sets, including microarray transcript (open 
markers), ICW (closed markers), and redox assay (cross markers) data sets.  C)  The 
biplot of the aggregated data PCA model, interrelating the information from the Scores 
and Loading Plots. 
  
 74 
4.2.6 Mesenchymal Phenotype is Stable to Redox Perturbation 
Based on antioxidant antagonism of TGFβ signaling and the observed decrease in 
nucleophilic tone during EMT, we hypothesized that enhanced redox processes and 
continued TGFβ signaling serve to stabilize the mesenchymal phenotype following EMT.  
To determine whether the maintenance of a mesenchymal phenotype is dependent on 
redox processes and/or continued TGFβ input, we established a regimen of daily TGFβ 
supplementation, up to 4 days.  After 2 days, TGFβ treatment media was exchanged in a 
set of intervention conditions with plain media or supplemented with neutralizing anti-
TGFβ antibody, TGFβ signaling inhibitor (A8301), NAC, ebselen, or DMSO for an 
additional 2 days.  Following treatment, we used ICW analysis to measure the response 
of epithelial, mesenchymal, antioxidant, and TGFβ signaling phenotype markers.  
The responses profiles of the variables to this course of treatments were varied.  
Following 4 days of TGFβ treatment, E-cadherin (Figure 4.8-A), glutaredoxin-1 (4.8-B), 
and catalase (4.8-C) and the Smads (4.8-G, I) underwent down-regulation while β-catenin 
(4.8-D), vimentin (4.8-E), Slug (4.8-F), pSmad3 (4.8-J), and pErk1/2 (4.8-K) exhibit up-
regulation.  Notably, at later time points, Smad2 and Smad4 levels increased, while 
pSmad3 levels decreased slightly, matching the trends of differential Smad regulation 







Figure 4.8  ICW Phenotype Profiles of Antioxidant Perturbed EMT. 
A549 cells were treated up to 4 days, with daily replacement of TGFβ, to induce EMT.  
An intervention set received 2 days of TGFβ treatment followed by replacement of TGFβ 
media with plain, neutralizing anti-TGFβ antibody, TGFβ inhibitor A8301, NAC, 
ebselen, or DMSO-containing media for additional 2 days.  The expression of 
epithelial/mesenchymal markers, antioxidants, Smads, and pErk1/2 were then measured 
via ICW assay.  Normalized data are the result of 3 independent biological replicates 
(n=3) and plotted as mean ± standard error of the mean. 
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Given the high dimensionality of this data set, we again used PCA to aid our 
analysis the transdifferentiation and response trajectories.  The rotational phenotype 
trajectory for EMT is evident as the solid line in the Scores plot (Figure 4.9-A).  
Compared to the EMT phenotype resulting from a single bolus addition of TGFβ (Figure 
4.2), the phenotype trajectory resulting from daily administration of TGFβ (Figure 4.9) 
shares similar temporal ordering of variable relationships, including anticorrelation of E-
cadherin and antioxidants with mesenchymal markers and differential Smad regulation.  
The conditions from the intervention set (dashed lines) arise from the 2-day TGFβ treated 
samples.  Examination of the Loading plot reveals familiar variable relationships, such as 
anticorrelation of E-cadherin and antioxidant markers with mesenchymal markers as well 
as anticorrelation of pSmad3 with Smad2/Smad4 (Figure 4.9-B).  The relationship 
between the variable loadings and the observation scores from all of the replicates are 
displayed in the Biplot (Figure 4.9-C).  
The response of marker expression to cessation of TGFβ signaling within the 
intervention set, 2 days of TGFβ treatment followed by supplemented media, was quite 
varied (Figure 4.8) though the resultant phenotypes of each treatment condition were 
similar (Figure 4.9).  Intervention of TGFβ treatment with supplemented media took 
place after 2 days of TGFβ treatment.  Compared to the 2-day treated condition, those 
within the intervention set are notable for little to no change in expression of E-cadherin, 
β-catenin, vimentin, and Smad3 while glutaredoxin-1, Slug, pSmad3, and pErk1/2 
expression decreases (Figure 4.8).  However, catalase, Smad2, and Smad4 expression 
increases following cessation (Figure 4.8).  PCA aids in visualizing these responses.  The 
intervention conditions (dashed lines) follow a trajectory along PC2, remaining fairly 
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constant along PC1 (Figure 4.9-A).  Variables with the largest response following 
intervention and cessation possess loading in latent variable space more heavily weighted 
along PC2 and less so along PC1 (Figure 4.9-B, e.g.  Smad4).  In contrast, variables 
exhibiting little change following cessation of TGFβ signaling possess loading mostly 







Figure 4.9  PCA of Phenotype Profiles During Antioxidant Perturbed EMT. 
Induction of EMT with daily 100 pM TGFβ treatment was intervened after 2 days with 
plain media, neutralizing anti-TGFβ antibody, A8301, NAC, ebselen, or DMSO.  A)  The 
scores from a representative replicate (replicate #2) are projected along the PCs.  The 
rotational trajectory of EMT is traced in black (solid) while the intervention set (dashed) 
is distinguished from the other conditions.  The phenotype trajectories replicates #1 and 
#3 can be seen in the biplot or in Figure A.12.  B)  Variable influence on PC composition 
reveals anticorrelation of E-Cadherin/Smad3/antioxidants with mesenchymal markers as 
well as of pSmad3/pErk1/2 with Smad2/Smad4.  C)  The differences in relative 
pSmad3/pErk1/2 and Smad2/Smad4 expression contribute to differentiation of 
intervention conditions from the 2-day TGFβ conditions while E-cadherin, antioxidant, 




Following TGFβ treatment, A549 cells undergo EMT, which is apparent by the 
down-regulation of E-cadherin and up-regulation of N-cadherin.  Overall trends in these, 
and other markers, match changes in expression previously reported during TGFβ-
mediated EMT in A549 cells (Kasai et al., 2005; Kim et al., 2007); however, each of the 
markers possesses a distinct dynamic profile (Figure 4.1 & 4.2).  Differential regulation 
of the Smads during TGFβ-mediated EMT has been previously reported (Brown et al., 
2004; Yanagisawa et al., 1998) and responses are cell-type specific. (Poncelet et al., 
2007).  Broadly speaking, the differentiation markers and Smads suggest the phenotype 
profile is dynamic and that no two time-points are the same; therefore accurately 
determining which variables contribute to this differentiation is challenging even in this 
modest sized data set.  Our implementation of the ICW assay has enabled greater 
resolution of the time course dynamics of Smad species along with epithelial and 
mesenchymal markers than is readily achievable using traditional western blotting 
approaches.  The higher throughput afforded by ICW coupled with multivariate analysis 
enabled us to resolve the time-dependent nature of differential Smad regulation within the 
context of EMT. 
Prior studies have identified TGFβ as a regulator of NOX4 and antioxidant 
enzyme expression.  For example, NOX4 up-regulation by TGFβ is Smad3-dependent 
(Boudreau et al., 2012; Hecker et al., 2009).  Similarly, TGFβ, via Smad3, mediated the 
up-regulation of NOX4 as well as the down-regulation of catalase and manganese 
superoxide dismutase (Michaeloudes et al., 2011).  In other studies, TGFβ led to the 
down-regulation of antioxidant components, such as catalase, glutathione reductase, 
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glutathione, glutathione synthetase (Arsalane et al., 1997; Jardine et al., 2002), glutamate 
cysteine ligase (Bakin et al., 2005), and glutaredoxin-1 (Peltoniemi et al., 2004).  
Significantly, these findings were observed in various cell types, with differing doses of 
TGFβ treatment, and at numerous times.  Our findings of 50-fold NOX4 up-regulation 
concomitant with down-regulation of numerous key antioxidant enzymes (Figure 4.3) 
establishes clear anticorrelative changes at a single time point but alone does not 
discriminate between the possible synchronous expression changes that may coordinate 
remodeling of the redox environment or asynchronous regulation that may lead to 
competitive dynamics between oxidases and reductases.  
The remodeling of phenotype following TGFβ treatment can be interrogated 
through a variety of methods, each of which, independently, has its own technical 
requirements and limitations.  The high degree of concordance between transcript and 
protein expression shown here and reported by Keshamouni et al. (Keshamouni and 
Schiemann, 2009), suggests that many of the transcript dynamics during EMT are likely 
to be reflected in the corresponding protein expression dynamics.  Additionally, the union 
of these data sets enables the comparison high dimensional time course data from 
dissimilar modalities.  A prominent feature of our PCA approach was the down-
regulation of antioxidant expression on the same time scale (along PC1) during which 
mesenchymal expression is acquired during TGFβ treatment.  Had the antioxidant and 
mesenchymal markers also been anticorrelated along PC2, it would have indicated that 
antioxidants were down-regulated before mesenchymal markers were up-regulated.  
Therefore, we find that the transcriptional down-regulation of antioxidant enzymes 
temporally coincides with the up-regulation of mesenchymal marker transcripts. 
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Because the set of epithelial markers (blue circles) did not covary in expression 
during EMT, some of these transcripts, assessed in isolation, may report a false 
characterization of phenotype.  Indeed, a survey of several models of TGFβ-induced 
EMT identified numerous mixed or up-regulated epithelial markers (Chai et al., 2010).  
As with the A549 cells, many of these cell lines were of cancerous origin.  Thus, such 
seemingly contradictory findings may not reflect the biological response of normal 
epithelia to TGFβ, but may be a feature not uncommon amongst highly transformed cells. 
We have demonstrated that, following the widespread down-regulation of 
antioxidants, functional aspects of the intracellular redox environment shift in a manner 
that would favor the stability and reactivity of electrophiles and reactive species.  
Increased CM-H2DCF-DA oxidation indicates that oxidizing reactions are more favored 
following TGFβ treatment, which is corroborated by decreased CM-H2DCF-DA 
fluorescence following pre-treatment with the antioxidants NAC and catalase (Figure 4.5 
B).  Following TGFβ treatment, enhancement of several possible redox mechanisms, in 
isolation or combination, may account for the increased CM-H2DCF-DA oxidation.  
Decreased kdeg rates (Figure 4.6-B) reflect an impaired ability to eliminate electrophiles, 
such as H2O2, which can contribute to CM-H2DCF-DA oxidation (Figure 4.5-A).  It is 
possible that decreased H2O2 transport rates across the plasma membrane could explain 
the decreased kdeg values; however, the equilibration of exogenous H2O2 across the 
plasma membrane occurs on the order of 1 second (Antunes and Cadenas, 2000), while 
the half-life of H2O2 in the media was on the order of 10 minutes, indicating that 
membrane transport is not a rate-limiting step.  A more likely mechanism of decreased 
kdeg values following TGFβ treatment is a decreased capacity for flux through the 
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multiple antioxidant pathways capable of degrading H2O2.  Finally, the more oxidizing 
EGSH indicates the electrochemical capacity of the GSH redox buffer to clear electrophiles 
through reductive mechanisms is decreased.  Therefore, the multifactorial effects of 
TGFβ on the redox environment result in decreased nucleophilic tone. (Forman et al., 
2014) Further, our results indicate that the effect of TGFβ on a specific redox couple, 
such as GSSG/2GSH, may reflect perturbed regulation of numerous redox interconnected 
pathways, which are maintained in a non-equilibrium state (Kemp et al., 2008).  For 
example, GSH (Arsalane et al., 1997; Bakin et al., 2005; Jardine et al., 2002), 
glutaredoxin-1 (Lee et al., 2010; Peltoniemi et al., 2004), MnSOD, catalase, and NOX4 
(Michaeloudes et al., 2011) are among the identified factors that have been found to be 
responsible for modulating the redox environment in response to TGFβ and the induction 
of EMT.  Choosing a specific antioxidant enzyme, however, while ignoring others, and 
attributing its activity to an isolated effect within the redox environment is a gross over-
simplification in the setting of TGFβ-mediated transcriptional reprogramming.  
We observe the loss of nucleophilic tone to be coincident with change in 
phenotype that defines EMT (Figure 4.7)  Furthermore, we observed the correlation of 
antioxidants with ferritin heavy chain (FTH1) expression (Figure 4.3 & 4.4).  Within 
A549 cells, increased free intracellular iron and down-regulation of antioxidants have 
been reported as mechanisms leading to increased H2DCF-DA oxidation following TGFβ 
treatment (Bakin et al., 2005; Jardine et al., 2002; Zhang et al., 2009), though ROS 
production may be a contributory factor following EMT.  NOX4 protein expression, and 
activity, producing H2O2, is known to vary proportionally with NOX4 mRNA transcript 
expression (Serrander et al., 2007).  Given the widely reported lack of specificity of 
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H2DCF probes for specific ROS or redox reactions (Kalyanaraman et al., 2012; Karlsson 
et al., 2010; Wardman, 2007), and the observed dynamics of the vast number of factors 
that regulate the redox environment, attempts to identify specific factors responsible for 
CM-H2DCF-DA oxidation would be a futile.  Increased NOX4, increased free iron, wide 
spread antioxidant down regulation, or any combination thereof are under dynamic 
control throughout EMT and can participate in processes that lead to CM-H2DCF-DA 
oxidation. 
Smads have been shown to exhibit redox regulation (Cucoranu et al., 2005; Fatma 
et al., 2009; Meurer et al., 2005; Michaeloudes et al., 2011; Ono et al., 2009) and TGFβ 
can induce changes in the redox environment (Arsalane et al., 1997; Boudreau et al., 
2012; Felton et al., 2009; Hecker et al., 2009; Lee et al., 2010; Peltoniemi et al., 2004; 
Zhang et al., 2009).  Therefore, it was possible that modulation of the redox environment 
precedes the differentiation along the epithelial/mesenchymal spectrum and alters Smad 
signaling in the process.  Our study allowed for elucidation of the temporal relationship 
between reprogramming of the redox environment and the induction of EMT by TGFβ.  
The dynamics of CM-H2DCF-DA oxidation and glutathione potential (Figure 4.6) are 
consistent with the results in Figure 4.4, indicating that decrease in nucleophilic tone 
occurs during the course of EMT, not preceding it.  Further, the decreased tone occurs at 
too late a time to account for elevation of pSmad3 levels (Figure 4.1-C).  These findings 
relate the natural dynamic response of the redox environment to signaling and 
differentiation caused by TGFβ during EMT.  Previous studies linking H2O2 treatment 
with the induction of TGFβ-mediated, pSmad3-dependent EMT in A549 cells relied upon 
exogenous administration of hyper-physiological levels of H2O2 (Gorowiec et al., 2012).  
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Our findings negate a potential mechanism of TGFβ-mediated EMT via an induced feed-
forward loop that would enhance Smad3 phosphorylation by decreased nucleophilic tone. 
We observed anticorrelation of pSmad3 with Smad2 and Smad4 (Figure 4.9-B), 
which was also a feature in the initial EMT time course study (Figure 4.2-B).  In 
agreement with previous studies (Brown et al., 2004; Poncelet et al., 2007; Yanagisawa et 
al., 1998), daily TGFβ treatment resulted in suppressed Smad3 levels (Figure 4.8-H).  
Cessation of TGFβ signaling had no effect on Smad3, suggesting its expression is 
independent of active TGFβ signaling.  Smad2 and Smad4, however, exhibited a strong 
up-regulation, suggesting that cessation of TGFβ signaling and pSmad3 activity may 
enable subsequent Smad2 and Smad4 up-regulation.  The differential Smad activities 
operated independently from the state of differentiation and presence of exogenous 
antioxidants. 
While we anticipated a relative loss of mesenchymal phenotype, via MET, for the 
intervention set conditions, the expression of E-cadherin, β-catenin, and vimentin 
remained largely unchanged.  The failure of most of these conditions to exhibit a relative 
MET is notable for several reasons.  NAC and ebselen treatments, common non-specific 
antioxidants, were not able to rescue an epithelial phenotype following EMT, nor were 
inhibitions of TGFβ.  Each of the intervention conditions, except plain media and DMSO, 
are known to inhibit TGFβ signaling at the concentrations used and through independent 
mechanisms: neutralizing anti-TGFβ antibody (Brown et al., 2012), A8301 (Aref et al., 
2013; Tojo et al., 2005), NAC (Cucoranu et al., 2005; Li et al., 2004; Lichtenberger et al., 
2006; Meurer et al., 2005; Rhyu et al., 2005), ebselen (Michaeloudes et al., 2011).  NAC 
(Felton et al., 2009; Rhyu et al., 2005) and A8301 (Tojo et al., 2005) inhibit TGFβ-
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mediated EMT, presumably through inhibition of TGFβ signaling and Smad3 
phosphorylation.  TGFβ signaling is decreased within the intervention set compared to 
the 2-day treatment condition, as indicated by decreased slug, pSmad3, and pErk1/2 
expression (Figure 4.8).  Smad expression exhibited vast remodeling, irrespective of 
maintenance of the mesenchymal phenotype or redox perturbation.  Therefore, it appears 
that sustained TGFβ signaling and pSmad3 activity is not required to maintain a 
mesenchymal phenotype and that the state of differentiation following 2 days of TGFβ 
treatment is stable over the course of 2 days, even in the absence of continued TGFβ 
signaling or when augmented by exogenous antioxidants. 
A8301-treated cells displayed a slight distinction from the rest of the intervention 
group in that in addition to displacement along PC2, its position also reversed along PC1 
compared to the 2-day treated condition, suggesting a slight MET-type differentiation 
(Figure 4.9).  Slight elevations in expression of markers correlated with an epithelial 
phenotype are consistent in the A8301 condition compared to the rest of the intervention 
set (Figure 4.8-A-C, H).  A8301, a TGFβ receptor kinase inhibitor, most strongly inhibits 
TGFβ signaling but it also significantly inhibits a number of other pathways, such as 
VEGFR, RIPK2, MINK1, p38α MAPK, PKD1, FGFR1, and CK1 (Vogt et al., 2011).  
Phospho-Erk1/2 expression is slightly suppressed in the A8301 condition, return to near 
baseline levels, while pErk1/2 levels remain slightly elevated compared to the untreated 
control (Figure 4.8-K).  
It is possible that pErk1/2 activity is sufficient to maintain the mesenchymal 
phenotype and that A8031 activity, directly or indirectly, inhibits pErk1/2 and in doing so 
induces MET.  MAPKs and a number of other signaling pathways are components of 
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non-canonical TGFβ signaling (Zhang, 2009).  However, as neutralizing anti-TGFβ 
antibody and exogenous antioxidants failed to induce MET, it appears that neither 
canonical nor non-canonical TGFβ signaling is responsible for maintenance of the 
mesenchymal phenotype.  Still, pErk1/2 may serve to maintain phenotype.  MEK 
inhibition has been demonstrated as a means to prevent TGFβ-mediated EMT, 
implicating a mechanism of Erk activation in the induction of EMT (Chen et al., 2011; 
Niu et al., 2012; Xie et al., 2004).  Alternatively, MEK inhibition was also demonstrated 
to be ineffective in the prevention of EMT but found to be critical for the induction of 
FGF1-mediated reversal of EMT (MET) (Ramos et al., 2010).  Similar findings have 
been described for other non-canonical pathways (Chen et al., 2011; Fong et al., 2009; 
Janda et al., 2002; Zhang et al., 2010).  The collaboration of multiple signaling pathways, 
sometimes referred to as cross-talk, in the propagation of signals are likely to be critical 
components in the determination of cell fate rather than auxiliary pathways.  Such 
scenarios highlight the complex, multivariate, non-linear nature in which biological 
systems are controlled. 
A549 cells are an immortalized lung carcinoma cell line (Giard et al., 1973), in 
which the responses to TGFβ have been studied extensively.  Studies of more focused 
aspects of phenotype (e.g.  EMT, antioxidant down-regulation, or NOX4 up-regulation) 
are critical for our understanding of molecular mechanisms of transdifferentiation but 
underappreciate the scope and scale in which TGFβ-mediated transformation occurs.  
Here we demonstrate that such characteristics do not operate in isolation and that the 
response of A549 cells to TGFβ involves remodeling of the redox environment, resulting 
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in decreased nucleophilic tone, induction of EMT, and perturbation of Smad transcription 
factor expression.  
Under normal developmental conditions, EMT is a highly coordinated and 
regulated effort, subject to control by multiple extracellular and intracellular signaling 
pathways, including MAPKs (Thiery et al., 2009).  Our results suggest that in the A549 
cell line, the induction of TGFβ-mediated EMT is intrinsically different from the reversal 
of EMT via MET.  A549 cells are, in a sense, primed for response to TGFβ as they 
possess an activating Ras mutation (Valenzuela and Groffen, 1986), which is a key 
enabler of TGFβ-mediated EMT (Horiguchi et al., 2008).  Similarly, in mouse mammary 
epithelial cells, transformation via H-Ras conferred the ability to undergo TGFβ-
mediated EMT and maintain the resultant mesenchymal phenotype to untransformed cells 
(Janda et al., 2002).  In the same cell lines, glutaredoxin down-regulation by TGFβ was 
found to be MAPK-mediated and its overexpression prevented induction of EMT (Lee et 
al., 2010) underscoring the interconnectedness of EMT and the redox environment.  
While the decreased nucleophilic tone acquired during EMT may not serve to stabilize 
the mesenchymal phenotype, the altered redox environment may play a role in other 
cellular behaviors such as enhanced cell motility (Boudreau et al., 2012; Tobar et al., 
2010) or apoptotic resistance (Black et al., 2004; Sancho and Fabregat, 2011).  Cannito et 
al. have presented an extensive review of the numerous redox mechanisms that have been 
identified within the context of various models of EMT (Cannito et al., 2010).  
Transformed cells may be primed for EMT through perturbed intracellular signaling or 
altered redox states.  Judicious attribution or negation of such mechanisms for a particular 
cell type would require extensive study.  
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The A549 cell line is a transformed carcinoma cell line that exhibits phenotypic 
deviations from healthy primary lung epithelia.  A549 cells exhibit an intermediate 
phenotype, displaying some mesenchymal characteristics alongside the epithelial 
phenotype (Huang et al., 2013).  Additionally, antioxidant enzymes are highly expressed 
(Eriksson et al., 2009; Kweon et al., 2006).  An impaired Keap1-Nrf2 interaction in A549 
cells has resulted in a much greater nucleophilic tone compared to non-malignant cells 
(Singh et al., 2006).  Therefore our observations about the multivariate nature of EMT 
should be best understood in the context of highly transformed cells responding to TGFβ, 
as might occur within the tumor microenvironment.  In such transformed tissues, 
reversion of a TGFβ-influenced mesenchymal phenotype is not likely to be as simple as 
blockade of TGFβ signaling.  Thus administration of treatments using non-specific 
antioxidants, small molecule inhibitors, or biologics that specifically target TGFβ 
signaling may be insufficient; however, such treatments may play key roles in 
combination therapies that attempt to restore normal function through systems level 
approaches.  More robust characterization of multivariate phenotype dynamics will allow 
for parsing of covariant phenotypic programs, which will improve our ability to modulate 
specific cellular behaviors and responses. 
4.4 Conclusions 
The phenotypic response of A549 cells to TGFβ treatment is an extensive and 
dynamic process with relevance to carcinogenesis and other pathologies.  The precision 
and reproducibility afforded by ICW techniques allowed us to construct a multivariate 
representation of phenotype dynamics during EMT using PCA.  This model demonstrated 
the validity of the approach, robustness of the transdifferentiation trajectories, and helped 
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generate additional research questions.  We examined the scope of redox remodeling 
during EMT and found that multiple antioxidants enzymes are down-regulated while the 
oxidase NOX4 is up-regulated by TGFβ on a time scale that matches the acquisition of a 
mesenchymal phenotype.  Increased CM-H2DCF-DA oxidation, decreased H2O2 
degradation, and elevated GSSG/2GSH redox potentials provided additional functional 
evidence of decreased nucleophilic tone in parallel with the acquisition of the 
mesenchymal phenotype.  Following EMT in A549 cells, the mesenchymal phenotype 
was stable in the presence of the antioxidants NAC and ebselen as well as TGFβ 
inhibition through neutralizing antibody and the small molecule inhibitor A8301.  
Additionally, we observed differential Smad dynamics operating independently of 
epithelial/mesenchymal differentiation.  This novel approach enabled the investigation of 
the dynamics of multivariate phenotype states as they developed over time.  This 
investigation yielded a new perspective on the state of intracellular redox environment 
within the context of EMT. 
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4.5 Materials & Methods 
4.5.1 Cell Culture & Treatment Conditions 
A549 lung carcinoma cells were obtained from American Type Culture Collection 
(ATCC; CCL-185) and maintained in high glucose DMEM with L-glutamine (Sigma 
D5796), 10% FBS (Sigma F4135) and penicillin (50 IU/ml)-streptomycin (50 µg/ml) 
(Cellgro 30-001-CI).  Cells were plated in 96-well plates at density of 5,000 cells per well 
in growth media and maintained at 37˚C and supplemented with 5% CO2.  The following 
day, the cells were serum starved with reduced serum (0.5% FBS) media for 24 hours 
prior to treatment.  Cells were maintained and treated in 175 µl media per well.  Cells 
were treated with a bolus of 200 pM TGFβ for the EMT time course, qRT-PCR, CM-
H2DCF-DA, and H2O2 degradation studies.  For the GSH study, cells were seeded in T-
75 flasks at a density of 5,000 cells/cm
2
 and maintained in 15 ml of culture media.  
Culture media for the EMT intervention study was changed daily and consisted of either 
plain media, 100 pM TGFβ (Millipore, GF111), 10 µg/ml neutralizing anti-TGFβ 
antibody (R&D Systems, MAB240), 2 µM A8301 (Santa Cruz, sc-203791; mobilized in 
DMSO), 2 mM N-Acetyl-L-cysteine (NAC; Sigma-Aldrich, A9165), 2 µM ebselen (Alfa 
Aesar, J63190; mobilized in DMSO), or 0.2% v/v DMSO (Fisher Scientific, BP231).  All 
experiments were the result of three independent biological replicate experiments. 
4.5.2 In-Cell Western (ICW) Assay 




 and fixed with 
100 µl 4% paraformaldehyde per well for 20 minutes at ambient temperature.  The cells 
were permeabilized by washing five times with 50 µl 0.1% Triton X-100 solution for 5 
min with gentle rotation at ambient temperature.  The plates were blocked with 100 µl of 
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blocking buffer consisting of 0.5x Rockland Blocking Buffer for Fluorescent Western 
Blotting (MB-070) in tris-buffered saline (TBS) for 1.5 hours with gentle rocking at 
ambient temperature.  Following blocking, cells were immunostained with 35 µl of 1˚ 
antibody solutions (Table S3) overnight at +4˚C with gentle rotation in blocking buffer 
supplemented with 0.1% Tween-20.  The plates were then washed five times with TBS-T 
(TBS with 0.1% Tween-20) under gentle rotation at ambient temperature for 5 minutes 
each.  Plates were stained with 45 µl Donkey anti-Rabbit antibody (1:800; LiCor, IRDye 
800CW, 926-32213) and CellTag 700 (0.2 µM; LiCor, 926-41090) in blocking buffer 
supplemented with 0.2% Tween-20 for 1.5 hours.  The plates were washed four times 
with TBS-T and once with TBS before being emptied and sealed for imaging.  Signal 
intensities in the 700 nm and 800 nm channels were measured on stained plates via LiCor 
Odyssey system and analyzed in LiCor Image Studio (v2.1.10).  For a given well, non-
specific secondary antibody background staining (800background) was subtracted from the 
raw 800 channel intensity (800raw) to yield the 800 channel signal (800signal) intensity.  
The loading control normalized signal intensity was determined by dividing 800signal by 
the 700 channel signal intensity.  To normalize individual signals across plates, the 
loading control normalized signal intensity was divided by the average loading control 




Table 4.1  Primary Antibody Conditions for ICW Staining 
Target Vendor Clone Product No. Dilution 
E-cadherin Cell Signaling 24E10 3195 1:400 
Vimentin Cell Signaling D21H3 5741 1:200 
β-catenin Cell Signaling 6B3 9582 1:200 
α-Smooth Muscle Actin abcam Polyclonal ab5694 1:100 
Smad2 Cell Signaling D43B4 5339 1:100 
Smad3 Cell Signaling C67H9 9523 1:100 
p-Smad3 abcam EP823Y ab52903 1:400 
Glutaredoxin-1 abcam Polyclonal ab45953 1:500 
Catalase Cell Signaling D4P7B 12980 1:800 




4.5.3 Quantitative Real-Time PCR 
Cells were seeded in T-175 flasks at a density of 5,000 per cm
2
 and serum starved 
(0.5% FBS) the next day.  On the following day, cells were treated with 200 pM TGFβ 
for 48 hours.  Cells were trypsinized and 10
6
 cells lysed and homogenized (QIAshredder, 
Qiagen, 79656).  Next, RNA was isolated via RNeasy Mini kit (Qiagen, 74104), genomic 
DNA digested (Qiagen, RNase-free DNase Set, 79254), and the RNA concentration 
determined by NanoDrop.  Isolated RNA (2 µg) was converted to cDNA (Qiagen, RT
2
 
First Strand Kit, 330401), prepared for amplification (Qiagen, RT
2
 SYBR Green ROX 
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qPCR Mastermix, 330522), loaded onto the Oxidative Stress Plus PCR Array (Qiagen, 
PAHS-065YC; primers detailed in Table S4), and amplified via thermocycling (Applied 
Biosystems, Step One Plus Real-Time PCR System; 40 cycles).  Genes in the array were 
categorized as “antioxidant”, “pro-oxidant”, “undetermined significance”, or as a 
housekeeping gene upon review of the particular entry in the NCBI Gene Database for 
each gene.  Following amplification, samples were analyzed as instructed by the Qiagen 
product materials, with the exception of using ANOVA with Fisher’s Least Squares 
Difference in place of the Student’s T-test to determine significance of up/down-
regulation of transcripts following TGFβ treatment.  P values < 0.0001 were arbitrarily 
set to 0.0001.  Transcript Ct values were normalized to loading controls ACTB, GAPDH, 
HPRT1, B2M, and RPLP0 to obtain ∆Ct values Statistical analyses were performed on 
the ∆Ct values.  Next ∆Ct values from TGFβ-treated samples were subtracted from 




4.5.4 Multivariate Analysis 
Umetrics SIMCA-P+ (v12.0.1.0) was used to perform principal component 
analysis (PCA).  Fold-change ICW data was log-transformed and unit variance scaled for 
modeling purposes.  Transcript expression of A549 cells during TGFβ treatment, over the 
course of 72 hours, was previously characterized by Keshamouni et al. using Affymetrix 
HG-U133_plus_2 microarrays (Keshamouni et al., 2009).  Data were obtained from the 
NCBI Gene Expression Omnibus entry GSE17708, which were uploaded following the 
work by Sartor et al. (Sartor et al., 2010).  A list of genes included in the analysis can be 
found in Table S1.  Many of the transcripts were measured with multiple primers.  When 
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multiple primers were present, the average of all the primers were used to create a single 
averaged response for each variable at each time point.  Transcript expression for each 
variable corresponds to log-transformed fold-change.  Uninformative probes were 
removed to improve model fit.  Data for the transcript-exclusive model were Pareto 
scaled while data for aggregated models were unit variance scaled.  Pareto scaling 
improves the fit by scaling variable variance according to its standard deviation such that 
experimental noise is minimized and the model structure is more preserved and is 
suitable for quantitative data, such as microarray analyses (van der Werf, 2006; 
Wheelock and Wheelock, 2013).  The significance of principal components was 
confirmed using cross-validation rules in SIMCA-P+.  Details of fit, quality, and 
construction for each model can be found in APPENDIX A . 
4.5.5 CM-H2DCF-DA Fluorescence 
Following treatment, cells were trypsinized (CellGro, 25-053-CI) and 
resuspended in HBSS without phenol red (Thermo Scientific HyClone, SH30268) at a 
working concentration of 5x10
5
 cells/ml.  Antioxidant pre-treatments of NAC or bovine 
catalase (Sigma-Aldrich, C1345) were applied for 1 hour prior to a 30 minute incubation 
with 10 µM CM-H2DCF-DA (Invitrogen, C6827).  Co-treatment with H2O2 (100 µM) 
occurred during the final 15 minutes of the CM-H2DCF-DA incubation.  The cells were 
then washed and co-stained with SYTOX Blue (Invitrogen, S34857, 1:1000) for 
live/dead discrimination.  A BD LSR II flow cytometer was used to resolve SYTOX Blue 
(λex=445, λem=473/10) and CM-H2DCF-DA (λex=488, λem=530/30) signals.  Cells were 
gated by FSC/SSC to exclude cellular debris, then by FSC-A/FSC-H to exclude non-
singular events, and finally by absence of SYTOX Blue staining, to exclude all non-
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viable cells.  CM-H2DCF-DA signals were then characterized by their geometric mean 
fluorescence intensity. 
The CM-H2DCF-DA fluorescence time course studies were performed in 96-well 
plates with 6 technical replicates per time point.  Following TGFβ treatment, the plates 
were washed with Hank’s balanced salt solution with calcium and magnesium (HBSS) 
and incubated with 10 µM CM-H2DCF-DA in 75 µl HBSS for 30 min at 37˚C with 5% 
CO2.  The cells were then washed with 150 µl HBSS and suspended in 75 µl HBSS for 
fluorescence measurement on a BioTek Synergy 4 plate reader (λex = 485/20 nm 
excitation, λem = 528/20 nm).  Next, the cells were stained with 5 µg/ml Hoechst 33342 
(AnaSpec, 83218) in 50 µl HBSS for 30 min at 37˚C with 5% CO2 (λex = 350 nm, λem = 
461 nm).  Unstained wells were used to subtract background fluorescence from both 
signals.  The CM-H2DCF-DA fluorescence intensity was then normalized with respect to 
Hoechst 33342 staining for each well and normalized to the untreated control, giving the 
loading normalized CM-H2DCF-DA signal. 
4.5.6 Luminol Assay for Hydrogen Peroxide 
Cellular H2O2 degradation rates were measured during the course of EMT using a 
luminol-based assay based on a method for determining the first-order kinetics of H2O2 
turnover.  A condition-specific rate constant was determined through sampling the 
supernatant for H2O2 at sequential time points following bolus addition of H2O2 (Sobotta 
et al., 2013).  Cells were treated with TGFβ for 1, 2, or 3 days in a 96 well plate.  
Following treatment, the cells were incubated with 20 µM H2O2 in HBSS for multiple 
time points up to 60 minutes.  H2O2 present at the end of the time course was measured 
with a luminol (50 µM; Alfa Aesar, 3-Aminophthalhydrazide monosodium salt, 
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L15205)/sodium hypochlorite (1 mM; Sigma-Aldrich, 239305)-based assay and 
compared against a titrated H2O2 standard.  Cell densities were normalized with Hoechst 
33342 staining.  H2O2 degradation rates (kdeg) were calculated by fitting the H2O2 
concentrations, incubation time, and cell density data to a curve of exponential decay 
derived from a model of H2O2 decay.  The kdeg values from each assay were normalized 
to the untreated condition.  More detailed information regarding the luminol assay can be 
found in APPENDIX A.7  Luminol Assay for Hydrogen Peroxide. 
4.5.7 Glutathione Concentration & Redox Potential Measurement 
Cells were treated with 200 pM TGFβ in the presence of 10% FBS for 48 and 96 
hours.  Following treatment, cells were trypsinized and analyzed via Beckman Coulter 
Vi-Cell XR to measure cell density, viability, circularity, and diameter.  The cells were 
transferred to a 96-well plate to measure the total GSH concentration (20,000 cells/well) 
and GSSG concentration (40,000 cells/well) compared to a standard curve using the 
Promega GSH/GSSG-Glo Assay (Cat. # V6611) with 3 technical replicates per condition.  
Cell shape was approximately spherical following trypsinization and spherical cell 
volumes calculated from diameters.  Intracellular reduced GSH and GSSG levels were 
calculated from the GSH/GSSG-Glo Assay conditions.  The redox potential was 
calculated according to the GSSG/2GSH half-cell reduction potential (EGSH) with the 









, T=310 K) (Schafer and Buettner, 
2001). 
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CHAPTER 5   DISTINCT DISTRIBUTIONS OF SINGLE-CELL 
TRANSPORTER HETEROGENEITY GOVERN SIDE 





Relapse is a significant obstacle in the treatment of cancer.  Hyper-mutability and 
unchecked proliferation of cancer cells can result in reemergence of disease if a subset of 
cancer cells survives chemotherapeutic interventions. (Hanahan and Weinberg, 2011) 
Multidrug resistance (MDR) is a cellular phenotype characterized by enhanced survival 
in presence of cytotoxic agents.  Up-regulation of the ATP-binding cassette (ABC)  G2 
(ABCG2/BCRP) transporter is a mechanism through which cells can enhance efflux of 
cytotoxic compounds and acquire a MDR phenotype. (Videira et al., 2014)  Patients with 
cancers expressing high levels of ABCG2 experience poorer prognoses, with decreased 
overall survival and higher rates of relapse. (Galimberti et al., 2007; Lee et al., 2012; 
Nasilowska-Adamska et al., 2013; van den Heuvel-Eibrink et al., 2007)  Therefore, the 
activity of ABCG2 is of great clinical significance. 
The ABC superfamily transporters are characterized by their ability to bind and 
export a wide array of substrates in an ATP-dependent manner. (Sharom, 2008)  ABCG2 
and a number of related transporters accept GSH as a substrate and mediate its efflux. 
(Brechbuhl et al., 2010; 2009; Leier et al., 1996; Lorendeau et al., 2014; Salerno and 
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Garnier-Suillerot, 2001; Salerno et al., 2004; SHEN et al., 1996)  Additionally, ABCG2 
expression is regulated by the antioxidant master regulator Nrf2 (Adachi et al., 2007; 
Hong et al., 2010; Singh et al., 2010; Wang et al., 2014), and ABCG2 activity produced 
antioxidant-like effects.  (Kubota et al., 2010; Maher et al., 2014; Shen et al., 2010)  
These findings indicate that ABCG2 activity and the MDR phenotype may be correlated 
with antioxidant expression within a cell population.  
ABCG2 activity is measured in a Hoechst staining assay, termed a side population 
assay, in which a particular sample is split into two conditions, one containing an 
inhibitor of ABCG2 (+FTC) and the other lacking inhibition (-FTC). (Golebiewska et al., 
2011; Kim et al., 2002; Scharenberg, 2002; Zhou et al., 2001)  Fumitremorgin C (FTC) is 
a potent and specific inhibitor of ABCG2. (Rabindran et al., 1998; 2000)  ABCG2 
activity is apparent in the assay as a difference in Hoechst staining between the +FTC and 
-FTC condition where enhanced transporter activity in the -FTC condition manifests as a 
discernible subpopulation, designated as the side population (SP), with decreased cell 
staining compared to equal staining non-side population (NSP) cells. (Petriz, 2013) 
The SP assay has been used to identify SP cells since its initial characterization in 
murine hematopoietic stem cells. (Goodell et al., 1996)  Since then, some reports equate 
SP cells with cancer stem cells, distinguished from non-cancer stem cell-like NSP cells, 
without any additional characterization of cancer stem cell phenotype. (Ho et al., 2007; 
Seo et al., 2007) Although there are numerous examples of the non-equivalence of SP 
cells with stem cells, (Broadley et al., 2011; Burkert et al., 2008; Li and Laterra, 2012; 
Lichtenauer et al., 2008; Morita et al., 2006), many studies erroneously conflate SP cells 
with cancer stem cells based on these early findings, and in spite of more recent reports 
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of the vast phenotypic heterogeneity of surface marker expression on SP cells. (Boesch et 
al., 2014; Naylor et al., 2005)  Some report the SP as an enriched source of cancer stem 
cells and characterize the necessary functional activities or surface markers that 
corroborate status as cancer stem cells. (Akunuru et al., 2012; Naylor et al., 2005; Yasuda 
et al., 2013) Therefore, the SP might be a source of relative cancer stem cell abundance 
but it is inaccurate to conceptualize a SP cell as a cancer stem cell based upon its staining. 
At its most basic level, the side population is a fluorescence-staining assay that is 
influenced by a number of kinetic factors, such as staining time and concentration.  Use 
of differing Hoechst concentrations, incubation time, inhibitors, or gating strategies can 
yield widely different SP sizes. (Golebiewska et al., 2011; Ibrahim et al., 2007; Smith et 
al., 2012)  However, the interpretation of transporter activities within an individual 
sample is valid as the staining conditions are internally consistent.  Transporter 
heterogeneity results in the formation of a SP.  Such heterogeneity may reflect other 
meaningful phenotype aspects.  Heterogeneity of the A549 cell line has been reported, 
including with respect to antioxidant expression profiles. (Bechyne et al., 2011; 
Watanabe et al., 2002)  It is possible that the heterogeneity of transporter activity is 
indicative of differences in antioxidant expression status.  
A difference in ABCG2 activity within a population is conducive to the formation 
of a SP; however, it is not understood how heterogeneity of transporter activity at the 
single-cell level manifests as a SP at the population scale.  Similarly, down-regulation of 
ABCG2 during TGFβ-mediated EMT decreases SP size (Akunuru et al., 2012; Ehata et 
al., 2011; Kabashima et al., 2009; Mallini et al., 2013; Yin et al., 2008), though it is not 
known how regulation of transporter activity modulates SP size.  We hypothesize that the 
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transporter activity of SP cells is significantly higher than that of NSP cells and that 
down-regulation of ABCG2 during EMT results in decreased frequency of high 
transporter-activity cells, suppressing the size of the SP. 
We sought to define the role of ABCG2 activity heterogeneity in formation of 
side populations through the implementation of a multiscale model where heterogeneity 
of transporter activity was simulated at the single-cell level as a means to investigate 
emergence of a SP at the population level.  We observed a SP in A549 cells that was 
dynamic in nature, and reduced with TGFβ treatment.  We developed and validated 
objective tools to measure SP size and implemented them in a computational 
investigation of SP emergence from in silico Hoechst stained cell populations.  We 
observed SP formation in heterogeneity scenarios in which a majority of the population 





5.2.1 Side Population in A549 Cells 
Following passage, A549 cells were maintained in culture for 4 days before being 
processed for a SP assay.  A discernible SP was observed as a region of increased cell 
density, with lower Hoechst Red and Hoechst Blue signal, in the -FTC condition 
compared to the +FTC condition (Figure 5.1-A).  TGFβ-treatment (100 pM, 4 days) of 
A549 cells eliminated the apparent SP (Figure 5.1-B).  Gating strategies for measuring 
the size of a SP are highly variable. (Akunuru et al., 2012; 2011; Liu et al., 2014; Sabisz 
and Skladanowski, 2009; Sung et al., 2008; Tirino et al., 2013; Yeh et al., 2013)  In an 
effort to be as consistent as possible, we followed a strict protocol for SP gating to 
minimize bias and subjectivity in our measurements.  Quantification of the %SP in the -
FTC conditions for an untreated control and TGFβ-treated samples reveals a decrease in 
the SP size following TGFβ treatment from  ~20% to ~0.1% (Figure 5.1-C). 
The SP assay involves splitting a sample into +FTC and -FTC conditions before 
Hoechst staining, followed by measurement of Hoechst fluorescence in two emission 
channels via flow cytometry (Figure 5.2-A).  The conceptual model that is the basis of 
the SP assay is depicted in Figure 5.2-B.  Staining involves diffusion of extracellular 
Hoechst through cell membranes.  The +FTC condition inhibits ABCG2-mediated efflux 
of Hoechst and is used to identify regions of Hoechst staining where transporter activity 
is negligible.  Cells within this region are termed non-side population (NSP) cells.  
Uninhibited in the -FTC condition, ABCG2 actively exports Hoechst from the cell, 
leading to decreased Hoechst staining and increased cell density in a region of lower 






Figure 5.1  Flow Cytometry Density Scatter Plots of a Side Population. 
A)  Hoechst Red and Blue channel emission in flow cytometry results from a 
representative sample from a SP assay in A549 cells 4-days after passage.  Plots are 
scatter plot densities with each condition normalized to its respective maximum value.  
Cells were incubated with 10 µM FTC or DMSO vehicle for 30 minutes prior to 90 
minutes of 5 µM Hoechst 33342 staining.  The SP is visible as the population of cells in 
the left quadrant gates of the -FTC condition.  The quantification of %SP in this plot was 
calculated to be 20%.  B)  A representative sample of SP assay results for A549 cells 
treated with 100 pM TGFβ for 4 days.  The quantification of %SP in this plot was 
calculated to be 0.12%.  C) %SP quantification from control (A) and TGFβ-treated (B) 
samples for 4 replicates.  Plotted as mean ± standard error of the mean.  Significance was 








Figure 5.2  Hoechst Staining Overview and SP Assay Conceptual Model. 
A)  Experimental workflow of sample preparation and processing in a SP assay.  Each 
sample (1) is split into two conditions, with (+FTC) and without (-FTC) the ABCG2 
inhibitor FTC (2).  Both conditions are then stained with Hoechst 33342 (3) and the 
resultant fluorescence measured via flow cytometry (4).  The +FTC condition is used to 
define a gate for the non-side population (NSP) region (5), which is then applied to the -
FTC condition (6) to identify the SP region (green box), which is measured as percent of 
the parent population (7).  B)  Schematic of the Hoechst transport processes presumed to 
underlie the SP assay.  Hoechst 33342 passively diffuses into the cell, where it is 
transported out of the cell via transporter (-FTC condition) or binds to DNA.  The in 
+FTC condition, FTC inhibits the transporter, preventing transporter-mediated efflux. 
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5.2.2 TGFβ-Mediated ABGC2 Down-Regulation 
Owing to decreased SP size in TGFβ-treated cells, we hypothesized that 
phenotypic transformation under TGFβ-treatment would involve down-regulation of 
ABCG2.  A549 cells were treated with 0, 1, 10, and 100 pM TGFβ for 4 days, after 
which they were stained for surface marker expression of E-Cadherin, N-Cadherin, and 
ABCG2 (Figure 5.3-A,B).  In a dose-dependent manner, TGFβ treatment led to decreased 
E-Cadherin, increased N-Cadherin, and decreased ABCG2 expression.  Shifts in the 
staining distributions reflecting these changes in expression are plotted pairwise in Figure 
B.1.  Furthermore, we observed a strong correlation between SP size and ABCG2 surface 
marker expression in A549 cells (Figure 5.3-C). 
5.2.3 SP Dynamics in Culture with TGFβ-Exposure 
Side population size was assessed as function of time after passage and of TGFβ 
treatment.  Four days after passage, A549 cells were again passaged to start the time 
course.  The day after passage corresponds to Day 0 of the time course, during which the 
SP size was first assessed (Figure 5.4-A).  On Day 0, TGFβ treatments were initiated at 0, 
1, 10, and 100 pM concentrations.  Side populations were then characterized for each 
sample at two-day intervals for six days.  The %SP was found to decrease from ~20% at 
the time of passage (Day 4) to ~2% on the following day (Day 0).  Increasing time in 
culture was associated with increasing SP size for untreated and 1 pM TGFβ conditions.  
Larger doses of TGFβ (10 & 100 pM) prevented the increase in SP associated with time 
after passage (Figure 5.4-A,B).  Attenuation of SP size by TGFβ was dose-dependent as 
was the range of SP staining intensity, with higher doses of TGFβ exhibiting less intense 









Figure 5.3  Surface Marker Staining Following TGFβ-Mediated EMT. 
Surface marker expression measured via flow cytometry after staining with anti-PE-
CF594/E-Cadherin, PE/N-Cadherin (A), and APC/ABCG2 (B) antibodies on live A549 
cells following 4-day treatment with 0, 1, 10, and 100 pM TGFβ.  Surface marker 
staining data were obtained from 3-color staining, with compensation, from 3 biological 
replicates.  Values are plotted as the geometric means ± 95% confidence interval of the 
sample geometric mean fluorescence intensities (GMFI).  A significant difference from 
the 0 pM TGFβ condition was determined with a two-way ANOVA, p<0.05, and are 
indicated by asterisks (*).  C)  Mean %SP plotted against ABCG2 expression for the Day 
4 condition from the SP time course experiment (Figure 5.4), along with a best-fit line 
from a linear regression, R
2









Figure 5.4  Time Course of %SP in Culture & with TGFβ Treatment. 
A) %SP in A549 cells in the days following passage (Day 0), treated with 0, 1, 10, or 100 
pM TGFβ for the entire time in culture.  Values are plotted as mean ± standard error of 
the mean.  Flow cytometry density scatter plots of SP assay -FTC conditions from a 
replicate of Day 4 samples in the %SP time course assay for 0 (B), 1 (C), 10 (D), and 100 




5.2.4 Objective Side Population Measurements 
SP size is conventionally characterized by %SP, defined as percent of parent 
population, with user-defined/manual gating of SP and NSP regions within a scatter plot 
along the Hoechst Red and Blue emission channels.  While scatter plots enable the range 
of staining values to be easily observed, they fail to faithfully convey information of 
population density.  Pseudo-colored scatter plots improve upon this by adding this 
dimension to the data.  In our plots of SP various sizes (Figure 5.4-B), with larger SP size 
we observe a larger range of Hoechst Red and Blue staining and a corresponding shift of 
cell density within the population.  Pseudo-colored scatter plots are still deficient in one 
key aspect.  While we could visualize the differences in cell population density within an 
individual SP plot, we could reliably compare differences in population density across 
different flow cytometry samples or even of +FTC to -FTC conditions.  We hypothesized 
that characterization of Hoechst Red and Blue signals will enable objective measurement 
of SP size and distributions. 
5.2.4.1 Preliminary Statistical Aspects of Hoechst Red and Blue Signals 
The conventional representation of side populations is a 2D scatter plot along 
Hoechst Red and Blue channels; however, when each of these channels is viewed as a 
histogram, we observe side populations as decreased staining in each of these channels 
(Figure 5.5-A).  From this perspective we note several key observations with respect to 
the -FTC condition compared to the +FTC condition: 1) increased width of the 
distributions, 2) decreased population density in the regions above and immediately 
surrounding the mode of the +FTC condition, 3) increased density in the region below the 
mode but above the lower extrema of the +FTC condition which is used to define the 
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lower border of the NSP in manual gating approaches.  This last observation was critical; 
it demonstrated the lack of a clear distinction between SP and NSP cells.  Increased 
density indicated that transporter mediated efflux affects cell staining in this region.  
Cells with a SP phenotype that were differentially stained with Hoechst in the presence of 
an ABCG2 inhibitor, fell within the NSP gating regions.  Thus, the distinguishing SP and 
NSP cells with an absolute cutoff is an over-simplification. 
We sought to identify objective measures associated with Hoechst Red and Blue 
signals in order to describe the influence of ABCG2 transporter on Hoechst staining.  
Despite arising from related sources, Hoechst Red and Blue channel signals are 
nonetheless defined in arbitrary units, subject to independent adjustment of detector 
voltage settings.  To make the data more consistent, we converted Hoechst signals (raw 
data in arbitrary units) from each of the channels into Hoechst Red and Blue Scores, 
transformed values representing distance from the +FTC signal mean in units of standard 
deviation.  Therefore, the Hoechst Red and Blue Scores of the -FTC condition were 
normalized to the +FTC condition, with a mean of 0 and standard deviation of 1 for both 
Hoechst Red and Blue. 
We sought to use statistical metrics to characterize the transporter activity 
associated with the formation of the SP.  Therefore, we computed the differences of these 
Hoechst metrics between +FTC and -FTC conditions.  Further analyzing the data from 
the SP time course experiment (Figure 5.4-A), we observed a decreased Hoechst Score 
mean in both the Red and Blue channels in the -FTC condition compared to the +FTC 
condition, which correlated with the previously measured %SP (Figure 5.5-B).  
Additionally, we observed a correlated increase in differences of Red and Blue channel 
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standard deviation with SP size as well as an increase in Hoechst Red and Blue 
covariance in the -FTC condition compared to the +FTC condition (Figure 5.5-B). 
Each of the Hoechst metrics was independently able to stratify differences in SP 
size observed in the SP time course study (Figure B.2).  Using a combination of metrics 
in a multilinear model, we estimated SP size with a high degree of accuracy (Figure B.3).  
In an independent experiment, individual high and low-ABCG2 expressing cells were 
isolated and expanded to form colonies (Figure B.6-A).  Notably, both expanded colonies 
from both high and low-ABCG2 expressing cells yielded both NSP and SP populations 
(Figure B.6-B).  The multilinear model was able to predict %SP in the independent set 
with a high degree of concordance with manually assessed %SP (Figure B.6-C). 
The most informative of these metrics for predicting SP size were changes in 
Hoechst Red and Blue means as well as the change in covariance (Table B.1, B.2).  These 
observations indicate that larger side populations exhibit a correspondingly large decrease 
in Hoechst staining along the diagonal of the Hoechst Scores plot.  Indeed, the 
differences of the Hoechst Red and Blue Score means projected onto a diagonal are 
highly correlated with the measured size of the SP in the sample (Figure 5.6-A). 
5.2.4.2 Hoechst Score Projection Gating 
The differences in population level statistics for Hoechst stained conditions can be 
translated into a means to analyze cells at the single cell level.  Using Hoechst Score data 
for individual cells within a set of flow cytometry data, the Hoechst Score projection was 
calculated.  Therefore the population was converted from a 2D Hoechst Score 
representation to a 1D dataset as a projection along the diagonal of the Hoechst Scores 
plot.  We took the 1
st
 percentile mark, i.e. 99% of the population had higher staining, to 
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be the lower limit of the NSP gate in the +FTC condition.  The positioning of this gate is 
visible as the grey line in the lower left of the Hoechst Scores plot (Figure 5.6-B).  When 
applied to the -FTC condition, it was used to measure the %SP in the sample in an 
objective manner.  The size of the SP measured using the projection gating approach was 
highly consistent with our manual approach (Figure 5.6-C) and further corroborates our 
measurements of SP dynamics during time in culture and with TGFβ treatment (Figure 
5.6-D). 
5.2.4.3 Hoechst Red and Blue Score Probability Density Functions (PDFs) 
The changes in Hoechst Score metrics for the populations were indicative of the 
SP size for a population; however, we still lack a means to objectively measure 
differences in population density across conditions and samples.  To address this issue, 
we converted SP flow cytometry scatter data into 2D probability density functions 
(PDFs) along Hoechst Red and Blue standard score dimensions (Figure 5.6-B).  Unlike 
pseudo-colored scatter plots, the density (color intensity) is now scaled consistently 
across different plots.  Furthermore, PDFs were constrained to a unit volume, which 
allowed for direct comparison of population density from both +FTC (PDF+FTC) to -FTC 
(PDF-FTC) conditions and from sample to sample.  Such comparison may be visual in 
nature (scaling) or mathematical in nature. 
5.2.4.4 Visualizing Differences in PDFs Across Multiple SP Samples 
Differential cellular distribution within a population in +FTC and -FTC 
conditions is the basis for the SP assay; however, precisely how the distributions differ 
can only be appreciated at a rough scale using scatter and pseudo-colored scatter plots.  In 
converting flow cytometry samples into PDFs, we were able to measure the differences in 
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cell density between +FTC and -FTC conditions.  Taking the difference between the 
respective cell density maps, PDF-FTC – PDF+FTC, we were able to measure the 
differences in population density (∆FTC) due to transporter-mediated Hoechst efflux 
across the range of Hoechst staining (Figure 5.7-A, B.4-A).  In the ∆FTC plot, red 
regions correspond to regions with increased relative cell density in the -FTC condition 
and therefore reflect increased population density when transporter-mediated Hoechst 
efflux is uninhibited.  In contrast, blue regions correspond to regions of higher relative 
cell density in the +FTC condition and reflect decreased population density when 
transporter-mediated Hoechst efflux is uninhibited. 
The probabilistic nature of the PDFs ensures that units and scaling are consistent 
across conditions, meaning that intensity in the PDFs is in units of likelihood.  Similarly, 
∆FTC plots are expressed in non-relative units with intensity reflecting differences in 
frequency between -FTC and +FTC conditions for a given sample.  Thus, the ∆FTC plot 
reflects the level of transporter-mediated dye efflux within a given sample.  The ∆FTC 
distribution permits the comparison of transporter activity across different samples in a 
quantitative manner.  To compare such differences, we took the difference of ∆FTC 
distributions to derive a ∆SP distribution, which measured the relative differences in 
∆FTC distributions between two samples (Figure 5.7-B, B.4-B).  To calculate the ∆SP, 
the ∆FTC distribution of the control (∆FTCctrl) was subtracted from the ∆FTC 
distribution of the particular test sample (e.g. ∆FTCTGFβ).  Therefore, red regions of the 
∆SP plot are indicative of regions with higher cell density within the test sample ∆FTC 
while blue regions correspond to regions with decreased density in the test sample ∆FTC 
distribution. 
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We processed the PDFs, ∆FTC, and ∆SP distributions for the simple SP 
experiment depicted in Figure 5.1.  The PDFs for each of the conditions for both the 
control and TGFβ-treated sample are depicted in Figure 5.6.  The ∆FTC plots both 
exhibit increased cell density in the region of decreased Hoechst Red and Blue staining 
relative to the means in the +FTC conditions (i.e. below 0 in both Hoechst Red and Blue 
channels; Figure 5.8-A).  We directly compared the control and TGFβ-treated samples in 
the ∆SPTGFβ distributions (Figure 5.8-B), where it was apparent that the TGFβ-treated 
sample exhibited diminished transporter-mediated Hoechst efflux compared to the 
untreated control.  These approaches to visualizing differences in transporter activity can 
be particularly useful for comparing differences in responses across a number of 
responses, such as the Day 4 conditions from the time course experiment (Figure B.4-C). 
Our statistical approach to characterization of distributions in the SP assay 
allowed for a more objective measurement of the influence of transporter-mediated efflux 
on Hoechst staining compared to conventional approaches for measuring the %SP.  
Moreover, the metrics are continuous in nature, which do not rely on strict cutoff in 
assign “SP” or “NSP” classification to cells.  Our efforts to investigate the kinetic 
mechanisms that give rise to SP responses in cells rely on the implementation of 
objective measures, such as change in Hoechst Score Projection and changes in Hoechst 







Figure 5.5  Hoechst Staining Histograms & PDFs of +FTC & -FTC Conditions. 
Histograms of Hoechst Red (A) and Hoechst Blue (B) staining of +FTC and -FTC 
conditions for the control sample in Figure 5.1-A, consisting of 51200 cells and 50329 
cells for the +FTC and -FTC conditions, respectively.  C)  Changes in Hoechst Red and 
Blue Score statistics in -FTC vs +FTC conditions plotted against their associated %SP.  
(X = X-FTC - X+FTC; HRSmean = change in Hoechst Red Score mean, HBSmean = 
change in Hoechst Blue Score mean, HRSSD = change in Hoechst Red Score standard 
deviation, HBSSD = change in Hoechst Red Score standard deviation, HSC = change 
in Hoechst Red & Blue Score covariance).  Lines of best fit from linear regression are 
shown along with the corresponding R
2




Figure 5.6  SP PDF Plots & Projection Gating %SP Measurement. 
A)  Hoechst Red and Blue score means for each of the samples in the time course 
experiment were projected onto a diagonal (y=x).  The difference between -FTC and 
+FTC conditions are then reported as –Hproj and ploted against the respective %SP for 
the sample.  B)  Hoechst Score probability density functions (PDFs) of cell populations in 
control and TGFβ-treated samples for +FTC (PDF+FTC) and -FTC (PDF-FTC) conditions, 
corresponding to flow cytometry data in Figure 5.1-A and 5.1-B.  Hoechst Red and Blue 
Scores transformations are determined by the mean and standard deviation of the +FTC 
condition.  Hoechst Scores are expressed as units of standard deviations from the mean.  
Density colormap values are normalized to a common maximum frequency across the 4 
conditions.  SP gates (gray lines) were set at the 1
st
 percentile level using the Hoechst 
Scores projection gating approach.  C)  The projection gating approach was used to 
measure the %SP (%SPproj) in each of the samples in the time course experiment and 
plotted against the %SP measured with the manual approach.  D)  Reconstruction of the 
%SP dynamics in the time course experiment (Figure 5.4-A) using the projection gating 
approach.  Values are plotted as mean ± standard error of the mean.  Lines of best fit 
from linear regression are shown along with the corresponding R
2









Figure 5.7  Schematic of FTC & SP Calculations from PDF Distributions. 
Differences in Hoechst Score PDFs are used to compare differences between +FTC and -
FTC conditions as well as between samples.  A)  The difference between PDF-FTC and 
PDF+FTC for the control sample is represented by the FTCcontrol plot.  B)  Differences 







Figure 5.8  FTC & SP Distributions of Control & TGFβ-Treated A549 Cells. 
A)  Differences in PDF density between PDF-FTC and PDF+FTC are displayed as FTC 
distribution plots for control and TGFβ-treated conditions plotted against Hoechst Red 
and Blue Scores.  B)  Differences in FTC distributions from the control sample FTC 
distribution are displayed as SP distributions for the control and TGFβ-treated samples.  
FTC and SP distributions are averaged from four replicates from the sample 
represented in Figure 5.1. 
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5.2.5 Up-Regulation of ABCG2 & SP Expansion with tBHQ Treatment 
We observed a reduction in SP size following down-regulation of ABCG2 
expression via TGFβ treatment.  In contrast, the antioxidant tert-butylhydroquinone 
(tBHQ) has been shown to induce increased expression of ABCG2. (Adachi et al., 2007)  
A549 cells were treated with 50 µM tBHQ for 48 hours and stained with an APC-labeled 
anti-ABCG2 antibody.  ABCG2 surface marker expression increased with tBHQ 
treatment upon imaging the stained cells in an imaging cytometer (Figure B.17-A). 
tBHQ-treated cells were prepared for SP analysis and imaged using an imaging cytometer 
where an increase in SP size was observed in tBHQ-treated cells (Figure B.17-B,C).   
Imaging cytometry generates data similar to flow cytometry data; however, it 
does so by collecting images of individual cells rather than through collection of light in 
photo-multiplier tubes, as is the case for flow cytometry.  In doing so, each collection 
event has a corresponding set of single-cell images containing both fluorescent and 
spatial information.  Using imaging cytometry we were able to collect images of Hoechst 
stained cells in both Hoechst Red and Blue channels along the diagonal (Figure 5.9).  In 
this series of images, the increase in Hoechst staining can be visualized as both Hoechst 
Red and Blue Scores increase.  
Imaging cytometry SP data was processed analogously to SP data obtained using 
flow cytometry (Figure B.17, 5.10-A).  The influence of transporter activity in the 
untreated control and tBHQ-treated samples from imaging cytometry data is discernible 
in the ∆FTCcontrol and ∆FTCtBHQ plots in Figure 5.10-A.  The increase in SP size in the 
tBHQ sample compared to the untreated control sample is apparent in the red regions of 
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the ∆SPtBHQ plot.  The difference of transporter influence on Hoechst staining is reflected 






Figure 5.9  Imaging Cytometry Visualization of Cells along the Projection. 
Image of Hoechst stained cells from imaging cytometry of A549 cells without FTC.  
Cells were selected at random along the Hoechst Scores diagonal, corresponding to the 
path of the hoechst projection (A).  Numbers correspond to event number ID values.  B)  








Figure 5.10  FTC & SP Distributions of Control & tBHQ-Treated A549 Cells. 
A)  Differences in PDF density between PDF-FTC and PDF+FTC are displayed as FTC 
distribution plots for control and tBHQ-treated conditions plotted against Hoechst Red 
and Blue Scores.  Differences in FTC distributions from the control sample FTC 
distribution are displayed as SP distributions for the control and tBHQ-treated samples.  
FTC and SP distributions are averaged from three replicates.  B)  The magnitude of 
the SP response in control and tBHQ-treated samples are reported as the –∆Hproj.  Values 
are plotted as the mean ± standard error of the mean of three biological replicates.   
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5.2.6 Multiscale Ensemble Modeling of Side Population Responses 
5.2.6.1 Ensemble Modeling Approach 
The SP assay is designed to recognize Hoechst staining heterogeneity with a cell 
population.  Additionally, it is a kinetic assay in that it results from the staining of cells 
with a dye that is transported through the cell and subject to differential transport and 
retention in a single cell context due to variation in cell size, transporter expression, and 
availability of DNA, which it strongly binds.  Therefore, we designed our approach to, as 
faithfully as possible, recapitulate the variability in the Hoechst transport landscape 
expressed within a cell population.  To do so, we derived population distributions from 
A549 cells, which were then converted into probability density functions and sampled to 
generate the in silico cell population (Figure 5.11-A). 
We considered 3 experimental models of differing transporter distributions within 
the cell population.  Model 1 exhibits a distribution of transporter number throughout the 
population, though with equal concentration.  Model 2 exhibits a distribution of 
concentration throughout the population, though with equal transporter numbers.  Finally, 
Model 3 has transporter distributions throughout the populations that are drawn from 
experimental ABCG2 expression distributions. 
Each of the transporter distribution models shared a common kinetic model of 
Hoechst staining, which was modeled with mass-action kinetics governing rates of 
reaction (Figure 5.11-B).  The reaction rates in this kinetic model are lumped parameters, 
meaning that the reactions depicted in the kinetic model correspond to a series or 
collection of true biochemical reactions.  Such parameters are ill defined and can differ 
depending on the particular cellular context.  Therefore, rather than focusing on finding a 
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parameter set that optimizes our output behavior of interest, we sought to examine the 
ability of particular transporter distributions to exhibit SP responses across a wide range 
of kinetic parameter space.  We used Latin hypercube sampling (LHS) of parameter 
space to ensure that the kinetic diversity within the parameter space was sampled as 
uniformly as possible for the given number of parameters simulated (M=10,000; Figure 
5.11-A). 
We assessed SP responses by conversion of Hoechst staining concentrations that 
resulted from single-cell kinetic simulations.  This process of in silico flow cytometry 
was used to generate Hoechst Red and Blue signals (Figure 5.11-C).  The simulated flow 
cytometry data was then processed in an identical manner as experimental flow 
cytometry data from SP assays by converting Hoechst signals into Hoechst Scores, PDFs, 
∆FTC, and ∆SP distributions (Figure 5.11-D,E).  Finally, the simulated Hoechst staining 
of the 4 transporter levels in both inhibited and un-inhibited conditions were analyzed for 
a SP response based on correlation of simulated Hoechst staining metrics with analogous 
metrics from experimental SP distributions from Day 4 of the SP time course (Figure 5.4, 
5.5, and B.4-C).  When the metrics of a particular ensemble is in agreement with each of 
the experimental metrics, the response is determined to be SP-like and the SP response is 
then ranked according to similarity to experimentally observed %SP.  
We define an ensemble as a particular pairing of a kinetic parameter set with a 
cell population in the context of a transporter distribution model.  An ensemble is 
distinguished from a kinetic parameter set as the biological subject of interest 
(heterogeneity of Hoechst staining) is observable only at the population level and a given 
kinetic parameter set within a completely homogeneous cell population would exhibit no 
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staining heterogeneity.  Therefore, the in silico response heterogeneity is a function both 
of the heterogeneity inherent to a cell population and of kinetic process that govern the 
staining dynamics.  A given set of kinetic parameters will exhibit variability in transport 
rates throughout a population due to the variability in the population of factors that 
influence transport, such as volumes, surface areas, and transporter concentrations.  Thus, 
we differentiate an ensemble from a set of kinetic parameters by recognizing the context 
in which it operates and leads to population-level effects. 
Ensembles that led to SP responses were then further analyzed at the single-cell 
level.  The SP responses of individual cells were measured across a population to obtain a 
SP response distribution.  The heterogeneity of the response distribution was measured 
for each population.  Finally, the range of response heterogeneity was compared across 
each of the models.  This approach was designed to permit the comparison of different 
modes of transporter heterogeneity within a population to the types of Hoechst staining 
responses that might be observed in a SP assay.  First, we wanted to determine whether a 
simple kinetic model of transporter-mediated Hoechst efflux in the context of population 
heterogeneity was consistent with the simple conceptual model that underlies our 
understanding of the mechanisms in action in the SP assay.  Second, we wanted to 
identify the types of single-cell behaviors that give rise to a SP within a population.  
Finally, we hoped that this approach would increase our understanding of what, from a 




Figure 5.11  Multiscale Ensemble Approach to Modeling SP Responses. 
Our approach to modeling side population response kinetics proceeded in a sequential 
manner.  A)  First, a heterogeneous in silico cell population was generated from 
experimental distributions, which was then paired with each of the kinetic parameter sets 
that were derived from Latin hypercube sampling of parameter space.  Three different 
models were implemented, each with differing transporter heterogeneity within a given 
population.  The cell population was implemented in 4 different transporter-variant 
 124 
versions, where relative transporter expression was derived from experimental data.  An 
ensemble is a pairing of a particular parameter set with the variety of populations for 
which it is simulated.  B)  For each ensemble, each of the 4 transporter-variant 
populations were underwent simulated Hoechst staining at the single-cell level both with 
and without transporter inhibition.  C)  The Hoechst concentrations following kinetic 
staining simulation were converted into Hoechst Red and Blue signals using a linear 
transformation that incorporates spectral excitation and emission properties of simulated 
Hoechst dye and flow cytometers.  D)  In silico flow cytometry signals were converted 
into Hoechst Scores and Hoechst Score PDFs.  Projection gating objectively assess SP 
size.  E)  Hoechst Score PDFs were used to measure ∆FTC and ∆SP distributions.  F)  
Hoechst staining metrics of Scores, PDFs, ∆FTC, and ∆SP were used to identify models 
exhibiting SP responses.  Ensembles meeting qualitative selection criteria are then scored 
according to their similarity in %SP to experimental data.  G)  The distribution of side 
population responses of individual cells within a population is analyzed for each of the 
ensembles passing qualitative selection. 
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5.2.6.2 Side Population Responses In silico 
Each of the models in consideration yielded ensembles that met all of the 
selection criteria for the recognition of a SP response on the order of ~1%.  Hoechst 
staining simulation results were visualized in analogous Hoechst Red and Hoechst Blue 
Scores PDF plots as experimental Hoechst stains (Figure 5.12-B).  Likewise, projection 
gating was used to measure %SP, for which were compared for fit against experimental 
data (Figure 5.12-C).  In silico flow cytometry data was further visualized by calculating 
the ∆FTC and ∆SP distributions (Figure 5.12-D). 
The ensemble responses appeared to exhibit two types of SP responses.  1)  The 
population mode changed little and an outgrowth of population density appears in the SP 
gate in the uninhibited condition (Figure 5.12).  The size of the side population was a 
function of the size of the outgrowth.  We describe this scenario as a Subpopulation Type 
response.  2)  The population as a whole underwent a shift into the SP gate (Figure 5.13).  
The size of the SP was a function of the size of the population displacement.  We 
describe this scenario as a Full Type response.  Both types of responses passed our 
selection criteria for identifying SP and were able to achieve RMSE values > 0.  This 
indicates that the cell density is increased in the SP gate in the uninhibited condition 
compared to the inhibited condition and that the differences between different transporter 
samples is stratified with the 0 pM TGFβ condition exhibiting the largest SP.  However, 







Figure 5.12  In silico Flow Cytometry Results of Subpopulation Type Response. 
In silico flow cytometry SP plots from an ensemble from Model 3.  A)  Schematic 
representation of the distribution of single-cell SP responses in a Subpopulation Type 
response.  B)  Hoechst Scores PDF+FTC and PDF-FTC plots for different transporter 
distribution samples drawn from 0, 1, 10, and 100 pM TGFβ  experimental conditions.  
Projection gating (gray line) was used to measure the %SP.  C) %SP from the ensemble 
is compared to the means of experimental conditions.  D)  Differences in PDF-FTC and 
PDF+FTC distributions from A are shown as ∆FTC for each transporter sample.  








Figure 5.13  In silico Flow Cytometry Results of Full Population Type Response. 
In silico flow cytometry SP plots from an ensemble from Model 2.  A)  Schematic 
representation of the distribution of single-cell SP responses in a Full Type response.  B)  
Hoechst Scores PDF+FTC and PDF-FTC plots for different transporter samples whose 
means were drawn from 0, 1, 10, and 100 pM TGFβ  experimental conditions.  Projection 
gating (gray line) was used to measure the %SP.  C) %SP from the ensemble is compared 
to the means of experimental conditions.  D)  Differences in PDF-FTC and PDF+FTC 
distributions from A are shown as ∆FTC for each transporter sample.  Differences in 
∆FTC distributions from the 0 pM sample are displayed as ∆SP distributions. 
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5.2.6.3 In silico Single-Cell Analysis of Side Population Responses 
Our computational approach to investigation of SP formation enabled us to 
visualize transporter activity at the single-cell level in a way that no experimental 
approach could achieve.  Identical cells, with the exception of transporter activity, were 
simulated in the inhibited (+FTC) and uninhibited (-FTC) conditions.  This was the case 
for every cell within each sample population.  This approach enabled us to examine the 
impact of transporter inhibition on Hoechst staining on otherwise identical populations.  
Using the Hoechst Score Projection (Hproj) values for each cell, which is used to set the 
SP gate in the projection gating approach, we were able to interrogate SP responses at the 
single-cell level. 
In the plot of Hproj staining without inhibition (Hproj-FTC) against Hproj staining 
with inhibition (Hproj+FTC), the SP and NSP gating of each individual cell is visualized 
for the inhibited and uninhibited conditions (Figure 5.14-A).  For example, a cell in the 
NSPNSP gate would be gated as a NSP cell in both conditions.  The NSPSP gate 
contains cells that would be NSP gated cells in the +FTC condition but SP cells in the -
FTC condition.  These are the cells that would be considered SP in the context of the SP 
assay.  In knowing the Hproj+FTC and Hproj+FTC values for each cell, we can calculate 
the difference in Hoechst staining along the projection for each individual cell, much as 
we had at the population level (Figure 5.6), where -∆Hproj = -(Hproj-FTC - Hproj+FTC) and 
a larger -∆Hproj corresponds to a larger SP response at the single-cell level. 
Within the Subpopulation Type response, some cells exhibited identical 
Hproj+FTC and Hproj-FTC staining (non-differential staining), which is visualized as the 
line of cells along the y=x diagonal, while others exhibited differential staining, including 
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cell that were gated as SP cells and cells gates as NSP cells in the -FTC condition (Figure 
5.14-A).  Within the Full Type response, each of the cells exhibited differential staining.  
The differences in Hproj-FTC and Hproj-FTC were readily observed in -∆Hproj plots.  
In the plot of -∆Hproj against transporter number (Figure 5.14-B), we observed non-
differential staining at low transporter numbers and increasingly differential staining 
potential at higher transporter numbers for the Subpopulation Type response.  In the Full 
Type response, which was selected from Model 2 where each cell within the population 
has an identical transporter number, the entire population exhibited differential staining.  
In the plot of -∆Hproj against Hproj+FTC, the magnitude of SP response is plotted 
as a function of the degree of staining in the inhibited condition.  In the Subpopulation 
Type response, we observed larger differential staining potential associated with larger 
Hproj+FTC values (Figure 5.14-C); however, non-differential staining cells were observed 
along the entirety of the Hproj+FTC range.  A similar covariant trend was observed for the 
Full Type response, though with the absence of non-differential staining cells.  SP 
response magnitude is shown for SP and NSP cells in the plot of -∆Hproj against Hproj-
FTC.  In the Subpopulation Type response, we observed SP cells have, in general, the 
largest differential staining (Figure 5.14-D).  In contrast, SP cells in the Full Type 
response have, relative to the NSP cells, the smallest differential staining. 
5.2.6.4 Side Population Response Profiles of Individual Populations 
The single-cell SP responses of the Subpopulation Type response indicate there 
are two varieties of response, a non-differential response that is unaffected by transporter 
inhibition and differential staining cells, in which the largest differential staining cells are 
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SP cells.  In contrast, the Full Type response is composed of exclusively differentially 
staining cells, the smallest of which constitute the SP. 
The diversity of single-cell SP response within a single population is represented 
as a histogram of the -∆Hproj responses.  In the Subpopulation Type response (Figure 
5.15-A), the most frequent -∆Hproj value was 0, the non-differential staining cells.  A tail 
extending from the non-differential staining cells in the positive direction represents the 
differential staining cells.  This tail gave the distribution a positive standard skew.  
Samples with larger tails correspond to samples with a larger SP.  
The SP response distribution of the Full Type response was noticeably different 
from the Subpopulation Type (Figure 5.15-B).  In each sample, all of the cells were 
differentially staining and has roughly even tails on either side of the distribution, which 
resulted in a standard skewness near 0.  Greater differential staining of the sample 
population corresponded with larger sample SP. 
The distributions of single-cell SP responses can be further characterized by a 
bimodality coefficient, which is derived from the standard skewness and standard 
kurtosis of the distribution.  A larger bimodality coefficient, with a maximum of 1, 
reflects a greater similarity to a pure binomial distribution while a smaller coefficient, 
with a minimum of 0, reflects a greater similarity to a distribution with a singular value.  
The Subpopulation-Type response in Figure 5.15 has a bimodality coefficient of ~0.8 
while the Full Type response is ~0.33, which is similar to that of a normal distribution.  
The Subpopulation Type response can be thought of as the union of two distributions, a 
narrow one centered near 0 and a smaller, wide distribution on the positive side of the 







Figure 5.14  Single-Cell Analysis of Hoechst Projections & -∆Hproj. 
In silico single-cell Hoechst Projection plots for the 0 pM TGFβ  sample for a 
Subpopulation Type and a Full Type response.  A)  Hoechst Score Projections in the 
uninhibited condition (Hproj-FTC) are plotted against Hoechst Score Projections in the 
inhibited condition (Hproj+FTC).  B)  The change in Hoechst Score Projection (-∆Hproj) is 
plotted as a function of number of transporters per cell.  C) -∆Hproj is plotted as a function 
of Hoechst Score Projection in the inhibited condition (Hproj+FTC).  D) -∆Hproj is plotted 
as a function of Hoechst Score Projection in the uninhibited condition (Hproj-FTC).  
Complete overviews for each transporter sample for each plot are depicted in (Figure 







Figure 5.15  Distributions of -∆Hproj for Subpopulation and Full Response Types. 
The -∆Hproj of cells in each transporter sample population of an ensemble is displayed in 
a histogram for a Subpopulation Type (A) and a Full Type Response (B).  The standard 
skewness (S), excess standard kurtosis (k), and bimodality coefficient (B) is listed in the 
upper right-hand corner for each distribution. 
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5.2.6.5 Side Population Response Profiles by Transporter Distribution/Model 
Each of the ensembles exhibiting a SP response did so within the confines of 
different and diverse sets of kinetic parameters (Figure B.11).  As such, the single-cell SP 
response distributions varied from ensemble to ensemble.  To obtain a more complete 
understanding of the forms of SP response distributions that give rise to SP responses, we 
plotted the bimodality coefficient against standard skewness for each of the SP-producing 
ensembles with RSME fits greater than 0 (Figure 5.16-A).  The Subpopulation Type 
response maps to the upper right-hand corner of the plot while the Full-Type response 
maps near the center.  The mapping of a number of example distributions helps identify 
the types of distributions associated with various regions of the map (Figure 5.16-B).  A 
more comprehensive example map can be found in (Figure B.14). 
In general, we observed ensembles from the transporter number (Model 1) and 
concentration (Model 2) models to resemble a relatively wide normal distribution with a 
slight positive skew (Figure 5.16-A).  Model 3, employing transporter expression from 
experimentally derived distributions and permitting non-linear scaling of activity, 
exhibited a more diverse set of ensemble responses, though they were more skewed and 
had a larger bimodality coefficient than those observed in Model 1 or 2 (Figure 5.16-A).  
Furthermore, Model 3 achieved better fits, larger RMSE, than Model 1 or 2 with larger 







Figure 5.16  SP Response Distribution Map of SP-Producing Ensembles 
A)  The single-cell SP response (-∆Hproj) distribution of each of the ensembles exhibiting 
a SP and having an RMSE > 0 for each model is depicted by its standard skewness and 
bimodality coefficient.  Mappings of the previously described Subpopulation Type and 
Full Type (Figure 5.12, 5.13, 5.14, and 5.15) responses are indicated by the arrows.  B)  
Example distributions are depicted along with representations of the range single-cell SP 
responses in an example cell population.  Lower case letters correspond to positioning on 




Enhanced efflux of cytotoxic agents by cells possessing a MDR phenotype is 
thought to underlie the mechanism of cell survival and resistance to some 
chemotherapeutics.  The decreased staining of a side population of cells in the SP assay is 
interpreted as an indicator or enhanced transporter-mediated efflux capacity in these cells 
relative to the other cells in the sample.  Though SP cells and the SP are referenced in a 
manner that suggests they have discrete identities, SP identity is not an immutable 
property.  
A key observation from this study is the plasticity exhibited in the SP/NSP 
phenotype. For example, the size of a SP for a given cell line is not a fixed value; rather it 
changes with time in culture (Figure 5.4-A).  Furthermore, both SP and NSP cells arise 
from single-sorted cells in both low- and high-ABCG2 populations (Figure B.6-B). As 
indicated preciously, the ABCG2 transporter activities of the cells cannot be fully 
determined. If the cells had been sorted by SP assay, they would have been identified as 
either SP or NSP cells. Thus, identification as SP or NSP cell does not restrict subsequent 
progeny to SP or NSP fates.  However, technical limitations still prevent direct 
measurement of ABCG2 activity at the single-cell level, thus we cannot determine 
whether the binary presence or absence of ABCG2 activity phenotypes collectively or 
individually give rise to populations possessing both side and non-side populations.  We 
argue that rather than lineagedetermining inheritance of SP/NSP phenotype, the 
heterogeneity of transporter expression gives rise to low- and high-transporter activity. 
The manifestation of this plasticity has major implications for those developing strategies 
 136 
to suppress the role of MDR phenotypes in the development of chemotherapeutic 
resistance.  
SP activity in a population is inextricably linked to activity of the ABCG2 
transporter, with higher expression levels of ABGC2 measured in SP compared to NSP. 
(Petriz, 2013)  However, due to the destructive nature of the SP assay, the differential 
staining of cells in the assay (with and without inhibition) cannot be performed on the 
same cell. Thus, associations between ABCG2 and SP-type responses exist only at a 
population level.  Assumed in the simplified conceptual model for the SP assay  (Figure 
5.2-B) is that SP cells have higher ABCG2 activity compared to NSP cells. However, 
staining of SP and NSP cells falls along a continuum with considerable overlap (Figure 
5.5-A), such than binary assignment of SP/NSP identity is non-trivial and suggesting that 
ABCG2 activity in SP and NSP cells is not categorically binary.  
In our study, we developed objective approaches to characterize SP assay data 
and developed a novel computational approach to investigate the role of single-cell 
kinetic mechanisms of transporter-mediated efflux on population-level responses.  Of the 
models of transporter activity heterogeneity, the Subpopulation Type response best 
approximated the experimental data (Figure B.15) and exhibited responses most 
consistent with those observed experimentally with a distinct subpopulation that extends 
as a tail into lower Hoechst Red and Blue intensity regions (Figure 5.12-B,D). (Akunuru 
et al., 2012; 2011; Liu et al., 2014; Sabisz and Skladanowski, 2009; Sung et al., 2008; 
Tirino et al., 2013; Yeh et al., 2013)  In the Subpopulation Type response, the staining of 
the majority of the cell population is little affected by transporter inhibition while the 
staining of a subpopulation is greatly diminished with transporter inhibition (Figure 5.15-
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A).  Using our approach, we were able to subject identical cells to an in silico SP assay, 
allowing direct relation of the degree of differential staining to the transporter activity on 
a single-cell level. From this, we observed that not all SP cells have high levels of 
transporter activity and not all NSP cells have low transporter activity (Figure 5.14-D).  It 
can be the case that a cell has a low degree of basal staining (+FTC condition) and that 
even a little transporter activity permits gating of the cell in the SP region (-FTC 
condition). Likewise, a cell may have a high degree of basal staining and even with high 
transporter activity is not sufficient to permit gating of the cell in the SP region.  Thus, 
referring to SP cells as high-ABCG2 activity cells and NSP cells as low-ABCG2 activity 
cells may be accurate as an average across these subpopulations; however, doing so fails 
to capture the heterogeneity of activity within these subpopulations. Such mechanisms 
may partially explain the discrepancies in the literature regarding the increased 
propensity but non-equivalence of SP cells with stem-like qualities and tumorigenic 
potential. (Broadley et al., 2011; Burkert et al., 2008; Li and Laterra, 2012; Lichtenauer et 
al., 2008; Morita et al., 2006)  These considerations are critical when attempting to use 
SP assay data as a surrogate for ABCG2 activity or MDR phenotype on a single-cell 
level. 
A key element of the Subpopulation Type response is the non-linear association 
between transporter expression and transporter activity. Only a modest increase in 
transporter activity is associated with increasing expression at low and moderate levels; 
however, at the higher range of expression, small increases in expression are associated 
with dramatic increases in transporter activity levels.  The biochemical basis for the non-
linear relationship between transporter expression and activity levels may arise from the 
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biochemical properties of ABCG2.  ABCG2 functions within multi-meric complexes and 
has been observed in complexes as homo-tetramers (McDevitt et al., 2006; Xu et al., 
2004) and 12-mers. (Xu et al., 2007)  At least three structural domains within ABCG2 are 
sufficient for oligimerization of ABCG2. (Mo and Zhang, 2012)  Further, ABCG2 
possesses multiple substrate binding sites, which exhibit cooperative binding of substrate. 
(Clark et al., 2006)  Therefore, elevated ABCG2 expression levels in a population may be 
indicative of a population that possess the potential for exhibiting a MDR phenotype but 
through a select subset with the highest levels of expression and activity. Validation of 
such a mechanism may permit therapeutic approaches that aim to normalize transporter 
expression across the population to sub-MDR levels by targeting the highest expressing 
cells rather than by depressing transporter expression across the entire population. 
In addition to the findings relating to SP dynamics and kinetic mechanisms that 
can generate SP responses, we have, in our investigation, developed a number of novel 
technical approaches to objectively measuring SP properties and modeling population-
level responses due to single-cell heterogeneity.  
Measurement of the SP has traditionally achieved through manual gating 
practices, comparing the +FTC and –FTC conditions to define boundaries to segregate SP 
and NSP regions. (Petriz, 2013)  Such user-defined gate methods for assigning SP and 
NSP gates are highly varied. (Akunuru et al., 2012; 2011; Liu et al., 2014; Sabisz and 
Skladanowski, 2009; Sung et al., 2008; Tirino et al., 2013; Yeh et al., 2013)  Approaches 
such as this are subjective and not without bias, making them difficult to reliably 
reproduce in different samples and investigations.  We observed correlation between 
objective measures of Hoechst staining and SP size (Figure 5.5-C, Figure 5.6-A), which 
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served as the basis for our approach for unbiased measurement of side population size as 
%SP using Projection Gating.  
Finally, we developed an ensemble computational approach (Figure 5.11) that 
enabled us direct measurements of the influences of heterogeneity in single-cell 
transporter activity on cell staining in an in silico fashion. This circumvented the 
destructive nature of the SP assay and permitted direct comparison of population-level 
responses of conditions that only varied by presence or absence of transporter inhibition.  
We achieved this by constructing a heterogeneous collection of individual cells whose 
properties were derived from experimental data and stained in silico according to mass-
action kinetic simulations with conditions of free and inhibited transporter.  The strength 
of this approach is that it permits comparison of controlled conditions that would be 
impossible to achieve in an experimental setting, and enables the study of heterogeneity 
of the single-cell response on the emergence of population-level properties. With the 
emergence of increasingly sophisticated tools for single-cell investigation, this type of 
modeling approach spans multiple biologic scales in a manner that places single-cell 
heterogeneity into a broader context as might occur in pathologic processes, such as 




We paired experimental and computational tools to investigate the role of 
transporter heterogeneity at the single-cell level on the emergence of a population level-
property, the SP, in the context of TGFβ-mediated EMT, which was found to modulate 
SP size.  In a time course study, we characterized the variable dynamics of size and 
differential staining magnitude of SPs.  A549 cells were found to have a ~20% SP after 4 
days in culture, which decreased to ~1% the next day, following passage, before 
returning to ~20% in a cyclic manner.  SP size was correlated with ABCG2 expression, 
which was down-regulated by the addition of TGFβ, leading to attenuation of SP size.  
Larger SPs were found to exhibit higher degrees of differential Hoechst staining and 
statistical methods were applied to Hoechst staining signals to objectively quantify SP 
size and visualize differences is SP densities.  We developed a multiscale computational 
model of SP responses in which ensembles of TGFβ-treated single-cell populations were 
simulated in SP assays and analyzed using an in silico flow cytometry approach to 
measure SPs.  SPs were quantified using the nascent statistical approaches and used to 
judge ensemble quality.  Each ensemble represented a unique kinetic schema for Hoechst 
staining and exhibited an associated single-cell SP response distribution.  The best 
performing ensembles exhibited a characteristic single-cell SP response distribution in 
which the majority of cells exhibited little to no differential Hoechst staining in the SP 
assay while an active minority exhibited differential staining.  Such a low frequency, high 
activity subpopulation may be functionally poised to overcome a cytotoxic insult that is 
sufficient to kill the high frequency, low activity main population, thereby establishing a 
drug resistant cell line.   
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5.5 Materials & Methods 
5.5.1 Cell Culture & Treatment 
A549 lung carcinoma cells were obtained from American Type Culture Collection 
(ATCC; CCL-185) and maintained in growth media, consisting of high glucose DMEM 
with L-glutamine (Sigma D5796), 10% FBS (Sigma F4135) and penicillin (50 IU/ml)-
streptomycin (50 µg/ml) (Cellgro 30-001-CI).  Cells were plated in flasks at density of 
3,000 cells per well in growth media (15 ml per T-75/35 ml per T-175) and maintained at 
37˚C and supplemented with 5% CO2.  TGFβ (Millipore, GF111) and tBHQ (ACROS  
Organics, tert-butylhydroquinone, AC15082) treatment took place in culture media.  
5.5.2 Side Population Assay 
Cells were trypsinized and resuspended in CO2 conditioned DMEM+, consisting 
of high-glucose DMEM without phenol red, 10 mM HEPES, 2% FBS, and 2 mM EDTA, 
at a concentration of 1x106 cells/ml.  Samples were then split into +FTC and -FTC 
conditions, which were supplemented with DMSO-mobilized FTC (EMD Millipore, 
344847) at a final concentration of 10 µM or DMSO alone, respectively.  The solutions 
were incubated at 37˚C for 30 minutes, after which they were supplemented with Hoechst 
33342 (Life Technologies Molecular Probes H21492) at a final concentration of 5 µM for 
90 minutes, with mixing at 30-minute intervals.  The staining solutions were then 
centrifuged at 1,000 RCF for 10 minutes and resuspended in HBSS+, consisting of HBSS 
without phenol red, 10 mM HEPES, 2% FBS, and 10 mM EDTA.  Cells were incubate 
with the viability stain SYTOX blue (Life Technologies Molecular Probes S34857, 
1:1000) for 5 minutes prior to fluorescence measurement via flow cytometry.  Positive 
controls for dead cell staining were obtained by incubating cells at 56˚C for 45 minutes 
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followed by SYTOX Blue staining.  Using a BD LSR II flow cytometer, samples were 
excited with a 355 nm UV laser with the Hoechst Red signal measured in a λem = 675/50 
nm channel with linear scaling and the Hoechst Blue signal measured in a λem = 450/50 
nm channel with linear scaling.  Additionally, samples were excited with a 445 nm violet 
laser with SYTOX blue emission measured in a λem = 473/10 nm channel with log 
scaling.  Sample gating proceeded as follows: 1)  Debris exclusion with FSC-area/SSC-
area (λex = 488 nm) gating, 2)  Single-cell selection with FSC-height/FSC-area, 3)  Live 
cell selection with the violet-λem = 473/10 nm channel.  Events retained through all 3 
gates were used for subsequent SP analysis in the Hoechst Red and Blue channels.  
Manual selection of SP gates were determined using the +FTC conditions where a 
quadrant gate was placed as tight as possible such that greater than 99% of the cells in the 
+FTC condition were located in the upper right quadrant.  The same gates were then 
applied to the -FTC condition where the two left gates were considered to be SP gates 
and the right two gates considered to be NSP gates.  The measured %SP in the manual 
gating approach is the sum of the percent of parent population in the SP gates.  For a 
given sample, the %SP was determined using the specific +FTC and -FTC conditions for 
that sample. 
5.5.3 Surface Marker Analysis 
Following 4 days of TGFβ treatment, surface marker expression of A549 cells 
was analyzed by flow cytometry following dissociation from culture flasks using non-
enzymatic means.  Following treatment, cells were dissociated with Enzyme Free 
Dissociation Solution (Millipore S-004-B) and resuspended in DMEM without phenol 
red supplemented with 2% fetal bovine serum, 10 mM EDTA, and 10 mM EGTA.  The 
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cells were then pelleted (1000 RCF, 10 minutes) and resuspended at a concentration of 
1x107 cells per ml in HBSS without phenol red, Ca2+, & Mg2+ supplemented with 1 mM 
HEPES, 2% fetal bovine serum, 1 mM EDTA, and 1 mM EGTA.  The cell solution was 
added to an equal volume of antibody staining solution and incubated for 30 minutes on 
ice with gentle rotation.  Antibody solutions (E-cadherin/PE-CF594, BD Biosciences, 
Clone 67A4, 2x dilution; N-cadherin/PE, BD Biosciences, Clone 8C11, 2x dilution; 
ABCG2/APC, BioLegend, Clone 5D3, 2x dilution) were prepared in the aforementioned 
HBSS solution.  Following incubation, cells were washed and resuspended in the HBSS 
solution.  Next the solutions were stained with SYTOX Blue to select for live cells.  A 
BD LSR II flow cytometer was used to analyze fluorescence of the stained cells with the 
following settings: FSC/SSC (λex = 488 nm), PE (λex = 488 nm, λem = 575/26 nm), PE-
C594 (λex = 488 nm, λem = 610/20 nm), APC (λex = 633 nm, λem = 660/20 nm), SYTOX 
Blue (λex = 445 nm, λem = 473/10 nm).  Unstained and singly stained samples were 
prepared and used for compensation matrix calculations within FlowJo on each day of 
data collection.  The following gating strategy was employed: debris exclusion 
(FSC/SSC), single events (FSC-H/FSC-A), and live cells (SYTOX Blue).  Upon gating 
for single, live-cell events, fluorescence intensities were measured as the geometric mean 
fluorescence. 
5.5.4 Single-Cell Sorting & Expansion 
To sort single-cells for clonal expansion, the A549 parent cell line was expanded 
in culture for 4 days following passage and prepared for ABCG2 surface marker staining 
as indicated previously.  Live cell selection took place with SYTOX Green (Life 
Technologies Molecular Probes S7020, 1:10,000).  Samples were then processed and 
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sorted in a BD FACS Aria IIIu.  Gates in the upper and lower 5% of the APC channel 
were defined to select low-ABCG2 and high-ABCG2 stained cells.  Individual cells were 
sorted into wells of a 96-well plate, containing 200 µl of growth media.  Cells were 
expanded in culture over the course of 30 days in growth media. 
5.5.5 Hoechst Score Processing of SP Data 
5.5.5.1 Hoechst Score Transformations 
Side population flow cytometry data for a particular sample consists of individual 
events with associated Hoechst Red and Blue signals for both +FTC and -FTC 
conditions.  The Hoechst Red and Blue signals are expressed in independent arbitrary 
units.  To generalize the interpretation of side populations from Hoechst signals, 
independent of raw signal units, Hoechst signals were converted into Hoechst Scores.  
Hoechst Scores are based upon the standard score, or z-score, in which a distribution is 
mean centered and normalized to the standard deviation.  To compute the Hoechst Score 
for the Hoechst Red channel, the mean and standard deviation of the Hoechst Red signal 
from the +FTC condition were calculated.  Next, the +FTC Hoechst Red mean was 
subtracted from the Hoechst Red signals from each of the events in the +FTC and -FTC 
conditions.  Similarly, each event in the +FTC and -FTC conditions were divided by the 
standard deviation from the +FTC condition.  The resulting event data, +FTC mean 
centered and +FTC standard deviation normalized, constituted the Hoechst Red Scores 
for the two conditions.  Hoechst Blue Scores were derived in an analogous fashion.  
Hoechst Scores were calculated at a per sample basis between each pairing of +FTC and -
FTC condition data. 
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5.5.5.2 Projection Gating for %SP Measurement 
Hoechst Scores Projections were derived from Hoechst Red and Blue Scores.  
Projections were derived from Score data and not signal data due to the arbitrariness of 
signal magnitude in the signal data.  Score data from Hoechst Red (HRS) and Blue (HBS) 
channels have common units and relative magnitudes.  Projection values were derived for 
each event within a sample, in which the Hoechst Score Projection (Hproj) was defined: 






(𝐻𝑅𝑆 + 𝐻𝐵𝑆)2 
Hoechst Projections were used to set a threshold, or gate, intensity at the lower 
limit of the NSP.  The 1
st
 percentile mark of the Hoechst Projection data from the +FTC 
condition was used define the threshold and applied to the -FTC condition.  The percent 
of events falling below the threshold in the -FTC condition was set as the %SP in this 
projection gating approach. 
5.5.5.3 Hoechst Scores PDF Distributions 
For a given Hoechst condition (+FTC or -FTC), Hoechst Red and Blue scores 
were provided transformed into a 2D probability density function (PDF) on the Hoechst 
Red and Hoechst Blue plane with the frequency, or cell density, defined at each paired 
Hoechst Red and Blue coordinate.  Smoothed surfaces over the Hoechst Red and Blue 
plane were derived by the method for smoothing scatter plot data described by Eilers et 
al. (Eilers and Goeman, 2004)  Next, the area under the surface was calculated and 
normalized to 1 for each condition.  
In its most basic form, flow cytometry data is a set of coordinate data/scatter, with 
each event represented by an intensity value along each of the measured dimensions.  
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Comparison of data between two sets relies on the comparison of some sort of statistical 
transformation of the data (i.e. mean or median).  However, such transformations result in 
loss of spatial information.  Histograms allow for comparison of spatial information, but 
differences in event number complicate interpretations.  In order to permit more rigorous 
comparisons, we converted Hoechst staining coordinate data into probability density 
functions along both Hoechst Red and Blue Score dimensions.  This was similar, in 
effect, to constructing a 2D histogram with smoothing and normalization to account for 
differences in event number between data sets.  In this format, spatial differences in 
staining distributions can easily be computed by taking the difference between PDFs. 
 
5.5.5.4 ∆FTC Distributions 
For a given sample, a ∆FTC distribution was calculated by taking the point-wise 
difference between the PDF of the -FTC condition (PDF-FTC) and PDF+FTC across the 
Hoechst Red and Blue plane to calculate the difference in normalized cell density. 
5.5.5.5 ∆SP Distributions 
To compare the difference between ∆FTC distributions between two samples we 
calculated a ∆SP distribution.  To compare a test sample to a control sample the ∆SP was 
derived as ∆FTCtest - ∆FTCcontrol, where the point-wise difference in ∆FTC intensities was 
calculated at each Hoechst Red and Blue pair.  
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5.5.6 Flow Sight Imaging Cytometer 
5.5.6.1 Data Acquisition  
Samples were imaged at 20X magnification using a FlowSight with the 
Quantitative Imaging Upgrade (Amnis, Seattle, WA).  Single color controls were used to 
set-up compensation matrices.  For the SP assay, the compensation matrix was manually 
edited to allow collection of the Hoescht Blue (470/35 nm) and Red (694/51 nm) signals 
using the 405 nm laser.  Images were analyzed with IDEAS analysis software (Amnis).  
Using the gradient root mean square feature for the brightfield channel, “Focused cells” 
were selected according to the manufacturer’s recommendation.  Debris was eliminated 
by gating single cells using the area and aspect ratio features for the brightfield channel.  
Live cells were gated using the intensity feature in the green channel (533/27 nm) for 
SYTOX Green staining.  For ABCG2 analysis, the intensity feature of the APC channel 
(694/51 nm; 642 nm excitation laser) was used to quantify the expression of ABCG2.  
For the side population assay, double positive cells from were selected by gating in the 
Hoechst Red and Hoechst Blue channels. 
5.5.6.2 Nuclear/Cytosolic Hoechst Signal Segmentation 
To process each data point channel information was saved in the image name 
such that for each sample, one each image for each channel was saved.  The Hoechst red, 
Hoechst blue, and bright field images were all exported from the FlowSight software and 
batch converted into a TIF format using ImageJ.  The images were processed using a 
custom python script, which utilized the open source SCIPY platform for image analysis.  
To obtain a whole cell mask, sobel edge detection was run on the brightfield image and 
the subsequent image was converted to a binary mask via the following steps: 
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thresholding, filling, binary closing.  The mask for the nucleus was calculated by 
thresholding the Hoechst blue signal by 25% of its maximum value.  The cytoplasmic 
mask was obtained by subtracting the image mask from the nucleus mask.  Hoechst red 
and blue signals were calculated by taking the average of each signal over the 
cytoplasmic and nuclear masks. 
5.5.7 Multiscale Ensemble Modeling of Side Population Responses 
5.5.7.1 General Overview of Approach 
Heterogeneous cell populations were simulated in an array of experimental 
conditions across a wide range of kinetic conditions to investigate the influence of 
transporter function on Hoechst staining kinetics that give rise to SP phenotypes.  Three 
models were generated describing numerical (Model 1), concentration (Model 2), and 
experimentally derived (Model 3) transporter distributions.  Individual cells (Pi) within a 
population (P) of size N=1,000 are described by a set of morphological parameters 
(volumes, surface areas, & DNA content).  The parameter values for the population were 
assigned via LHS of PDFs derived from experimental distributions of cell radii, nuclear 
radii, and DNA content.  Kinetic parameter sets (M=10,000) were obtained from LHS of 
uniform distributions in log space.  (Figure 5.11-A)  For each parameter set, Hoechst 
staining is simulated in the cell population across multiple transporter conditions and with 
and without transporter inhibition, simulating +FTC and -FTC conditions. (Figure 5.11-
B)  Each population simulation consists of N single-cell mass-action ODE simulations of 
Hoechst staining.  Following the kinetic simulations, Hoechst concentrations within 
individual cells are converted to Hoechst Red and Blue signals via linear transformation 
with a signal matrix accounting for the spectral excitation and emission properties of free 
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and DNA-bound Hoechst dyes as well as an in silico flow cytometer.  (Figure 5.11-C)  
Simulated flow cytometry signals, in arbitrary units, were then converted to Hoechst 
Score PDFs where projection gating was applied to measure the %SP.  (Figure 5.11-D)  
Hoechst scores PDFs are used to calculate FTC and SP distributions, which allow for 
visualization of differences in population simulations with and without transporter 
inhibition as well as across different transporter conditions.  (Figure 5.11-E)  Hoechst 
score metrics from in silico flow cytometry populations are compared to metrics derived 
from experimental data to gauge the extent of SP response in the populations.  Parameter 
sets with in silico populations meeting the selection criteria for identifying a SP are then 
accepted and ranked according to similarity to %SP measured experimentally according 
to the normalized root mean-squared error (RMSE, Figure 5.11-F).  Accepted sets are 
then analyzed at the single-cell SP response.  The distribution of responses to inhibition 
are used to classify the homo/heterogeneity of response magnitudes as well as the 
uniformity/bimodality of response frequency (Figure 5.11-G). 
5.5.7.2 Whole Cell and Nuclear Radii Probability Density Functions 
FlowSight imaging cytometry was used to measure whole cell and nuclear radii of 
Hoechst stained cells in the presence of FTC as per the imaging cytometer instructions.  
Cells and nuclei had aspect ratios > 0.9 and were assumed to be spherical for the 
purposes of simplification.  Whole cell and nuclear areas, reported in micrometers, were 
then used to estimate cell and nuclear radii for the population of A549 cells (Figure B.8-
A).  The size of the nucleus was not independent of the whole cell size (Figure B.8-B), 
therefore, instead of treating each as in independent distribution, a 2D PDF was 
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constructed in a manner analogous to the used to calculate PDFs for Hoechst Red and 
Blue Scores. 
5.5.7.3 Different Transporter Expression & Distributions 
5.5.7.3.1 Transporter Expression 
Different models of transporter distribution across a population were 
implemented; however, at the single-cell level, the Hoechst staining kinetic model was 
identical.  Therefore, what differed between the models was how different cells within a 
given population were assigned transporter expression.  In each of the models, 
experimentally-derived expression levels were used to inform model expression.  In 
Models 1 & 2, the relative geometric mean expression of ABCG2 from TGFβ -treated 
A549 cells (Figure 5.3-B) were used while in Model 3, the flow cytometry staining 
distribution served as a probability density function from which transporter expression 
frequency was sampled (Figure B.7-A). 
5.5.7.3.2 Model 1: Number Distribution/Equal Concentration 
Each population was associated with the geometric mean as the relative 
transporter level for the population.  This factor served as the scaling factor relative to the 
maximum geometric mean intensity from the untreated control condition.  The magnitude 
of the relative differences between transporter levels of the samples was set by 𝑘8.  The 
relative differences of transporter levels were reconfigured for each kinetic parameter set.  
Once the relative transporter level was determined, it was set as the maximum transporter 
concentration in the cytosol or nucleus where the relative intensities of cytosolic to 
nuclear transporter activities were expressed as: 
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𝑇𝐶𝑇𝐴 = 𝑘7𝑇𝑁𝑇𝐴 
Each cell within the population was assigned total cytosolic and nuclear 
transporter activities of 𝑇𝐶𝑇𝐴 & 𝑇𝑁𝑇𝐴, respectiviely. 
5.5.7.3.3 Model 2: Concentration Distribution/Equal Number 
Transporter activity for Model 2 proceeded in the same manner as Model 1; 
however, after calculation of 𝑇𝐶𝑇𝐴 & 𝑇𝑁𝑇𝐴, the average number of molar equivalents in 
cells of the distribution was calculated.  Each of the cells in the population were then 
assigned the same number of molar activity equivalents, which was then converted to 
concentration activity equivalents on a cell-by-cell basis using the cytosolic and nuclear 
volumes. 
5.5.7.3.4 Model 3: Experimental Distribution 
Flow cytometry ABCG2 surface marker staining data from TGFβ -treated A549 
cells were exported from FlowJo as compensated fluorescence intensities.  The 
distributions were then loaded into MATLAB where they were converted to PDFs for 
each individual replicated.  PDFs were generated with the ksdensity function.  For a 
particular sample, a final PDF was taken as the unit normalized average PDF of three 
experimental replicates.  The distributions were then scaled to fall between 0 and 1 
(Figure B.7-A).  Therefore values within the distribution reflect relative expression 
within the distribution. 
Relative transporter levels within a distribution (𝑇𝑇𝑜𝑡𝑎𝑙) were randomly selected 
values (𝑃𝑇𝑖) from ABCG2 expression PDF distributions where 𝑖 = [1,4], corresponding 
to ABCG2 distributions from 0, 1, 10, & 100 pM TGFβ treatments, respectively.  𝑇𝑇𝑜𝑡𝑎𝑙 
 152 
levels are expressed in units of 𝑇𝐿𝑒𝑣𝑒𝑙.  Next, the relative transporter levels in cytosolic 
(𝑇𝐶𝑇) and nuclear (𝑇𝑁𝑇) compartments were calculated under the assumption that the total 
transporter level is split into cytosolic and nuclear compartments at a fixed ratio, which 
remains constant during the simulation. 
 
 Total Transporter Level:    
𝑇𝑇𝑜𝑡𝑎𝑙 = 𝑇𝐶𝑇 + 𝑇𝑁𝑇 
 Cytosolic/Nuclear Transporter Levels:  
𝑇𝐶𝑇 = 𝑘7𝑇𝑁𝑇 
 
Total transporter activity levels were then calculated from the Hill equation (𝜃𝑐), 
reflecting the cooperative interactions of transporters within each compartment: 
 Total Cytosolic Transporter Cooperatively:   
𝑇𝐶𝑇𝐴 = 𝜃𝑐(𝑇𝐶𝑇) 
 Total Nuclear Transporter Cooperatively:   
𝑇𝐶𝑁𝐴 = 𝜃𝑐(𝑇𝑁𝑇) 
Transporter Cooperatively:  





5.5.7.3.5 Transporter Activity Level Inhibition 
Prior to kinetic modeling of Hoechst staining, each cell was assigned a total 
cytosolic and nuclear transporter activities, 𝑇𝐶𝑇𝐴 & 𝑇𝑁𝑇𝐴.  The absolute transporter 
activity in the kinetic simulation was then determined by the absolute scaling factor 𝑘6 as 
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well as the degree of transporter inhibition (𝑖𝑇), where 𝑖𝑇 = 0.99 in the inhibited 
condition(+FTC) while 𝑖𝑇 = 0 in the uninhibited condition (-FTC). 
 Total Cytosolic Transporter Activity:    
𝑇𝐶𝐴 = 𝑘6(1 − 𝑖𝑇)𝑇𝐶𝑇𝐴 
 Total Nuclear Transporter Activity:    
𝑇𝑁𝐴 = 𝑘6(1 − 𝑖𝑇)𝑇𝐶𝑁𝐴 
5.5.7.4 Hoechst/DNA-Binding Site Expression Probability Density Function 
DNA content distributions within cell populations can be measured with Hoechst 
staining. (Darzynkiewicz, 2001)  Therefore we took the +FTC Hoechst stained samples to 
represent the relative distribution of DNA content within a population.  Hoechst Blue 
signals for each of the +FTC conditions in the SP time course study were loaded into 
MATLAB and converted into a PDF using the ksdensity function.  An overall distribution 
was constructed from the average of the 39 individual PDFs (Figure B.7-B).  The 
distribution was then normalized to the mode so that the distribution represented a 
distribution relative to the mode.  The mode was assume to represent a cell in the G0/G1 
phase and have a relative DNA content of the size of 1 genome for an A549 cell.  We 
used this distribution to estimate the number of Hoechst-binding sites in DNA (Figure 
B.7-B). 
A549 Genome Size = 7.3x10
8
 Base Pairs   
Base Pairs Per Hoechst Binding Site = 80  (Loontiens et al., 1990) 
Binding Site Number per Mole (𝐴𝑣𝑔𝑁) = 6.022x1023 
For a given cell, the relative DNA level sampled as 𝐷𝑁𝐴𝐿 with units of 𝐷𝑁𝐴𝐿𝑒𝑣𝑒𝑙.  
Within the population, each of the DNA intensities was identically scaled, though 
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maintaining their relative distribution, to determine absolute binding sites and converted 
to molar binding sites.  Finally, binding site number was factored by nuclear volume to 
derive a molar concentration of binding site number. 
𝐷𝑁𝐴𝑇𝑜𝑡𝑎𝑙 = 𝐷𝑁𝐴𝐿 ∙ (𝐺𝑒𝑛𝑜𝑚𝑒 𝑆𝑖𝑧𝑒) ∙ (𝐵𝑎𝑠𝑒 𝑝𝑎𝑖𝑟𝑠 𝑝𝑒𝑟 𝑠𝑖𝑡𝑒) ∙ 𝑘2/𝐴𝑣𝑔𝑁 
5.5.7.5 Sampling PDFs to Construct In silico Cell Populations 
To sample PDFs and produce in silico populations, PDFs were converted, 
approximately, to cumulative distribution functions (CDF) by taking the cumulative sum 
of a PDF.  The CDFs were then normalized to a range of 0 to 1.  To generate a population 
of N cells from the PDF, N random numbers were drawn from the interval of 0 to 1 and 
mapped to the CDF to find the corresponding expression value.  In our observation, 
random sampling over the entire interval produced highly variable stochastic effects.  To 
circumvent this issue, we implemented Latin hypercube sampling (LHS) of the CDF, 
which more uniformly sampled the distribution.  To sample the radii, Nx2 random 
numbers between 0 and 1 were generated.  The whole cell PDF was sampled as an 
independent PDF.  Next, the nuclear PDF for the given whole cell radii was sampled to 
sample the conditional PDF for nuclear radii size.  Reconstructed cell populations of 
various sizes are shown in Figure B.8-C.  After the radii were sampled for a given cell, 
the radii were used to calculate cell and nuclear volumes and surface areas, assuming 
spherical morphology.  Cytosolic volumes were taken as the difference between whole 
cell and nuclear volumes.  Notably, the same LHS vector was used to sample the 
different CDFs of transporter expression.  Therefore, the sampling of transporters 





Table 5.1  Single-Cell ODE Model Morphology & Expression Variables. 
The variables listed below were assigned by LHS of experimental distributions for each 
cell within an in silico cell population.  
Parameter Symbol Units 
Cytosolic Volume 𝑉𝐶 𝑝𝑙 
Plasma Membrane Surface Area 𝐴𝐶  µ𝑚
2 
Nuclear Volume 𝑉𝑁 𝑝𝑙 
Nuclear Surface Area 𝐴𝑁 µ𝑚
2 
Relative DNA Level 𝐷𝑁𝐴𝐿 𝐷𝑁𝐴𝐿𝑒𝑣𝑒𝑙 
Relative Transporter Level 𝑇𝑇𝑜𝑡𝑎𝑙 𝑇𝐿𝑒𝑣𝑒𝑙 
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5.5.7.6 Latin Hypercube Sampling (LHS) of Kinetic Parameter Space 
M combinations of kinetic parameters (𝑘𝑞) were assigned via LHS, which 
segments a dimension of parameter space into uniform segments.  Within each segment, 
a parameter value is selected from a uniform random distribution.  Thus, LHS generates a 
collection of randomly chosen parameter choices with nearly uniform sampling of the 
parameter space.  Within MATLAB, the lhsdesign function was used to generate an MxQ 
LHS matrix of M samples within the interval (0,1) for each of the L parameters (Models 
1 & 2, Q=8; Model 3, Q=9).  The criterion correlation and maxmin were enabled and 50 
iterations were permitted to reduce correlation and maximize point-to-point distance 
within the LHS matrix. 
To convert the LHS of the parameter space ranges in Log10 space for a given 
parameter 𝑘𝑞, the q
th
 column of the LHS matrix was scaled by the Log10 of the range size 
and increased by Log10 of the lower limit of the range.  Finally, the parameter value 𝑘𝑚𝑞 
was obtained by taking the antilog of the m,q
th 
 entry of the transformed LHS matrix.  In 
Model 3, the Hill Half-Maximal Level, 𝑘9, was sampled uniformly from 0 to 1. 
Initial modeling included 𝑘𝑜𝑓𝑓 within the parameter search space; however, early 
interrogation of the system demonstrated insensitivity to variation in 𝑘𝑜𝑓𝑓.  Therefore we 
maintain a fixed 𝑘𝑜𝑓𝑓 relative to 𝑘1 in all ensembles based on the reported KD of 10
-7
. 
(Loontiens et al., 1990) 
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Table 5.2  Single-Cell ODE Model Kinetic Parameters.  
Sets of random kinetic parameters were assigned using LHS to uniformly sample the 
parameter range in Log10-spaced intervals.  The set of kinetic parameters is a uniformly 
applied across a population. 
Parameter Symbol Range Units 





µ𝑀 ∙ 𝑚𝑖𝑛⁄  
†Hoechst-DNA Dissociation Rate 𝑘𝑜𝑓𝑓 𝑘1 ∙ 10
−7 1
𝑚𝑖𝑛⁄  










µ𝑀 ∙ µ𝑚2 ∙ 𝑚𝑖𝑛⁄  





µ𝑀 ∙ 𝑚𝑖𝑛⁄  




























** Transporter Half-Maximal Level 𝑘9 0-1 𝑇𝐿𝑒𝑣𝑒𝑙 
* Model 1 & 2 
**  Model 3 
† 𝑘𝑜𝑓𝑓 set according to the value reported by (Loontiens et al., 1990) 
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5.5.7.7 Kinetic Model of Hoechst Staining 
Simulation of Hoechst staining took place at the single-cell level.  Within each 
population, cells were assigned variable cell and nuclear sizes, DNA content, and, in 
Model 3, relative transporter levels.  Across the set of kinetic parameters were common 
across the entire population.  Hoechst staining within a single cell was modeled using 
mass-action kinetics to describe the rates of reaction the transport across plasma and 
nuclear membranes (Figure B.9-A).  Each single cell system was modeled with three 
spatial compartments and was simulated with 90 minutes of staining. 
In each simulation, cells were initialized with no Hoechst species within the cell.  
The extracellular compartment was assumed to be so large so as to not experience 
changes in Hoechst concentration throughout the simulation.  Total DNA binding sites, 
cytosolic transporter, and nuclear transporter levels were assumed to be conserved during 
the time course of the staining and, using conservation of mass, used algebraically to 
reduce the order of the system, setting the order of the system at 5 differential variables 
(Table 5.3).  The set of kinetic reactions were used to compose the set of differential 
equations, which governed the dynamics of Hoechst-associated species within the kinetic 
model. 
For each single-cell simulation, variables were assigned initial conditions and 
submitted with system reaction equations to the ode15s solver in MATLAB.  Constant 
variables remain unchanged during the course of the simulation.  Algebraic variables are 
derived from constant and differential variables using algebraic conservation equations at 
each time point in the solver.  Differential variables are solved at each time point in the 





Table 5.3  Single-Cell ODE Model Mass-Action Variables. 
The variables listed below are those that are species involved in mass-action kinetic 
reactions that simulate the staining of cells with extracellular Hoechst.   
Species Symbol Initial Condition Variable Type 
Extracellular Hoechst 𝐻𝑒 5 µM Constant 
Cytosolic Hoechst 𝑥1 0 Differential 
DNA-Bound Hoechst 𝑥2 0 Differential 
Unbound DNA Binding Sites 𝐷𝑁𝐴 𝐷𝑁𝐴𝑇 Algebraic 
Total DNA Binding Sites 𝐷𝑁𝐴𝑇  𝐷𝑁𝐴𝑇𝑜𝑡𝑎𝑙 Constant 
Hoechst-Bound Cytosolic Transporter 𝑥3 0 Differential 
Unbound Cytosolic Transporter 𝑇𝐶 𝑇𝐶𝐴 Algebraic 
Total Cytosolic Transporter 𝑇𝐶𝐴 𝑘6𝑇𝐶𝑇𝐴 Constant 
Nuclear Hoechst 𝑥4 0 Differential 
Hoechst-Bound Nuclear Transporter 𝑥5 0 Differential 
Unbound Nuclear Transporter 𝑇𝑁 𝑇𝑁𝐴 Algebraic 
Total Nuclear Transporter 𝑇𝑁𝐴 𝑘6𝑇𝑁𝐴 Constant 
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5.5.7.7.1 Mass Conservation Equations 
During a simulation of Hoechst staining in a single cell, the amount of transporter 
and Hoechst/DNA-binding sites are assumed to be conserved and un-changed in total 
quantity.  Algebraic terms accounting for this conservation are substituted into the model 
for simplification and to reduce the order of the model.  
 Hoechst/DNA-Binding Sites:   
𝐷𝑁𝐴𝑇 = 𝐷𝑁𝐴 + 𝑥2 
 Cytosolic Transporter:   
𝑇𝐶𝐴 = 𝑇𝐶 + 𝑥3 
 Nuclear Transporter:    
𝑇𝑁𝐴 = 𝑇𝑁 + 𝑥5 
5.5.7.7.2 Kinetic Reaction Equations 
 Plasma Membrane Diffusion:      
𝑟1 =  𝑘3
𝐴𝐶
𝑉𝐶
(𝐻𝑒 − 𝑥1) 
 Hoechst-DNA Association:      
𝑟2 =  𝑘1𝑥4𝐷𝑁𝐴 
 Hoechst-DNA Dissociation:      
𝑟3 =  𝑘𝑜𝑓𝑓𝑥2 
 Cytosolic Hoechst-Transporter Association:    
𝑟4 =  𝑘4𝑥1𝑇𝐶 
 Cytosolic Hoechst-Transporter Dissociation & Efflux:  
𝑟5 =  𝑘5𝑥3 
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 Nuclear Membrane Diffusion:     
𝑟6 =  𝑘3𝐴𝑁(𝑥4 − 𝑥1) 
 Nuclear Hoechst-Transporter Association:    
𝑟7 =  𝑘4𝑥4𝑇𝑁 
 Nuclear Hoechst-Transporter Dissociation & Efflux:   
𝑟8 =  𝑘5𝑥5 
5.5.7.7.3 Differential Equations 
 Cytosolic Hoechst:      
𝑑𝑥1
𝑑𝑡







 DNA-Bound Hoechst:     
𝑑𝑥2
𝑑𝑡
=  𝑟2 − 𝑟3 
 Cytosolic Transporter-Bound Hoechst:   
𝑑𝑥3
𝑑𝑡
=  𝑟4 − 𝑟5 
 Nuclear Hoechst:      
𝑑𝑥4
𝑑𝑡




 Nuclear Transporter-Bound Hoechst:    
𝑑𝑥5
𝑑𝑡
=  𝑟7 − 𝑟8 
5.5.7.8 In silico Flow Cytometry Simulation 
Conversion of simulated Hoechst staining into Hoechst Red and Blue signals was 
mediated by a linear transformation of DNA-bound Hoechst and non-DNA-bound (free)  
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Hoechst species within each cell in a process we refer to as in silico flow cytometry.  
Following the kinetic simulation of Hoechst staining, the molar quantity of total free 
Hoechst and DNA-bound Hoechst are determined for each cell.  The quantities of these 
dyes are then used to calculate a corresponding Hoechst Red and Hoechst Blue signal.  
Hoechst Red and Blue signals result from the combination of Hoechst Red and Blue 
emission from both DNA-bound and free Hoechst species (Figure B.9-B).  DNA-bound 
and free Hoechst dyes possess different spectral properties, including quantum yield, 
excitation maxima, and emission maxima. (Cosa et al., 2001)  These differences manifest 
as differences in relative excitation efficiency and emission strength in the Hoechst Red 
and Blue emission channels (Figure B.9-C).  Accounting for these factors, we are able to 
formulate a signal transformation matrix with which we can transform quantities of 
DNA-bound and free Hoechst into relative Hoechst Red and Blue signals.  The 
formulation of the signal transformation matrix is detailed in Appendix B.5.2 . 
5.5.7.9 Hoechst Score & PDF Conversion of Flow Cytometry Signals 
Following the calculation of in silico flow cytometry values of Hoechst Red and 
Blue signals for each cell in a population, Hoechst Scores data was derived from Hoechst 
signal data.  Processing of data from the in silico flow data was identical to that of data 
processed in real flow cytometry data.  For a given in silico sample (inhibition and no 
inhibition pairing), PDF+FTC, PDF-FTC, and ∆FTC distributions were calculated.  The SP 
size was measured using the projection gating approach.  Finally, across the four 
conditions, the ∆FTC distributions were compared to the ∆FTC distribution from the 
highest transporter sample, corresponding to untreated control, to calculate ∆SP 
distributions.  
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5.5.7.10 Data-Driven Qualitative Selection of SP Responses 
Simulation of each of the ensembles produced the following data: differences in 
Hoechst Scores staining metrics, Hoechst Score PDF+FTC, Hoechst Score PDF-FTC, 
∆FTC, and ∆SP relative to the control, and %SP for each in silico sample.  In the 
analogous experimental conditions, Day 4 of the SP time course with 4 differing TGFβ  
sample conditions, we possess equivalent experimental data (Figure 5.4-A, 5.5-B, B.4-C).  
We used the experimental data to guide selection of models in terms of SP response.  A 
series of selection check points were setup, which each ensemble was required to meet all 
selection criterion in order to be accepted as exhibiting a SP response. 
First, the two highest transporter conditions were required to have negative 
∆HRSmean and ∆HBSmean values, reflecting an over all decrease in Hoechst staining.  
Next, the PDF+FTC and PDF-FTC were not allowed to share any less than 25% overlap, 
indicating that the entire range of population did not shift without inhibition.  The 
responses across all of the transporter conditions were required to reflect that of the 
experimental data.  Ensembles were required to demonstrate a positive correlation for 
both the ∆HRSmean with experimentally observed ∆HRSmean values and ∆HBSmean with 
experimentally observed ∆HBSmean values.  Experimental PDF+FTC, PDF-FTC, ∆FTC, and 
∆SP distributions for all conditions were exported from the SP time course study.  The 
normalized, aligned 2D cross correlation was calculated for each simulation/experimental 
pairing.  Within each of the categories, PDF+FTC, PDF-FTC, ∆FTC, and ∆SP, the average 
cross correlation of all of the conditions was required to be positive.  Finally, ensembles 
were required possess a %SP of at least 5% for the control sample and a differential %SP 
of 2.5% between the control and lowest transporter expressing sample.  Ensembles 
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meeting the selection criteria were then scored according to the normalized root mean-
square error (RMSE) of the %SP and differences in %SP with the experimental data.  
Ensembles with RMSE < 0 were excluded from SP response distribution analysis. 
5.5.7.11 Analysis of Single-Cell Side Population Response Distributions 
Within an ensemble, each of the cell populations is identical to one another, 
except for the relative amount of transporter activity.  Unlike experimental assays, cells 
within the in silico assay are indexed and differences between samples perfectly 
controlled for.  Therefore we can examine how the exact same cell will stain differently 
under very tightly controlled alternate scenarios.  Because of this feature, we can tabulate 
the difference in Hoechst Score projection in the inhibited and uninhibited Hoechst 
staining simulations.  Thus, for each cell in a sample, we determine the difference 
between these two conditions as -∆Hproj, in which a larger value corresponds to a larger 
single-cell SP response.  For each ensemble passing the qualitative selection process, the 
distributions of -∆Hproj values for each of the samples was further analyzed to interrogate 
the “shape” of the distribution.  For each sample distribution, the 3
rd
 standardized 
moment (skewness) and 4
th
 standardized moment (kurtosis) was calculated.  The 
skewness and kurtosis were used to calculate the bimodality coefficient: 




5.5.7.12 Model Implementation 
At the start of each simulation, an in silico population of N cells was generated and M 
kinetic parameter sets constructed using LHS.  In parallel, kinetic parameter sets were 
submitted with cell populations to conduct the simulations within an ensemble.  Many 
 165 
parameter sets were stiff to numerical solving.  To prevent stalled simulation of the 
overall model, populations or single-cells that failed to solve within and allotted time 
window were aborted.  Upon completion each ensemble was checked for a SP response.  
Upon completion of all of the models, the single-cell SP response distributions were 
analyzed for each of the passing ensembles in a model and aggregated for comparison. 
5.5.8 Software 
Flow cytometry and Flow Sight imaging cytometry data were processed and 
analyzed using FlowJo for Mac OS X version 10.0.7, Tree Star, Inc.  Statistical analyses 
of experimental data were performed within Graphpad Prism for Mac OS X version 6.0e.  
Imaging Cytometry images were segmented using ImageJ and the SCIPY platform in 
python.  Cytometry distribution analyses were performed using MATLAB version 2014a 
(64-bit), MathWorks Inc, in 64-bit Windows 8.1.  Side population simulations were 
implemented in MATLAB version 2014a for Linux and run in parallel on the PACE 
cluster at Georgia Tech, which consisted of 64 single core 3.8 GHZ AMD processors 
with over 240 GB of total RAM available (10 GB per node).  The following MATLAB 
File Exchange entries (accessed on 11/5/14) were implemented in MATLAB to analyze 
or display cytometry or simulation data: smoothhist2d (13352) (Perkins, 2009), 
tight_subplot (27991) (Kumpulainen, 2010), suplabel (7772) (Barrowes, 2005),  redblue 
(25536) (Auton, 2009), progress monitor (32101) (Jeremy, 2011), and distributionPlot 
(23661) (Jonas, 2009). 
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The body of work presented in this dissertation advances the field of cancer 
biology by implementation of the multivariate phenotype analysis techniques, and 
through development of a novel modeling approach.  The objective of this research was 
to investigate how redox regulated processes contribute to complex phenotypes that arise 
in the context of TGFβ-mediated EMT using multivariate and systems approaches.  We 
reconciled the coexistence of dual redox regulatory motifs, antioxidant attenuation of 
TGFβ signaling and TGFβ-mediated antioxidant attenuation, within the same 
experimental model in Chapter 3.  In Chapter 4 we investigated the possibility that the 
two regulatory motifs could operate across biological and temporal scales during the 
course of EMT.  Finally, in Chapter 5 we investigated the types of transporter activity 
distributions that emerge as drug resistant subpopulations.  Each chapter has added to our 
understanding of the regulatory processes that operate during TGFβ-mediated EMT.  
The observations in Chapter 3 that TGFβ signaling in A549 cells is inhibited by 
cell-retained antioxidants, and that TGFβ signaling leads to down-regulation of cellular 
antioxidants in the same experimental model, were significant because of the potential to 
observe a systems level property.  Numerous studies have been conducted with A549 
cells and focus on the aspect of antioxidant down-regulation, inhibition of TGFβ 
signaling, or induction of EMT.  However, we hypothesized in Chapter 4 that increased 
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cellular oxidation during TGFβ-mediated EMT reinforces TGFβ signaling in a feed-
forward manner as well as contributes to maintenance of mesenchymal phenotype 
(Figure 3.12).  A positive feedback loop can only operate in the context of a system.  The 
findings that originally supported the concept of a redox-mediated positive feedback loop 
during EMT were obtained by various investigators under many disparate experimental 
conditions.  We observed the manifestation of multiple redox mechanisms in a single 
experimental model. 
Our intent to investigate the dynamics of the intracellular redox environment in 
the context of EMT presented a significant challenge.  Yet, to assess the potential 
influence of redox processes on the acquisition of phenotype, time course dynamics were 
necessary.  The multivariate nature of such an experiment posed several challenges, one 
of which was visualizing high dimension time course data in a manner that preserves the 
benefits of taking a systems approach.  Another issue was the incompleteness of larger 
datasets that contained more experimental conditions, some of which were not taken at 
every time point (Figure 4.7).  Our choice to implement principal component analysis 
was very conducive to overcoming these issues.  While we did not observe a redox-
mediated feedback loop at work in our system, the multivariate time course approach we 
took is applicable in other settings and itself is a noteworthy addition to a biologically 
oriented field. 
One of the more significant aspects of our characterization of redox environment 
during EMT was the scope on which it was conducted, both on temporal and functional 
scales.  We observed extensive antioxidant down-regulation (Figure 4.3) coupled with an 
impaired capacity to clear electrophilic insults (exogenous H2O2) (Figure 4.6).  These 
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findings suggest that the down-regulation of antioxidants is truly coordinated in a 
regulated fashion, and is not simply an outlier response observed due to chance. 
Enhanced ABCG2 transporter activity in the SP compared to NSP cells is the 
accepted basis for the formation of a SP in a Hoechst staining condition without 
transporter inhibition.  Aside from inequality (SP activity > NSP activity), little was 
known about the absolute or relative transporter activities in SP and NSP cells.  In 
Chapter 5, we developed a novel modeling approach that simulated Hoechst staining of 
heterogeneous cell populations, assessed SP formation in silico, and analyzed the 
resulting data in a manner that was perfectly analogous with experimental SP data.  This 
modeling approach was developed for use in analyzing SP data; however, the same 
computational framework could be applied to investigate other models of heterogeneity.  
An extensive array of single-cell transporter activity distributions produced a 
roughly qualitative SP response; however, we observed better-fit models and visually 
more congruent distributions in highly skewed and bimodal distributions (Figure 5.16).  
The high-frequency/low-response in this distribution was coupled with a low-
frequency/high-response subpopulation.  If MDR phenotypes arise in the setting of 
chemotherapy, the distribution of transporter kinetics may be informative for choosing 
alternative treatment strategies.  
When conventional methods for measuring SP size were employed, we 
encountered a significant obstacle.  Applying such an approach in a very large parameter 
set would have been nearly impossible due to the subjective nature of the reported 
approaches.  In addressing this modeling challenge, we developed an objective 
methodology to measure side populations in terms of %SP, the conventionally reported 
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value (Figure 5.6).  We also investigated a number of other potential metrics and found 
that differences in Hoechst staining between inhibited and uninhibited conditions were 
correlated to %SP (Figure 5.5). Therefore, we have demonstrated a number of objective 
approaches to measuring SP responses that eliminate user-defined bias. 
6.2 Future Directions 
6.2.1 Cycling of Epithelial/Mesenchymal Differentiation  
In our investigation on the effects of antioxidants on phenotype following 
epithelial/mesenchymal differentiation (Figure 4.9), we observed no difference in the 
degree of differentiation of antioxidant-treated and untreated samples.  Additionally, the 
cell degree of phenotype remained largely unchanged from the 48 hours condition.  
During our SP time course study (Figure 5.4), we observed a cyclic trend in SP size, 
indicating that some aspect of the phenotype was being reset upon passage.  A key 
difference in the antioxidant challenge and the SP time course experiment is the 
implementation of passage.  Whether passaging of epithelial cells has an analogous reset 
of epithelial phenotype that it does on the SP is unknown.   
6.2.2 Additional Research Questions 
 Does nucleophilic tone correlate with ABCG2 activity across a population, 
and therefore exhibit heterogeneity? 
 Does epithelial/mesenchymal differentiation correlate with ABCG2 
activity across a population, and therefore exhibit heterogeneity?  
 Do equivalent ABCG2/transporter distributions arise de novo from single 
cell clones? 
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APPENDIX A  SUPPLEMENTARY DATA AND ADDITIONAL 
ANALYSES ON THE MULTIVARIATE CHARACTERIZATION 







A.1  Quantitative Real-Time PCR (qRT-PCR) 
Table A.1  PCR Transcript Primers & Classification. 
Overview of transcript primers on the Qiagen Oxidative Stress Plus PCR Array with the 
gene classification (A = Antioxidant; P = Pro-oxidant; H = Housekeeping Gene; U = 
Undetermined Significance). 
 
UniGene RefSeq Symbol Gene Class 
Hs.592379 NM_000477 ALB 
Albumin 
A 
Hs.654431 NM_000697 ALOX12 
Arachidonate 12-lipoxygenase 
P 
Hs.406238 NM_001159 AOX1 
Aldehyde oxidase 1 
P 
Hs.654439 NM_000041 APOE 
Apolipoprotein E 
A 
Hs.125213 NM_004045 ATOX1 ATX1 antioxidant protein 1 homolog 
(yeast) 
A 
Hs.144873 NM_004052 BNIP3 BCL2/adenovirus E1B 19kDa interacting 
protein 3 
U 
Hs.502302 NM_001752 CAT 
Catalase 
A 
Hs.514821 NM_002985 CCL5 
Chemokine (C-C motif) ligand 5 
U 
Hs.502917 NM_005125 CCS Copper chaperone for superoxide 
dismutase 
A 
Hs.292356 NM_000397 CYBB 
Cytochrome b-245, beta polypeptide 
P 
Hs.95120 NM_134268 CYGB 
Cytoglobin 
A 
Hs.498727 NM_014762 DHCR24 
24-dehydrocholesterol reductase 
U 
Hs.272813 NM_175940 DUOX1 





Table A.1 continued 
UniGene RefSeq Symbol Gene Class 
Hs.71377 NM_014080 DUOX2 
Dual oxidase 2 
P 
Hs.171695 NM_004417 DUSP1 
Dual specificity phosphatase 1 
U 
Hs.212088 NM_001979 EPHX2 
Epoxide hydrolase 2, cytoplasmic 
U 
Hs.279259 NM_000502 EPX 
Eosinophil peroxidase 
P 
Hs.735243 NM_021953 FOXM1 
Forkhead box M1 
U 
Hs.712676 NM_002032 FTH1 
Ferritin, heavy polypeptide 1 
A 
Hs.654465 NM_001498 GCLC Glutamate-cysteine ligase, catalytic 
subunit 
A 
Hs.76686 NM_000581 GPX1 
Glutathione peroxidase 1 
A 
Hs.2704 NM_002083 GPX2 
Glutathione peroxidase 2 (gastrointestinal) 
A 
Hs.386793 NM_002084 GPX3 
Glutathione peroxidase 3 (plasma) 
A 
Hs.433951 NM_002085 GPX4 Glutathione peroxidase 4 (phospholipid 
hydroperoxidase) 
A 
Hs.248129 NM_001509 GPX5 Glutathione peroxidase 5 (epididymal 
androgen-related protein) 
A 
Hs.271510 NM_000637 GSR 
Glutathione reductase 
A 
Hs.82327 NM_000178 GSS 
Glutathione synthetase 
A 
Hs.523836 NM_000852 GSTP1 
Glutathione S-transferase pi 1 
A 
Hs.655292 NM_001513 GSTZ1 
Glutathione transferase zeta 1 
A 
Hs.702139 NM_005345 HSPA1A 
Heat shock 70kDa protein 1A 
U 
Hs.80828 NM_006121 KRT1 
Keratin 1 
U 
Hs.234742 NM_006151 LPO 
Lactoperoxidase 
P 
Hs.517586 NM_005368 MB 
Myoglobin 
U 





Table A.1 continued 
UniGene RefSeq Symbol Gene Class 
Hs.458272 NM_000250 MPO 
Myeloperoxidase 
P 
Hs.75659 NM_002437 MPV17 MpV17 mitochondrial inner membrane 
protein 
P 
Hs.490981 NM_012331 MSRA 
Methionine sulfoxide reductase A 
A 
Hs.73133 NM_005954 MT3 
Metallothionein 3 
A 
Hs.655201 NM_000265 NCF1 
Neutrophil cytosolic factor 1 
P 
Hs.587558 NM_000433 NCF2 
Neutrophil cytosolic factor 2 
P 
Hs.709191 NM_000625 NOS2 
Nitric oxide synthase 2, inducible 
P 
Hs.371036 NM_016931 NOX4 
NADPH oxidase 4 
P 
Hs.657932 NM_024505 NOX5 NADPH oxidase, EF-hand calcium 
binding domain 5 
P 
Hs.534331 NM_002452 NUDT1 Nudix (nucleoside diphosphate linked 
moiety X)-type motif 1 
A 
Hs.368525 NM_020992 PDLIM1 
PDZ and LIM domain 1 
U 
Hs.731900 NM_002574 PRDX1 
Peroxiredoxin 1 
A 
Hs.432121 NM_005809 PRDX2 
Peroxiredoxin 2 
A 
Hs.523302 NM_006793 PRDX3 
Peroxiredoxin 3 
A 
Hs.83383 NM_006406 PRDX4 
Peroxiredoxin 4 
A 
Hs.502823 NM_181652 PRDX5 
Peroxiredoxin 5 
A 
Hs.731505 NM_004905 PRDX6 
Peroxiredoxin 6 
A 
Hs.610285 NM_183079 PRNP 
Prion protein 
U 
Hs.201978 NM_000962 PTGS1 
Prostaglandin-endoperoxide synthase 1 
(prostaglandin G/H synthase and 
cyclooxygenase) 
P 
Hs.196384 NM_000963 PTGS2 
Prostaglandin-endoperoxide synthase 2 





Table A.1 continued 
UniGene RefSeq Symbol Gene Class 
Hs.134623 NM_014245 RNF7 
Ring finger protein 7 
U 
Hs.32148 NM_203472 VIMP 
Selenoprotein S 
A 
Hs.745017 NM_005410 SEPP1 
Selenoprotein P, plasma, 1 
A 
Hs.253495 NM_003019 SFTPD 
Surfactant protein D 
U 
Hs.466693 NM_012237 SIRT2 
Sirtuin 2 
U 
Hs.443914 NM_000454 SOD1 
Superoxide dismutase 1, soluble 
A 
Hs.487046 NM_000636 SOD2 
Superoxide dismutase 2, mitochondrial 
A 
Hs.2420 NM_003102 SOD3 
Superoxide dismutase 3, extracellular 
A 
Hs.724025 NM_003900 SQSTM1 
Sequestosome 1 
U 
Hs.516830 NM_080725 SRXN1 
Sulfiredoxin 1 
A 
Hs.467554 NM_000547 TPO 
Thyroid peroxidase 
P 
Hs.134602 NM_003319 TTN 
Titin 
U 
Hs.443430 NM_006440 TXNRD2 
Thioredoxin reductase 2 
A 
Hs.80658 NM_003355 UCP2 Uncoupling protein 2 (mitochondrial, 
proton carrier) 
P 
Hs.734597 NM_001354 AKR1C2 
Aldo-keto reductase family 1, member C2 
(dihydrodiol dehydrogenase 2; bile acid 
binding protein; 3-alpha hydroxysteroid 
dehydrogenase, type III) 
U 
Hs.745046 NM_004282 BAG2 
BCL2-associated athanogene 2 
U 
Hs.443687 NM_001450 FHL2 
Four and a half LIM domains 2 
U 
Hs.315562 NM_002061 GCLM Glutamate-cysteine ligase, modifier 
subunit 
A 
Hs.69089 NM_000169 GLA 
Galactosidase, alpha 
U 
Hs.517581 NM_002133 HMOX1 




Table A.1 continued 
UniGene RefSeq Symbol Gene Class 
Hs.525600 NM_001017963 HSP90AA1 Heat shock protein 90kDa alpha 
(cytosolic), class A member 1 
U 





Hs.171426 NM_181782 NCOA7 
Nuclear receptor coactivator 7 
U 
Hs.406515 NM_000903 NQO1 NAD(P)H dehydrogenase, quinone 
1 
A 
Hs.584864 NM_012212 PTGR1 
Prostaglandin reductase 1 
U 
Hs.390594 NM_014331 SLC7A11 
Solute carrier family 7 (anionic 
amino acid transporter light chain, 
xc- system), member 11 
U 
Hs.407856 NM_003122 SPINK1 Serine peptidase inhibitor, Kazal 
type 1 
U 
Hs.466929 NM_024108 TRAPPC6A Trafficking protein particle 
complex 6A 
U 
Hs.435136 NM_003329 TXN 
Thioredoxin 
A 
Hs.654922 NM_003330 TXNRD1 
Thioredoxin reductase 1 
A 
Hs.520640 NM_001101 ACTB 
Actin, beta 
H 
Hs.534255 NM_004048 B2M 
Beta-2-microglobulin 
H 
Hs.544577 NM_002046 GAPDH Glyceraldehyde-3-phosphate 
dehydrogenase 
H 
Hs.412707 NM_000194 HPRT1 Hypoxanthine 
phosphoribosyltransferase 1 
H 
Hs.546285 NM_001002 RPLP0 





Figure A.1  Full Volcano Plot of Anti- & Pro-oxidant Gene Regulation by TGFβ. 
A549 cells were treated with 200 pM TGFβ for 48 hours, after which the expression of 
antioxidant and pro-oxidant genes were compared against untreated controls via qRT-
PCR.  Genes demonstrating a greater than 2-fold change in expression and a p value less 
than 0.05 are labeled with the gene name.  P values were determined by two-way 
ANOVA with multiple comparisons and the fold-change plotted as the mean ± standard 
error of the mean.  Data are the result of 3 independent biological replicates (n=3).   
















































































































A.2  Considerations for PCA Model Quality 
Each of the models reported were considered to be of good quality.  We based this 
determination on a number of metrics for each model.  Overviews of the quality of the 
models can be found in the following sections.  Each of the models was fit with 2 PCs.  
The distribution of data across these PCs indicates the degree to which variable 
responses, i.e. variance, is explained by the PCs.  Both the eigenvalue and R
2
X for a PC 
describe how much of the data is accounted for by a particular PC.  While eigenvalues 
will scale with the size of the data, the R
2
X is a metric restricted between 0 and 1.  
Comparison of these values for each of the PCs indicates the how much of the variance is 
captured by each of the PCs.  By construction, R
2




Total variance explained by the model can be determined by the summation of all 
R
2
XPC values, or R
2
Xcum, which is simply referred to as R
2
X in the text.  In addition to 
R
2
X, which describes how much of the data is explained, the Q
2
 metric provides an 
indication of goodness of prediction.  Q
2
 is determined by a leave-one-out cross-
validation and indicates how well the model can predict missing data.  By construction, 
R
2
X will always be greater than Q
2




 should not be 
too large.  In our case, a 0.3 threshold was set. 
PCs were determined to be significant when meeting a number of requirements.  
The eigenvalue should be greater than 1.  Q
2
 values should increase, compared to the 
previous PC, indicating that inclusion of the PC improves model prediction.  For each 









 values.  We can use these metrics to judge variable quality.  The 
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threshold for variable quality is dependent on the construction of the model.  Variables 
with R
2
XV values greater than A/K, where K is the number of response variables and A 
is the number of principal components, are considered well fit by the model.  Within 
SIMCA-P+, PC significance is further evaluated though cross-validation metrics.  
Significant PCs can meet several significance criteria and determined to be significant 
according to rules, e.g.  Rule 1 (R1), in which Q
2
 is greater than a limit set by the number 
of PCs used in the model or Rule 2 (R2), in which Q
2
V is greater than the limit for at 
least 20% of X variables (K>25) or sqrt(K)*log10(max(10,K-20)) when K≤25.  
Otherwise, the PCs were determined to be not significant (NS).  
Quality of observations can also be used to determine the merit of a model.  Plots 
of observations in the Hotelling’s T
2
 indicate whether there are strong outliers, which 
could skew modeling fitting.  Thresholds are set, under which 99% or 95% of the 
observations must reside, such that strong outliers do not have an overwhelming 
influence on construction of the PCs.  The distance to the model in X space (DModX) 
plot is a sum of observation residuals that remain after fitting with 2 PCs.  Falling below 
the Dcrit threshold indicates that an observation is well explained.  The DModX is a test 
for moderate outliers. 
A.3  PCA Model of ICW Time Course Data 
Input data for PCA consists of a set of observations, in our case individual 
replicates from each time point (3 replicates x 11 time points = 33 observations).  Each 
observation was itself a vector composed of a set of measurements from each of the 8 
response variables.  Thus our PCA model encompassed 264 data points in a 33x8 matrix, 
containing descriptions of A549 multivariate phenotypes throughout the progression of 
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EMT.  The ICW data was fit by 2 PCs, with roughly 82% of variance explained 
(R
2
X=0.82) and variable prediction through cross-validation with a Q
2
=0.58.  
Replicate experiments of samples obtained at the same time points closely 
followed the same trajectory through the latent variable space, demonstrating that i) the 
PCs were able to resolve differences in expression profiles according to its time of 
treatment, and ii) that replicate measurements were tightly correlated.  Importantly, this 
was an unsupervised approach, meaning that no explicit information about grouping or 
ordering, such as treatment time or replicate number, was included as an input variable.  
The inherent structure of the data, i.e. the collection of dynamic response profiles, is 
responsible for the grouping of similar time points and differentiation of dissimilar time 
points.  Thus the variance contained within the input data is representative of a biological 




Table A.2  ICW PCA Quality Metrics. 









cum CV Sig. 
Component 1 3.43 0.429 0.429 0.059 0.059 R2 








Figure A.2  Quality Metrics for the PCA of ICW Data of the EMT Time Course. 
A)  The Hotelling’s T
2
 plot outlines the limits under which 95% and 99% of the 
observations should reside.  B)  The DModX is a test for moderate outliers (greater than 
Dcrit).  C)  Variables are considered well explained if their R
2
VX value, i.e. explained 





















































































A.4  PCA Model of Microarray Data 
A.4.1  Additional Details and Analysis 
Data produced by Keshamouni et al. in 2009 was published in the NCBI Gene 
Expression omnibus as raw data. (Keshamouni et al., 2009) Each time point was 
normalized to the expression of the housekeeping genes ACTB, GAPDH, HPRT1, B2M, 
and RPLP0.  Further, the fold-change was calculated with respect to the mean of the 
untreated controls.  Data corresponded to log-transformed fold-change from the untreated 
condition.  The 26 observation by 59 variable data matrix was fit by 2 PCs (R
2
X=0.82) 
and cross-validation was of high quality (Q
2
=0.77).  The transcript PCA model of EMT 
phenotype dynamics demonstrated a correlation structure that is in many ways similar to 
the ICW PCA model.  The phenotype exhibited a similar rotational trajectory, though in a 
clockwise manner contrasting the counter-clockwise trajectory observed in the ICW 
model (Figure 4.4-A, 4.2-A).  In essence, PC2 was reflected about the origin compared to 
the ICW model due to the weighting of the variables along PC2 during model fitting.  
The positive orientation of the PC was assigned to the side of the origin with the greatest 
total loading; however the qualitative difference did not affect the 
correlation/anticorrelation relationships within the model. 
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A.4.2  Comparison of PCR and Microarray Change in Gene Expression 
 
Figure A.3  PCR & Microarray Transcript Concordance In TGFβ Response. 
Comparison of the change in gene expression following TGFβ-treatment determined by 
PCR with values reported by Keshamouni et al., which were determine by microarray.  
The fold-change values determined by PCR and via microarray at 24 (blue) and 72 (red) 




Table A.3  PCR & Microarray Transcript Correlation In TGFβ Response. 
Correlation between change in gene expression determined by PCR and microarray 
reported by Keshamouni et al. 
PCR vs.  Microarray 24 Hours 72 Hours 
Pearson r (95% CI) 0.464 (0.110,0.714) 0.657 (0.375,0.827) 
R
2
 0.216 0.431 
p value (two-tailed; α=0.05) 0.0128 0.0001 

































A.5  Overview of Model Quality 
 




Table A.4  Microarray Data PCA Quality Metrics. 









cum CV Sig. 
Component 1 18.34 0.706 0.706 0.667 0.667 R1 
Component 2 3.06 0.118 0.823 0.293 0.765 R1 
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Table A.5  Microarray Transcripts Chosen as PCA Variables. 
Transcript expression of A549 cells were measured by Keshamouni et al. in 2009 was 
published in the NCBI Gene Expression Omnibus (GSE17708) as raw data. (Keshamouni 
et al., 2009) The following markers were selected for inclusion in our PCA model. 
 





















alpha Smooth Muscle Actin (αSMA) 
ACTA2 Mesenchymal 
Zinc finger E-box-binding homeobox 1 
ZEB1 Mesenchymal 

















SMAD family member 2 (Smad2) 
SMAD2 Smad 
SMAD family member 3 (Smad3) 
SMAD3 Smad 






Cytochrome b-245, beta polypeptide 
CYGB Antioxidant 
Glutamate-cysteine ligase, catalytic subunit 
GCLC Antioxidant 
Glutamate-cysteine ligase, modifier subunit 
GCLM Antioxidant 
Glutathione peroxidase 1 
GPX1 Antioxidant 
Glutathione peroxidase 2 (gastrointestinal) 
GPX2 Antioxidant 














Superoxide dismutase 1, soluble 
SOD1 Antioxidant 
 186 











Thioredoxin reductase 1 
TXNRD1 Antioxidant 
Selenoprotein P, plasma, 1 
SEPP1 Antioxidant 
NAD(P)H dehydrogenase, quinone 1 
NQO1 Antioxidant 






Nuclear factor, erythroid 2-like 2 
NFE2L2 Antioxidant 




Neutrophil cytosolic factor 1 
NCF1 Pro-oxidant 
Neutrophil cytosolic factor 2 
NCF2 Pro-oxidant 
NADPH oxidase 4 
NOX4 Pro-oxidant 
Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H 
synthase and cyclooxygenase) 
PTGS2 Pro-oxidant 





A.7  Luminol Assay for Hydrogen Peroxide 
A.7.1  Background 
Luminol is a probe that undergoes chemiluminescence following oxidation.  The 
chemistry of luminol (LH
-
) is complex in that is capable of both one and two-electron 
oxidation by a number of reactive species, the key step being the formation of the α-
hydroxy-hydroperoxide intermediate (LOOH
-
), which spontaneously decomposes to the 
excited 3-aminophthalate, which emits light. (Merényi et al., 1990) This protocol is 
adapted from the reported procedure to measure H2O2 in a number of experimental 
settings with luminol/sodium hypochlorite derived chemiluminescence, which was earlier 
developed for to assay H2O2 production upon neutrophil activation. (Mueller, 2000; 
Mueller and Arnhold, 1995) Early adoption of luminol to measure reactive oxygen 
species makes use of luminol alone. (Allen and Loose, 1976) When used in this manner, 
the luminescence is not specific to any particular reactive species and cannot be used in a 
quantitative manner. (Wardman, 2007) Inclusion of sodium hypochlorite (NaOCl) shifts 
the reaction into the two-electron pathway through efficient conversion of LH- into the 
H2O2-reactive intermediate, diazaquinone (L). (Brestel, 1985) The chemiuminesence 
produced in this assay is quantitatively dependent on both the concentration of OCl
-
 and 
H2O2. (Arnhold et al., 1991) This is evident when assessing the inhibition of 
luminescence of the luminol/hypochlorite assay in the presence of numerous agents.  
Notably, thiol-containing compounds attenuate signal, presumably through competitive 
reaction with OCl
-
.  Moreover, catalase had the strongest inhibition among those tested, 
while superoxide dismutase, at lower levels, increased signal, presumably through 
dismutation of O2˙
-
 into H2O2. (Arnhold et al., 1993) Thus, the luminol/hypochlorite 
 188 
assay can be used to determine H2O2 concentrations when compared against a known 
standard.  Such applications have been highlighted in cell homogenates and intact cells. 
(Mueller, 2000) More recently, is has been used for comparison of bolus and glucose 
oxidase/catalase derived H2O2, where the first-order kinetics of H2O2 turnover was 
determined through sampling the supernatant for H2O2 at sequential time points 
following bolus addition. (Sobotta et al., 2013) Using this approach, the following 
protocol aims to measure the capacity of a population of cells to eliminate H2O2 from the 
media over time and, thus, provide a semi-quantitative insight into the antioxidant 
capacity of the cells. 
 
A.7.2  Model Construction  
In this assay, we will assume that the degradation of H2O2 will be proportional to 
the number of cells per well and the concentration of H2O2, such that the rate equation is 
second-order.  The change in the quantity of H2O2 (Q) is therefore defined as: 
𝑑𝑄
𝑑𝑡
=  −𝑘𝑁[𝐻2𝑂2] 













We are able to measure [H2O2], time, and the relative number of cells using the 
Hoechst stain.  Assume that the Hoechst stain is proportional to the number of cells such 








We then redefine k in relative terms for comparison of cells of equal staining per 
volume by setting kdeg = kβ/V. 
𝑑𝑄
𝑑𝑡
=  −𝑘𝑑𝑒𝑔𝑆[𝐻2𝑂2] 
We wish to fit our data to our model in order to derive the rate constant kdeg.  We 
are able to measure the H2O2, time, and Hoechst stain.  To simplify the approach, we 
introduce the latent variable α to allow two-variable fitting ([H2O2], α) to estimate kdeg, 
rather than trying to fit the data to a three-variable model ([H2O2], N, t).  Let α = St such 




=  −𝑘𝑑𝑒𝑔𝑄    ⟹     
𝑑𝑄
𝑄
=  −𝑘𝑑𝑒𝑔𝑑𝛼 
ln|𝑄(𝛼)| =  −𝑘𝑑𝑒𝑔𝛼 + 𝐶0     ⟹     𝑄(𝛼) =  𝐶1𝑒
−𝑘𝑑𝑒𝑔𝛼 
Where we can solve for the initial condition Q(α) = Q0 = [H2O2]iV at α=0 (t=0), 
which reduces to C1 = Q0.  Thus, the governing equation for Q and  [H2O2] with respect 
to our latent variable α is: 
𝑄(𝛼) =  𝑄0𝑒
−𝑘𝑑𝑒𝑔𝛼 
[𝐻2𝑂2](𝛼)𝑉 =  𝑄0𝑒
−𝑘𝑑𝑒𝑔𝛼 = [𝐻2𝑂2]𝑖𝑉𝑒
−𝑘𝑑𝑒𝑔𝛼    
[𝐻2𝑂2](𝛼) = [𝐻2𝑂2]𝑖𝑒
−𝑘𝑑𝑒𝑔𝛼 
This model of simple exponential decay can be used to fit to the parameter kdeg 
from the data obtained from the luminol assay.  As the kdeg is an aggregate value 
 190 
dependent on density and staining, the comparison between kdeg values of different 
samples can only be made within the same assay and relative to a standard. 
A.7.3  Protocol 
Cells were grown and treated in 96-well plates with each row representing a 
different treatment condition in an 8x8 configuration with 4 empty columns.  Each 
treatment was performed with 2 technical replicates in adjacent rows.  The number of 
columns corresponds to the number of time points to be sampled to measure H2O2 





columns of the 96-well plate at specified times.  Following treatment, 50 µl of the 
supernatant was transferred to a 96-well plate and subjected to H2O2 concentration 
measurement via luminol/hypochlorite assay.  A BioTek Synergy 4 plate reader was use 
to automate dispensing of 50 µl of 50 µM luminol to the isolated supernatant, which was 
followed by 5 second of shaking.  Next, 25 µl of 1 mM sodium hypochlorite was 
dispensed into the well and the resultant luminescence measure for 2 seconds.  The cells 
remaining in the 96-well plate for culture were treated with 1 mg/ml Hoechst 33342 for 
30 min at 37˚C.  The cell density was measured by fluorescence with excitation at λ = 
350 nm and absorbance measured at λ = 461 nm.  The H2O2 concentration in each well 
was calculated based on the standard curve.  For each well, the variable α (α = N*t) was 
calculated by multiplying the time of H2O2 incubation with the Hoechst staining value.  
The decay rate for each treatment condition was determined by fitting to a non-linear 
model of one-phase decay in Prism.  H2O2 was fit as a function of the variable α with 
model constraints of shared an initial H2O2 concentration and lower asymptotic limit.  
The relative kdeg values for each treatment condition were determined through division by 
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the kdeg value measured for the untreated condition.  The significance of deviation from 
the initial condition was determined by one-way ANOVA. 
A.7.4  Results 
The H2O2 concentration in each well was calculated based on the standard curve.  
For each well, the variable α (α = N*t) was calculated by multiplying the time of H2O2 
incubation with the Hoechst staining value.  The decay rate for each treatment condition 
was determined by fitting to a non-linear model of one-phase decay in GraphPad Prism.  
H2O2 was fit as a function of the variable α with model constraints of shared an initial 
H2O2 concentration and lower asymptotic limit.  For each replicate, an alternative model 
was tested in which the kdeg values for each condition were shared.  For each replicate, 
the model with independent kdeg values was determined to be the more appropriate 
model, having a greater R
2
.  The relative kdeg values for each treatment condition were 




Table A.6  Overview of Relative kdeg Values and Model Fit Quality.  
Replicate Untreated 1 Day 2 Days 3 Days Goodness of Fit 
1 1 0.736 0.771 0.795 R
2
 = 0.9353 
2 1 0.665 0.937 0.872 R
2
 = 0.9020 
3 1 0.714 0.893 0.673 R
2




A.8  Alternate Mechanisms of Increased GSSG/2GSH Redox Potential 
 
 
Figure A.5  ViCell XR Analysis of A549 Cells Following TGFβ Treatment. 
A)  Cell viability determined by absence of Trypan Blue staining decreased 1% following 
96 hours TGFβ treatment.  B)  Cell circularity was high (>0.8) and not significantly 
affected by TGFβ treatment.  C)  Mean cell diameter decreased following TGFβ 
treatment.  D)  Spherical cell volume was calculated from the measured cell diameters.  
Data are the result of 3 independent biological replicates (n=3) and plotted as mean ± 
standard error of the mean.  Time points differing significantly from the untreated 
control, as determined by one-way ANOVA (** p=0.05), are enclosed within the shaded 
regions.  Note: ANOVA was not performed for cell volume estimates.   
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Figure A.6  GSH/GSSG-Glo Assay GSH Standard Curve. 
Log2 serial dilutions of 16 µM GSH were loaded in each experiment.  A non-linear 
standard curve, using a one-phase association function, was fit and used to calculate total 






Figure A.7  Diminished GSH and GSSG Levels Following TGFβ Treatment. 
Following 48 and 96 hours of 200 pM TGFβ treatment, decreased intracellular A) total 
GSH, B) reduced GSH, and C)  GSSG levels were observed.  Data are the result of 3 
independent biological replicates (n=3) and plotted as mean ± standard error of the mean.  
Time points differing significantly from the untreated control, as determined by one-way 
ANOVA (* p < 0.1), are enclosed within the shaded regions.   
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A.8.1  Confounding by Non-Viable Cells 
GSSG and GSH concentrations were measured from pooled cells, in which some 
degree of non-viable cells will be present.  ViCell XR analysis revealed a slight but 
significant 1% decrease in cell viability in the 96 hour treated condition (97.8% viable) 
compared to the untreated condition (98.8% viable).  Following TGFβ treatment, the 
GSSG/2GSH redox potential increases (Figure 4.6-C).  The GSSG/2GSH redox potential 
of dead and apoptotic cells is known to be higher than live cells (Schafer and Buettner, 
2001).  Therefore, we considered the possibility that TGFβ has no effect on the redox 
potential of live cells but is increasing the overall redox potential though an increased 
proportion of non-viable, high redox potential cells.  We define the unknown redox 
potential of live cells as El and of non-viable cells as En (mV units).  Then we allow the 
overall observed redox potentials to be a function of the proportion of viable and non-
viable cells and their respective redox potentials: 
Untreated Condition:    0.988 ∙ 𝐸𝑙 + 0.012 ∙ 𝐸𝑛 = −238.1 𝑚𝑉 
96 Hour Treated Condition   0.978 ∙ 𝐸𝑙 + 0.022 ∙ 𝐸𝑛 = −231.4 𝑚𝑉 
 
Then solving the two-equation system, we arrive at: 
𝐸𝑙 =  −246.1 𝑚𝑉    𝐸𝑛 = +423.9 𝑚𝑉 
Without prior constraint, we find that El < En, which is consistent with our 
hypothesis.  However, the +424 mV value for the redox potential of non-viable cells 
would indicate that, essentially, 100% of the cellular GSH is bound in GSSG.  Further, 
the redox potential of non-viable cells is reported to be in the -200 to -160 mV range 
(Schafer and Buettner, 2001), which is quite substantially lower than +424 mV.  Thus, 
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the increase in redox potential following TGFβ treatment cannot adequately be explained 
by decreased cell viability and a confounding affect by non-viable cells. 
A.8.2  Effects of Cell Volume on GSH Concentration Calculations 
Accurate measurement of the GSSG/2GSH redox potential relies on absolute, not 
relative, measurements of GSSG and GSH concentrations within the cell of interest.  
Therefore, we sought to determine the effect of cell volume on the calculation of the 
intracellular GSH and GSSG and its subsequent determination of redox potential.  In the 
main scenario, we calculated the intracellular GSSG and GSH concentrations using 
treatment condition-specific volumes (Figure A.5-D), which were used to calculate their 
redox potentials (Figure 4.6-C)  To examine the effect of cell volume, we considered the 
possibility that the cell volume is unaffected by TGFβ and that the cells in all conditions 
have a common cell volume.  Further, we considered the possibilities that this volume 
was our smallest or largest measurements, 2.3 and 2.8 pl.  In the small volume scenario, 
the 96 hour condition redox state is unaffected while the redox state of the untreated and 
48 hour treated condition decrease compared to the main scenario (Figure A.8-A; Figure 
4.6-C).  Alternately, when using the largest volume for calculations, the redox potential 
of the untreated condition remains unaffected while the redox potential of the 48 and 96 
hour treated conditions increase compared to the main scenario (Figure A.8-B; Figure 
4.6-C).  In each of these alternative scenarios, the difference of redox potential between 
the untreated and 96-hour treated condition increased from +6.5 mV to ~ +9mV.  
Therefore, our use of treatment condition specific cell volumes to calculate intracellular 
GSSG and GSH reflects the most conservative estimate of the increase in GSSG/2GSH 







Figure A.8  Alternate Volumes in Calculations of GSSG/2GSH Redox Potential. 
A)  Redox potentials using the smallest measured cell volume (2.3 pl) for GSSG and 
GSH concentration calculations.  B)  Redox potentials using the largest measured cell 
volume (2.8 pl) for GSSG and GSH concentration calculations.  Data are the result of 3 
independent biological replicates (n=3) and plotted as mean ± standard error of the mean.  
Time points differing significantly as determined by one-way ANOVA (** p=0.05). 
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A.9  Aggregated Data PCA Models 
A.9.1  Aggregated Data Model Quality 
To obtain the aggregated data matrix, each of the data sets were prepared and then 
merged into a full aggregated set.  For each time point, replicate measurements were 
averaged.  Data was derived from the microarray, ICW time course of EMT, CM-
H2DCF-DA, H2O2 degradation, and GSSG/2GSH redox couple assays (Figure 4.7).  
Microarray transcripts of interest were retained while the majority of data were culled.  
Transcripts of interest were those that had previously been reported in the context of ROS 
production and degradation as well as the regulation of the GSSG/2GSH redox couple.  
Within SIMCA-P+, each of variable sets was prepared in a similar manner as previously.  
Microarray, ICW, CM-H2DCF-DA, and H2O2 degradation data were entered as fold-
change values and the GSH/GSSG values were entered as concentration and potential 
values.  The data were mean-centered and unit-variance scaled.  Due to the nature of data 
aggregation, technical replicates are not consistent from one experimental modality to 
another.  By averaging technical replicates for each time point, we sacrifice potentially 
informative inter-assay variability for the ability to evaluate the relationships present in 









Table A.7  Aggregated Data PCA Quality Metrics. 









cum CV Sig. 
Component 1 2.86 0.573 0.573 -0.026 0.1 R2 
Component 2 1.77 0.354 0.927 0.573 0.530 R1 
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A.9.2  ICW, Microarray, and CM-H2DCF-DA Aggregated Data Model 
We constructed a model consisting of microarray transcript expression, ICW 
protein expression, and CM-H2DCF-DA oxidation data during the time course of EMT 
(Figure A.10).  Similar to the model presented in Figure 4.7, this model is populated with 
time-point averaged data.  Notably, the overall relationships between variables in the 
ICW and microarray transcript expression are maintained.  The correlation between pairs 
from ICW and microarray studies is an apparent feature.  This is further detailed below 
(Figure A.11).  Additionally, the expression of SNAI1 (Snail) is correlated with pSmad3 




Table A.8  ICW, Microarray, and CM-H2DCF-DA Aggregated Data PCA Quality. 
Overview of quality metrics for the EMT time course PCA model with ICW, microarray, 









cum CV Sig. 
Component 1 5.84 0.649 0.649 0.441 0.441 R1 






Figure A.10  Overview of ICW, Microarray, and CM-H2DCF-DA Aggregated PCA . 
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A.9.3  Paired ICW & Microarray Data PCA Model.  
Data from the full aggregated data model were used.  All variables were then 






Table A.9  Paired ICW & Microarray Data PCA Quality. 










cum CV Sig. 
Component 1 6.01 0.668 0.668 0.288 0.288 R1 




Figure A.11  Overview of Paired ICW & Microarray Data PCA . 
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A.10  EMT & Antioxidant/TGFβ Inhibitor Intervention PCA Model 
PCA of ICW expression data, shown in Figure 4.9, consisted of 10 treatment 
conditions assessed with 10 response variables (Slug was excluded due to poor fitting).  
The resultant model was fit by 2 PCs (R
2







Table A.10  EMT & Antioxidant Data PCA Quality. 










cum CV Sig. 
Component 1 4.2 0.417 0.417 0.131 0.131 R1 
















APPENDIX B  SUPPLEMENTARY DATA AND ADDITIONAL 
ANALYSES ON THE INVESTIGATIONS OF THE KINETIC 









Figure B.1  Multicolor Flow Cytometry Analysis of Surface Marker Staining 
Representative density scatter plots of staining of A549 cells maintained in culture for 4 
days with 0, 1, 10, and 100 pM TGFβ treatment (rows).  Columns correspond to the 
pairwise plots of PE, PE-Texas Red, and APC detection channels with compensated 
arbitrary fluorescence units.  Surface markers were stained with anti-PE-CF594/E-
Cadherin (PE-Texas Red Channel), PE/N-Cadherin (PE Channel), and APC/ABCG2 
(APC Channel), antibodies and cells counter-stained with SYTOX Blue to exclude dead 
cells.  Density plots correspond to summary of geometric means displayed in Figure 5.3-
A & B.   
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B.2  Multilinear Modeling of Hoechst Score Statistics & %SP 
B.2.1  Multilinear Model Formulation 
Numerous Hoechst Score metrics were observed to differ between +FTC and -
FTC conditions in proportion to the associated SP size (Figure 5.5-C).  Differences in 
each of the metrics is correlated with %SP and can stratify the SP time course data in a 
manner that is consistent with the observed trends using manual gating to measure %SP 
(Figure 5.4-A, B.2).  We hypothesized that a multiliner model containing a combination 
of the metrics may provide a means to objectively estimate the %SP in a given sample.  
We constructed 6 models, consisting of different combinations of metrics and evaluated 
them for their quality using SP time course data for training (Table B.1).  The optimal 
model under these conditions was Model 3, consisting of ∆HRS, ∆HBS, and ∆HSC 
Hoechst metrics.  The model fit the %SP with little residual error (Figure B.3-A) and 
stratified time course data well (Figure B.3-B). 
B.2.1.1  General Model for % SP Estimation: 
𝑦 = 𝑏0 + 𝑏1∆𝐻𝑅𝑆 + 𝑏2∆𝐻𝐵𝑆 + 𝑏3∆𝐻𝑅𝑆𝑆𝐷 + 𝑏4∆𝐻𝐵𝑆𝑆𝐷 + 𝑏5∆𝐻𝑆𝐶 
𝑦 :   % SP predicted by multilinear model (%SPMLE) 
∆𝐻𝑅𝑆 :  Change in Hoechst Red Score Mean 
∆𝐻𝐵𝑆 :  Change in Hoechst Blue Score Mean 
∆𝐻𝑅𝑆𝑆𝐷 :  Change in Hoechst Red Score Standard Deviation 
∆𝐻𝐵𝑆𝑆𝐷 :  Change in Hoechst Blue Score Standard Deviation 
∆𝐻𝑆𝐶 :   Change in Hoechst Score Covariance 
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B.2.2  Model Evaluation & Selection 
Models were scored on several criteria.  The F-value for each of the models was 
much greater than the F-crit level, accordingly, the p-values were very small.  The 
models exhibited a range of R
2
 values, though most fit the data very well.  Finally, the 
residual sum of squares (RSS) values were used to compute relative differences in the 
AICc values for the model.  AICc scores a model’s ability to fit data accurately and 
efficiently, incorporating both the quality of the model fit (RSS) and the complexity of 
the model (k) into its score.  These results indicate that Model 3 is the most appropriate 
model (Table B.1). 
B.2.2.1  AICc Equation 
AICc is used when the ratio of observations to model parameters is low.  It 
prevents overestimation of model quality for small n conditions.  It may also be used in 
general as the additional term converges to 0 as n becomes large. 
𝐴𝐼𝐶𝑐 = 𝑘 + 𝑛 (ln (
2𝜋𝑅𝑆𝑆
𝑛 − 𝑘
) + 1) +
2𝑘(𝑘 + 1)









Figure B.2  Trends of Differences in Hoechst Score Statistics by Time in Culture. 
The difference between Hoechst Score statistics (X) are plotted against culture 
conditions and are determined by X = X-FTC - X+FTC where A) HRSmean=change in 
Hoechst Red Score mean, B) HRSSD=change in Hoechst Red Score standard deviation, 
C) HSC=change in Hoechst Red & Blue Score covariance, D) HBSmean=change in 
Hoechst Blue Score mean, E) HBSSD=change in Hoechst Red Score standard deviation, 







Figure B.3  Multilinear Model Estimation of %SP Using Hoechst Statistics. 
A multilinear model (Model 3) consisting of HRSmean, HBSmean, & HSC x-variables 
was constructed by regression against the y variable %SP.  The model was trained using 
the %SP time course data (Figure 5.4-A).  A)  The multilinear model measurement for 
each data point (%SPMLE) is plotted against its corresponding %SP measured by manual 
gating approaches.  The plotted line corresponds to perfect concordance between manual 
gating and multilinear estimate approaches.  B)  The results of the SP time course 




Table B.1  Overview of Multilinear Models & Fit. 
Coefficients are the result of multilinear regression using changes in Hoechst statistics to 
estimate %SP.  Data from the time course experiment (Figure 5.4-A) were used to train 
the model.  The quality of multilinear model estimation of %SP (%SPMLE) compared to 
the %SP measured by manual gating is displayed in terms of R
2
 and RSS.  The models 
were compared to each other in terms of complexity and quality with their ∆AICc values.  
Additional metrics of multilinear model quality can be found in Table B.2. 
Model 
Coefficients 
(𝑏𝑖 = 0 unless otherwise indicated) 
R
2
 RSS ∆AICc 
1 
𝑏0 = 0.004,    𝑏1 = −9.36,   𝑏2 = −17.3, 
 𝑏3 = −0.139,   𝑏4 = 3.24, 𝑏5 = 13.6 
0.951 119.9 5.72 
2 
𝑏0 = −0.271,    𝑏1 = −8.73, 𝑏2 = −19.5,
𝑏3 = 9.36, 𝑏4 = 20.4 
0.950 121.0 3.11 
3 
𝑏0 = 0.0238, 𝑏1 = −9.95,
𝑏2 = −16.3,   𝑏5 = 15.3 
0.951 199.9 0 
4 
𝑏0 = 4.79, 𝑏3 = −112, 𝑏4 = −161,
𝑏5 = 163 
0.813 453.4 51.8 
5 𝑏0 = 0.127, 𝑏1 = −7.21, 𝑏2 = −30.8 0.877 297.4 32.8 




Table B.2  Extended Overview of Multilinear Model Quality Results. 
Model k F-value (crit) p-value R
2
 RSS ∆AICc 
1 6 126 (3.3) 1.5E-20 0.951 119.9 5.72 
2 5 162 (3.6) 1.7E-21 0.950 121.0 3.11 
3 4 225 (3.9) 6.7E-23 0.951 199.9 0 
4 4 51 (3.9) 7.9E-13 0.813 453.4 51.8 
5 3 129 (4.4) 3.9E-17 0.877 297.4 32.8 
6 3 37 (4.4) 1.9E-9 0.672 794.1 71.1 
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B.3  Hoechst Score PDF Calculation of ∆FTC & ∆SP 
 
Figure B.4  Overview of FTC & SP Calculations & Day 4 Plots. 
A) FTC plots are generated by subtracting the PDF+FTC distribution from the PDF-FTC 
distribution.  The example shown is the formation of the Day 4 0 pM TGFβ (control) 
condition (green box) from the difference of the average PDF-FTC and PDF+FTC 
distributions from 3 experimental replicates.  Red regions of the ∆FTC plot correspond to 
regions that have higher density in the -FTC condition while blue regions have density in 
the +FTC condition.  B)  The SP plot for a given sample is generated by subtracting the 
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∆FTC distribution of the control sample (∆FTCctrl, green box) from the ∆FTC distribution 
for the sample, (∆FTCD4-1pM, purple box), which gives rise to the ∆SP (∆SPD4-1pM, orange 
box).  Red regions of the ∆SP plot correspond to regions with higher density in the 
sample condition while blue regions have higher density in the control condition.  C)  The 
∆FTC and ∆SP plots are displayed for the Day 4 samples in the SP time course 
experiment.  The %SPproj is reported for each sample. 
  
 215 
B.4  Single-Cell Clones Regenerate Side & Non-Side Populations 
A549 cells were stained with anti-ABCG2 antibody and sorted by high and low-
ABCG2 expression into individual wells of a 96-well plate (Figure B.6-A).  The cells 
were then expanded in culture before being prepared for side population analysis.  
Colonies from both high and low-ABCG2 expressing cells we found to exhibit side and 
non-side population cells (Figure B.6-B).  The size of the SP was measure with both 
manual gating approaches and multilinear model estimation of %SP using Hoechst Score 





Figure B.5  SP & NSP Cells Arrise from Single-Cell A549 Clonal Cell Lines. 
A)  Schematic of the isolation and expansion of low- and high-ABCG2 expressing clonal 
cell lines from the parent A549 cell line prior to SP analysis.  B)  Manual and multilinear 
model measurement of %SP in expanded low- and high-ABCG2 expressing clonal cell 
lines following expansion in culture for 30 days.  C)  Comparison of manual and 
multilinear model measurement of %SP in expanded low- and high-ABCG2 expressing 
clonal cell lines.  The plotted line corresponds to perfect concordance between manual 
and multilinear model measurement.   
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B.5  Multiscale Ensemble Modeling of SP Kinetics 






Figure B.6  ABCG2 and Hoechst Binding Site Distributions 
A)  ABCG2 surface marker staining data from flow-cytometry studies (Figure 5.3-B, 
n=3) converted into PDFs of ABCG2 expression in A549 cells.  Expression levels were 
normalized to the mode of the control condition.  B)  Distribution of Hoechst binding 
sites available in each cell, estimated from the averaged Hoechst Blue distribution from 
all of the +FTC conditions, the genomic DNA content of A549 cells, and Hoechst 










Figure B.7  Whole Cell & Nuclear Radii Distributions of A549 Cells 
A) 2D PDF of Flow Sight imaging cytometry measurements of whole cell and nuclear 
radii using Hoechst stained cells with FTC.  B) 2D Distribution of nuclear radius to 
whole cell radius ratios plotted against whole cell and nuclear radii.  C)  Sampling of N 
cells from a 2D PDF of whole cell and nuclear radii (A) reconstructed as a 2D PDF. 
  
 218 
B.5.2  In silico Flow Cytometry Considerations 
Most flow cytometric techniques aim to isolate the signal from an individual 
fluorophore to a single detection channel.  The SP assay, however, relies on spectral 
spillover of the Hoechst emission into two detectors, Hoechst Red and Hoechst Blue.  
Inherent spectral differences in DNA-bound (𝐻𝑏) and non-DNA-bound/free (𝐻𝑓)  
Hoechst dyes would indicate that the two forms of Hoechst can influence the detected 
signal in each of these channels (Figure B.9-C).  For example, the quantum yield of 
DNA-bound Hoechst (0.38) is roughly 10-fold larger than that of free Hoechst (0.034). 
(Cosa et al., 2001)  This indicates that it more readily is induced to emit fluorescent light 
upon excitation.  Further, the excitation/emission maxima of Hoechst in the DNA-bound 
form differs from the free form. (Cosa et al., 2001)  The differences in emission spectra 
result in differential emission contributions to each of the detection channels (Figure B.9-
D).  In this schema, a number of factors influence the magnitude of the Hoechst Red and 
Blue emission signals.  Nonetheless, it is a somewhat constrained system in that the 
Hoechst Red signal is composed of emission from both DNA-bound and free Hoechst 
and the Hoechst Blue signal is composed of emission from both. 
Formation of Hoechst signals is based upon the quantities of DNA-bound and free 
Hoechst species within the cell, the spectral properties of the Hoechst species, and the 
spectral properties of the simulated flow cytometer used to excite and measure Hoechst 
fluorescence.  Hoechst Red signal (𝐻𝑅𝑠𝑖𝑔) is the sum of the emission from DNA-bound 
(𝐻𝑏)  Hoechst in the Hoechst Red channel and from free Hoechst (𝐻𝑓) in the Red 
Channel.  The emission from 𝐻𝑏 in the Hoechst Red channel is proportional to its 
excitability (quantum yield, 𝑄𝑏), relative excitation efficiency (𝐸𝑏), the area of spectral 
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emission overlap with the Hoechst Red channel (𝑅𝑏), and the amount of 𝐻𝑏.  Likewise, 
The emission from 𝐻𝑓 in the Hoechst Red channel is proportional to its corresponding 
𝑄𝑓, 𝐸𝑓, 𝑅𝑓, and 𝐻𝑓.  Signal for the Hoechst Blue channel can be similarly constructed. 
𝐻𝑅𝑠𝑖𝑔 = 𝑄𝑏𝐸𝑏𝑅𝑏𝐻𝑏 + 𝑄𝑓𝐸𝑓𝑅𝑓𝐻𝑓 
𝐻𝐵𝑠𝑖𝑔 = 𝑄𝑏𝐸𝑏𝐵𝑏𝐻𝑏 + 𝑄𝑓𝐸𝑓𝐵𝑓𝐻𝑓 
We are then able to modify the representation of this to obtain the linear 
























] = 𝑆 
The Hoechst Red and Blue signals resulting from linear transformation with the 
signal matrix are arbitrary in that the units do not have a specific meaning.  Nonetheless, 
within a range of Hoechst signals produced under the same circumstances, differences in 
magnitude reflect differences in the quantities of Hoechst dyes used to generate them.  
Therefore, the Hoechst signals can be used to compare staining within populations.  
Similarly, with identical conditions, comparisons can be made across populations.  
Conversion of Hoechst signals into Scores is an approach to make measured changes in 




Figure B.8  Schematics of Kinetic Modeling & In silico Flow Cytometry 
A)  Hoechst staining dynamics were simulated at the single-cell level with each cell 
represented by a set of ODEs governed by mass-action kinetics in a well-mixed three-
compartment system.  The species, compartments, and reactions are depicted.  Each cell 
differs from the rest of the population in terms of volumes, surface areas, and transporter 
levels.  Within a given population, all of the cells share a set of kinetic parameters (k) in 
common.  B)  At the completion of the kinetic simulations, the total quantity of free and 
DNA-bound Hoechst dye species are added up within within an individual cell.  The free 
and DNA-bound dyes are converted to Hoechst Red and Blue signals according to their 
spectral properties.  C).  Excitation and emission spectra for free and DNA-bound 
Hoechst species displayed along side Hoechst Red and Blue channels within our 
cytometer configuration and modeled in silico.  Also shown is the excitation laser 
wavelength (355 nm).  D)  Signals from the Hoechst Blue and Hoechst Red channels are 
products of emission from both free and DNA-bound Hoechst, though relative efficiency 









Table B.3  Spectral Quantities for In silico Flow Cytometry Signal Transformation 
















Quantum Yield 𝑄𝑏 0.34 
Excitation Efficiency 𝐸𝑏 0.9902 
Hoechst Red Emission 𝑅𝑏 29.86 










Quantum Yield 𝑄𝑓 0.038 
Excitation Efficiency 𝐸𝑏 0.6764 
Hoechst Red Emission 𝑅𝑓 464.2 
Hoechst Blue Emission 𝐵𝑓 1914 
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B.5.3  Preliminary Hoechst Staining Model Considerations 
 
Figure B.9  Preliminary Considerations in the Modeling of Hoecsht Staining 
A)  Simulated Hoesht staining for a population of single-cells were used to find a mean 
staining signal for 5 and 10 µM Hoechst concentrations.  The relative kinetics of the two 
conditions to the 5 µM condition were compared to similarly normalized experimental 
data.  Staining took place in the presence of FTC to inhibit any transporter mediated 
efflux.  B)  Simulation of Hoechst Red/Blue Signals in stained permeabilized cells 
against data published by Smith, et al. (Figure 3a, [fuinsREF Smith paper])  Membrane 
transport was increased by a factor of 10
3
 to simulate increased rates of transport in the 
presence of permeabilized membranes.  C)  The simple models were compared over a 
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range of parameter sets, assigned vis LHS, and scored according to their relative fit in 
both time course staining (A) and ratiometric staining (B).  The relative error from the 
two objectives were combined into an overall 
2
 fit score.  D)  One model consisted of 
simple transport and DNA-binding kinetics.  The simple and non-specific binding model 
incorporated an element of non-specific binding and included additional terms for non-
specific association/dissociation as well as non-specific mass.  E)  The scores from best 











Figure B.10  Simulation Results by Model of Parameter Outcomes and %SP Fit. 
Each of the models was seeded with M=10,000 kinetic parameter sets.  A)  By model, the 
percent of sets having been fully simulated or aborted is shown.  Additionally, of the sets 
that finished, the percent of sets failing or passing qualitative selection is shown.  B)  






Figure B.11  Distributions of Parameters from SP-Ensembles vs Sampled 
Sets of kinetic parameters were assigned using LHS of Log10-uniform distributions 
(blue).  The parameter distributions from ensembles demonstrating SP responses (red) are 
a subset of the total sampled distribution.  Shown are histograms from the lower to upper 




B.5.5  Single-Cell SP Response Distributions 
 




Figure B.13  In silico Single-Cell Analyis of SP Responses of Full Response Type.   
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B.5.6  Single-Cell SP Response Distribution Analysis 
 
Figure B.14  SP Response Distribution Landscape. 
Distributions of SP response (-∆Hproj) in individual cells within the populations of 
ensembles meeting SP selection criteria were characterize by standardized skewness and 
bimodality.  Simply put, skewness measures the degree of asymmetry of a distribution 
around the mean with a value of 0 corresponding to symmetry and positive values 
corresponding to distributions with larger ranges in the distribution above the mean.  
Likewise, negative skew values correspond to distributions with a larger range in the 
distribution below the mean than above it.  The bimodality coefficient is calculated from 
the standardized skewness and standardized kurtosis.  It has a range from 0 to 1, in which 
a value of 0 reflects a distribution with a single value while 1 corresponds to a 
distribution with exactly two values.  Distribitions with two fairly distinct modes score 
closer to 1 while distributions with a singular mode with a higher frequency score closer 
to 0.  The mappings of a wide variety of example distributions are depicted along with 
representations of the range single-cell SP responses in an example cell population.  









Figure B.15  %SP Fit by Ensemble vs Skewness and Bimodality Coefficient. 
The %SP fit score (RMSE) of each ensemble demonstrating a SP response and having a 
RMSE > 0 is plotted against the standard skewness (A) and bimodality coefficient (B) of 
the single-cell SP response distribution.  Values are from Model 1 (blue), Model 2 (red), 
and Model 3 (green).  Larger data points with black outlines represent the averages from 
each of the models.   
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Figure B.16  Flow Sight ABCG2 Staining & SP Plots of Control and tBHQ Samples. 
A549 cells were treated with 50 µM tBHQ for 48 hours and analyzed using a FlowSight 
imaging cytometer.  A)  Samples were stained with an anti-ABCG2 antibody labeled with 
APC.  B)  Samples were prepared for a SP assay and Hoechst Red and Blue signals 
measured.  %SP using manual gating approach is displayed.  C)  Representative plots of 
Hoechst Red and Blue channels are shown.  Both ABCG2 and SP experiments were 
performed in triplicate with dead cells excluded from analysis by positive staining of 






Figure B.17  Hoechst Staining Distributions of Control & tBHQ-Treated Samples. 
2D PDFs of cell populations in control and tBHQ-treated samples for +FTC (PDF+FTC) 
and -FTC (PDF-FTC) conditions, corresponding to flow cytometry data in Figure B.16.  A)  
Control +FTC condition.  B)  Control -FTC condition.  C) tBHQ-treated +FTC condition.  
D) tBHQ-treated -FTC condition.  Units of the Hoechst Scores are in terms of standard 
deviations from the mean.  Colormap density values are normalized to a common 
maximum frequency across the 4 conditions.  
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B.7  Hoechst N/C Ratio & DNA-Bound/Free Hoechst Analysis 
B.7.1  Theoretical Approach 
Fluorescence signals in biological assays are used as reporters of biological 
processes or species of interest.  The fluorescence emissions in such settings are often 
only interpretable in arbitrary units.  Relative deviations are meaningful in context but 
without some sort of reference, the signals are indeed arbitrary.  A defining feature of the 
SP assay is the use of a single fluorescent reporter with variable spectral properties that is 
measured in multiple detection channels.  In our implementation of in silico flow 
cytometry, we utilize these spectral properties to construct representations of Hoechst 
Red and Blue signals.  Here we will extend that process with a spatial component, 
considering nuclear and cytosolic Hoechst Red and Blue signals.  Flow cytometry is 
incapable of producing spatial data such as this.  Our use of imaging cytometry has 
provided us a unique means to interrogate Hoechst staining within the cell.  Imaging 
cytometry images of Hoechst stained cells from SP assays were segmented into nuclear 
and cytosolic spatial components and the Hoechst Red and Hoechst Blue signals 
extracted for each cellular compartment. 
Consider the Hoechst Red signal for a given cell.  The Hoechst Red signal can be 
decomposed as the sum of Hoechst Red signal from the nucleus (𝐻𝑅𝑛) and cytosol (𝐻𝑅𝑐) 
𝐻𝑅𝑡𝑜𝑡𝑎𝑙 = 𝐻𝑅𝑛 + 𝐻𝑅𝑐 
𝐻𝐵𝑡𝑜𝑡𝑎𝑙 = 𝐻𝐵𝑛 + 𝐻𝐵𝑐 
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The nuclear and cytosolic Hoechst Red and Blue signals are, analogous to the 
whole cell, derived from the quantities of DNA-bound (𝐻𝑏) and free (𝐻𝑓) Hoechst dye in 
the nucleus and cytosol. 
𝐻𝑅𝑛 = 𝑠11𝐻𝑏𝑛 + 𝑠12𝐻𝑓𝑛 
𝐻𝐵𝑛 = 𝑠21𝐻𝑏𝑛 + 𝑠22𝐻𝑓𝑛 
𝐻𝑅𝑐 = 𝑠11𝐻𝑏𝑐 + 𝑠12𝐻𝑓𝑐 
𝐻𝐵𝑐 = 𝑠21𝐻𝑏𝑐 + 𝑠22𝐻𝑓𝑐 
However, we assume that any DNA in the cytosol is negligible and set 𝐻𝑏𝑐 = 0 
𝐻𝑅𝑛 = 𝑠11𝐻𝑏𝑛 + 𝑠12𝐻𝑓𝑛 
𝐻𝐵𝑛 = 𝑠21𝐻𝑏𝑛 + 𝑠22𝐻𝑓𝑛 
𝐻𝑅𝑐 = 𝑠12𝐻𝑓𝑐 
𝐻𝐵𝑐 = 𝑠22𝐻𝑓𝑐 









These ratios are, mostly, interpretable because Hoechst Red and Hoechst Blue 
signals are obtained on independent channels, which are therefore subject to independent 
scaling.  We assume linear scaling 𝛽𝑅 and 𝛽𝐵 for the Hoechst Red and Blue channels. 
𝐻𝑅 = 𝛽𝑅(𝑠11𝐻𝑏 + 𝑠12𝐻𝑓) 
𝐻𝐵 = 𝛽𝐵(𝑠21𝐻𝑏 + 𝑠22𝐻𝑓) 
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Then, for each of the nuclear and cytosolic components we have: 
𝐻𝑅𝑛 = 𝛽𝑅(𝑠11𝐻𝑏𝑛 + 𝑠12𝐻𝑓𝑛) 
𝐻𝐵𝑛 = 𝛽𝐵(𝑠21𝐻𝑏𝑛 + 𝑠22𝐻𝑓𝑛) 
𝐻𝑅𝑐 = 𝛽𝑅𝑠12𝐻𝑓𝑐 
𝐻𝐵𝑐 = 𝛽𝐵𝑠22𝐻𝑓𝑐 





which simplifies to:  











where the ratio of signals from within the same channel cancels out the scaling 
factors 𝛽𝑅 and 𝛽𝐵, in effect normalizing the ratio.  Thus, we arrive at:  






where the 𝐻𝑓𝑐 term is eliminated, yielding  




















) 𝐻𝑏𝑛 = (1 − 𝑅𝑁/𝐶)𝐻𝑓𝑛 
finally arriving at: 
𝐻𝑏𝑛
𝐻𝑓𝑛











Therefore, in measuring nuclear and cytosolic Hoechst Red and Blue signals, the 
auto-normalized expression 𝑅𝑁/𝐶 can be calculated.  If the information expressed within 
the signal transformation matrix 𝑆 is known, then 𝑅𝑁/𝐶 and 𝑆 can be used to calculate the 





Table B.4  Quantities for In silico Imaging Cytometry Signal Transformation 
















Quantum Yield 𝑄𝑏 0.34 
Excitation Efficiency 𝐸𝑏 0.03463 
Hoechst Red Emission 𝑅𝑏 38.17 










Quantum Yield 𝑄𝑓 0.038 
Excitation Efficiency 𝐸𝑏 0.01176 
Hoechst Red Emission 𝑅𝑓 571.1 
Hoechst Blue Emission 𝐵𝑓 4573 
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B.7.2  Free Hoecsht in Excess of DNA-Bound Hoechst in the Nucleus 
The combination of dual Hoechst signal sources and spatial staining information 
presents a unique opportunity to measure relative Hoechst concentrations in the nucleus.  
Because Hoechst Red and Blue signals arise from both free and bound Hoechst dye, 
neither Hoechst Red nor Blue signals can be directly ascribed to represent Hoechst 
concentration.  Using the basis for our in silico flow cytometry signals, we are able to 
calculate a Hoechst N/C Ratio, which is the ratio of Hoechst Blue to Hoechst Red signal 
in the nucleus divided by the ratio of Hoechst Blue to Hoechst Red signal in the cytosol.  
Using this ratio, the relative concentration of DNA-bound Hoechst compared to free 
Hoechst in the cytosol can be measured.  In the computational model of Hoechst staining, 
the distribution of DNA-bound to free nuclear Hoechst is quite large, but with a 
maximum frequency in the range of 0.01 to 0.1 (-2 to -1 in Log10 units), indicating a 
relative free Hoechst concentration in excess of DNA-bound Hoechst on the order of 10 
to 100-fold (Figure B.18-A).  
Imaging cytometry single-cell images were segmented into cytosolic and nuclear 
spatial components, for which Hoechst Red and Blue signals were measured.  The 
cytosolic and nuclear Hoechst signals were then used to calculate a Hoechst N/C ratio for 
each individual cell.  Hoechst N/C ratios were then used to calculate the relative ratio of 
DNA-bound to free Hoechst in the nucleus (Figure B.18-B).  The Hoechst N/C ratio was 
measured to be ~ (~2.8 in Log10 units), indicating that the relative Hoechst Blue to 
Hoechst Red signal in the nucleus is larger than that of the cytosol.  This corresponds to a 
ratio of DNA-bound to free Hoechst in the nucleus of ~0.06 (~ -1.25 in Log10 units).  
Therefore, the apparent relative ratio of DNA-bound to free nuclear Hoechst measured 
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via imaging cytometry fell within the most frequently range of ratios generated by SP-
generating ensembles in our Hoechst staining simulations.  
The Hoechst N/C ratio is significant in that it is dimensionless and eliminates the 
arbitrariness associated with fluorescent signals.  Occurs due to the formulation of the 
ratio in which the ratios of Hoechst Red and Hoechst Blue signals in the nucleus and 
cytosol are normalized to each other.  Based on this composition, the Hoechst N/C ratio 
cancels out any factors that might influence scaling signals and instead the ratio is itself 
meaningful.  The ratio, being greater than 1, indicates that the ratio of Hoechst Blue to 
Red in the nucleus is larger than that of the cytosol.  This supports the assumption in the 
construction of our computational model that spectral differences in DNA-bound and free 
Hoechst dyes contribute to the formation of Hoechst Red and Blue signals differentially.  
Our modeling approach is further validated by the observation of a ratio of DNA-bound 
to free Hoechst within the highest frequency range produced by the computational model.  
Notably, the model was not trained or optimized towards achieving such a ratio.  In 
contrast, the ensembles from the model that produced SP behavior most frequently 
possessed a ratio in the range that was observed experimentally.  The agreement between 
this experimentally observed ratio and our model, for which the model was not explicitly 









Figure B.18  Nuclear/Cytosolic Signal Ratios Estimate Nuclear Dye Concentrations. 
A)  Histogram of Log10 ratio of DNA-Bound to free Hoechst in the nucleus from 
ensembles demonstrating a SP response.  B)  Imaging cytometry images were used to 
measure the Hoechst Red and Blue signals in the cytosol and nucleus.  The values were 
used to calculate a dimensionless Hoechst signal ratio.  The dimensionless ratio, the 
spectral properties of Hoechst, and the spectral properties of the imaging cytometer were 
used to estimate the relative concentrations of free and DNA-bound Hoechst in the 
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